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Abstract 
Plasmodiumfalciparum, a protozoan parasite, causes more than 500 million clinical 
cases of malaria every year. It is a disease that is on the increase due to factors such 
as drug resistance and political instability in affected regions. Although differences 
in virulence between P. falciparum strains were described more than sixty years ago, 
how parasite virulence factors may contribute to the development of severe malaria 
has been largely neglected in malaria research and is not well understood. In this 
thesis I describe my work on potential Plasmodium falciparum virulence factors 
related to parasite invasion and multiplication during the asexual blood stage of 
infection. 
Parasite multiplication rates and red blood cell (RBC) selectivity of Thai field 
isolates have previously been shown to be associated with severe malaria. In 
contrast, I found that clinical isolates from Malian and Kenyan children diagnosed 
with uncomplicated or severe malaria did not differ in their multiplication rates or 
RBC selectivity. Furthermore I show an unexpected finding that isolates from 
hyperparasitaemic children had significantly lower multiplication rates than isolates 
from children with uncomplicated malaria. These results raise the possibility of 
differences in malaria virulence factors between sub-Saharan Africa and Asia. 
I investigated RBC selectivity as a potential virulence factor further in a rodent 
malaria model using Plasmodium chabaudi. The experimental design allowed me to 
look at the selectivity index in congenic lines, which significantly differed in their 
virulence to the host. Supporting my P. falciparum data, no association between the 
selectivity index and virulence was seen. This is the first description of the selectivity 
index in P. chabaudi and RBC invasion was found to be very unselective as expected 
for a malaria parasite which does not exhibit a reticulocyte preference. 
The Kenyan field isolates were also typed for their RBC invasion pathway profile by 
measuring their invasion into enzyme-treated RBC. Although invasion profiles of 
field isolates have been reported previously, as far as I am aware, this is the first 
report looking at invasion profiles of field isolates in relation to disease severity. In 
line with previous results, field isolates invade RBC by multiple invasion pathways. 
No difference between the invasion profiles of isolates from uncomplicated or severe 
malaria patients was seen. 
Finally, I looked at rosetting, another potential virulence factor, in laboratory strains 
to examine its possible role in enhancing parasite invasion and evading host 
immunity. I found that isogenic rosetting and non-rosetting parasites were inhibited 
to the same degree by invasion-inhibitory antibodies, indicating that rosetting does 
not enhance invasion in the presence of host immunity. 
Overall my thesis presents a detailed study of potential P. falciparum virulence 
factors related to invasion, working both with clinical isolates and laboratory strains. 
Severe malaria in Africa was not found to be associated with parasite multiplication 
rates, RBC selectivity or specific invasion pathways. Other virulence factors such as 
rosetting and platelet-mediated clumping may be of major importance in this region. 
This work suggests the possibility of differences in malaria virulence factors between 
sub-Saharan Africa and Asia, which may need to be taken into consideration for drug 
and vaccine design. 
11 
Acknowledgements 
I would like to thank the Wellcome Trust for funding this PhD project and those who 
organised it. In particular Margaret Heck, who does an excellent job organising 
symposia and alternative career events for the Wellcome students. 
In Kilifi, Kenya, I was impressed by how I was made to feel very welcome despite 
the large number of visiting scientists they have to cope with each year. So a big 
thank you goes to Kevin Marsh, Brett Lowe, Moses, Mohammed, Barnes, Liz, 
Oscar, Helen, Lucy, Rachel, Cleo, Emma and Francis, only a few of all the lovely 
people in Kenya. Thank you to Susana Nery and to Britta Urban, who I worked 
alongside in Kilifi and who made some frozen isolates available to me. Back in 
Edinburgh, I have enjoyed working with Helen and Jean-Philippe in my laboratory. I 
would like to thank Ian, for his friendship and input. Billy in stores, Jayne in 
accounts and Carole in the general office have all been great sorting out the more 
administrative parts of the PhD. Thank you to Ahmed for showing me all I needed to 
know about culturing Plasmodiumfalciparum and travelling all the way to Kenya to 
help me collect field isolates. Sally was a fantastic colleague and brightened up many 
a day. Thank you to Margaret Mackinnon for providing me with advice when I was 
trying to get my head around statistics, but she also helped make my stay in Kilifi 
pleasant, teaching me to sail and taking me to the Boatyard for weekend lunches. 
I am grateful to my supervisor Alex Rowe, without her none of this would have been 
possible. She provided endless support and friendly encouragement. I also want to 
thank Alex for giving me the opportunity to work in Kenya, which was a unique 
experience. 
I would like to thank Lucy for many a coffee and walk on the beach. I am grateful to 
Tine, who supported me throughout with encouragement and by introducing me to 
the joys of an Islay Whisky by a fire in a bothy. I would also like to thank Colleen, 
iv 
Hanne, Catriona and Anja, who have been great friends. And a special thanks to 
Katrin in Germany. 
My family has been incredible by believing in me that I can do this and always 
supporting me. So thanks to: Mum, for simply always being there and providing a 
home to come back to; Mike for all your support and interest in my work; Katherine, 
for the weeks you spoilt me with your lovely cooking and Tina for all your support 
and keeping my music collection full of great tracks. 




ANOVA analysis of variance 
CR1 complement receptor 1 
cRPMI complete RPMI 
CT chymotrypsin 
DBL Duffy-like binding domain 
EBP erythrocyte binding protein 
GPA Glycophorin A 
GPB Glycophorin B 
GPC Glycophorin C 
Hb haemoglobin 
HEPES 4-(2-hydrocyeethyl)-piperazine-ethanesUlfOflic acid 
Ht haematocrit 
1gM immunoglobulin M 
incRPMI incomplete RPMI 
IQR interquartile range 
iRBC infected red blood cell 
Nm neuraminidase 
PCR polymerase chain reaction 
Pcv packed cell volume 
PMR parasite multiplication rate 
PNA peanut (Arachis hypogaia) lectin 
Pt parasitaemia 
R resistant 
RBC red blood cell 
RF rosette frequency 
S sensitive 
SI selectivity index 
SRC spearman rank correlation 
vi 
Stdev 	standard deviation 
STI 	soybean trypsin inhibitor 
T 	trypsin 
VSA 	variant surface antigen 
vii 
TABLE OF CONTENTS 
Abstract 
Declaration 	 iii 
Acknowledgements 	 iv 
Abbreviations 	 vi 
Table of Contents 	 viii 
CHAPTER 1: Introduction 	 1 
1.1 Severe malaria 1 
1.1.1 Malaria 1 
1.1.1.1 'World distribution 1 
1.1.2 Malaria - the parasite and disease 2 
1.1.2.1 Plasmodium 2 
1.1.2.2 Plasmodium fa/ciparum - life cycle 3 
1.1.2.3 Malaria - the disease' 5 
1.1.3 Factors affecting severe malaria 6 
1.1.3.1 Overview 6 
1.1.3.2 Non-parasite factors 7 
1.1.3.3 Parasite virulence factors 7 
1.2 P. falciparum multiplication rate and selectivity index 10 
1.2.1 Parasite multiplication rate 10 
1.2.2 RBC selectivity 12 
1.3 P. falciparum invasion pathways 14 
1.3.1 Basic description of invasion 14 
1.3.2 P. falciparum merozoite antigens 15 
1.3.2.1 The EBP protein family 15 
1.3.2.2 The RBL protein family 16 
1.3.2.3 MSP1 17 
Viii 
1.3.2.4 AMA1 	 18 
1.3.2.5 Overview 	 18 
1.3.3 Erythrocyte receptors 	 19 
1.3.4 Invasion pathways 	 20 
1.3.5 Field isolate data 	 21 
1.4 P. falciparum rosetting 	 22 
1.4.1 Association with severe malaria 	 22 
1.4.2 Molecular basis of rosetting 	 23 
1.4.3 Why rosette? 	 24 
1.4.4 Rosetting as a mechanism to evade Invasion inhibitory 25 
antibodies 
1.5 Aim of thesis 	 27 
CHAPTER 2: Low multiplication rates of African Plasmodium 
falciparum isolates and lack of association of multiplication rate and 
red cell selectivity with malaria virulence 
2.1 Abstract 28 
2.2 Introduction 	 V 28 
2.3 Materials and Methods 30 
2.3.1 Parasite isolates 30 
2.3.2 Parasite culture 31 
2.3.3 Thin blood smears for selectivity index calculations 32 
2.3.4 Selectivity index 32 
2.3.5 In vitro PMR assay 33 
2.3.6 Rosetting 34 
2.3.7 Statistical analysis 34 
2.4 Results 35 
2.4.1 Growth of field isolates in vitro 35 
2.4.2 Clinical and laboratory details of patients in the PMR 36 
lx 
study 
2.4.3 Field isolate multiplication rates are not associated 38 
with disease severity in Kenya and Mali 
2.4.4 Clinical and laboratory details of patients in the 42 
Si study 
2.4.5 Selectivity index of field isolates is negatively 44 
correlated with parasitaemia 
2.4.6 Selectivity index of field isolates is not associated 46 
with disease severity 
2.4.7 Multiplication rate in relation to the selectivity index 46 
2.4.8 ABO blood group of the patient is not associated with 47 
PMR or SI of the parasite isolate 
2.5 Discussion 	 48 
CHAPTER 3: RBC selectivity is not associated with virulence in P. 
chabaudi infections 
3.1 Abstract 54 
3.2 Introduction 54 
3.3 Materials and Methods 57 
3.3.1 Experimental design 57 
3.3.2 Selectivity index 60 
3.3.3 Statistical analysis 60 
3.4 Results 61 
3.4.1 The SI is associated with parasitaemia 61 
3.4.2 SI is not related to clone virulence 64 
3.4.3 Mosquito transmission and the selectivity index 66 
in P. chabaudi 
3.4.4 The SI over the course of the infection 67 
3.4.5 The SI in naïve compared to immunised mice 68 
x 
3.4.6 The SI is not associated with RBC count or the 	69 
proportion of reticulocytes 
3.5 Discussion 	 71 
CHAPTER 4: Invasion profiles of Kenyan P. falciparum field isolates 
4.1 Abstract 	 76 
4.2 Introduction 	 76 
4.3 Materials and Methods 81 
4.3.1 Parasite isolates 81 
4.3.2 Selectivity Index 82 
4.3.3 Parasite culture 83 
4.3.4 Donor erythrocytes 83 
4.3.5 Enzyme preparation 83 
4.3.6 Enzyme treatment 84 
4.3.7 Agglutination of enzyme treated RBC 84 
4.3.8 Invasion pathway assay 85 
4.3.9 Statistical analysis 85 
4.4 Results 86 
4.4.1 Controlling for enzyme treatment of RBC by 86 
autoaggl utination 
4.4.2 Controlling for enzyme treatment of RBC with 87 
P. falciparum laboratory isolates of a known invasion phenotype 
4.4.3 Invasion profiles of Kenyan P. falciparum isolates 88 
4.4.4 Invasion profiles and malaria severity in Kenyan 90 
isolates 
4.4.5 Invasion profiles and ABO blood group type in Kenyan 92 
isolates 
4.4.6 Invasion profiles and the selectivity index 	 93 
4.5 Discussion 	 93 
xl 
CHAPTER 5: P. falciparum: rosettes do not protect merozoites from 
invasion-inhibitory antibodies 
5.1 Abstract 98 
5.2 Introduction 98 
5.3 Materials and Methods 102 
5.3.1 Parasite culture 102 
5.3.2 Invasion assays 102 
5.3.3 Assessment of rosette frequency 103 
5.3.4 Statistical analysis 104 
5.4 Results 105 
5.4.1 Invasion rates of isogenic rosetting and non-rosetting 105 
parasites 
5.4.2 Identification of an invasion-inhibitory antibody 106 
5.4.3 Invasion rates of isogenic rosetting and non-rosetting 108 
parasites in the presence of antibodies to MSP-1 
5.4.4 Invasion inhibition of shaking cultures 110 
5.5 Discussion 111 
CHAPTER 6: Discussion 
6.1 Summary 	 114 
6.2 Severe malaria - Africa and Asia 	 114 
6.3 Plasmodium chabaudi as a model to study RBC 	118 
selectivity 
6.4 Severe malaria - rosetting as a virulence factor 	119 
6.5 Conclusions 	 119 
Bibliography 	 121 
Appendix 	 157 
xii 
CHAPTER 1: Introduction 
1.1 Severe malaria 
1.1.1 Malaria 
In over 100 years of malaria research, despite major advancements in our 
understanding and treatment of the disease, parasite drug resistance and political 
instability have led to a recent increase in malaria cases (World Health Organization 
2003). There are an estimated 500 million clinical cases annually (Snow et al. 2005) 
and all efforts are needed to further enhance our current knowledge about the causes, 
pathology and treatment of this disease to prevent a further increase of cases and 
discover new strategies to combat it. 
1.1.1.1 World distribution 
Although in the distant past malaria occurred throughout Europe, malaria has been 
eradicated from large parts of the world in a major effort in the 20 th Century and now 
is predominant throughout the tropical regions of the world (figure 1). 
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Figure 1: 
Worldwide malaria distribution in 2002 
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Figure 1: Malaria distribution in 2002. 
(From: http://globalatlas.who.int/globalatlas/InteractiveMapping).  
1.1.2 Malaria - The parasite and disease 
1.1.2.1 Plasmodium 
Malaria is caused by a parasite of the genus Plasmodium, which belongs to the 
Apicomplexa phylum, as characterised by their apical complex. The apical complex 
typically contains electron dense polar rings, two or more rhoptries and also 
micronemes. Four of the Plasmodia species infect humans: P. vivcix, falciparum, 
ovale and malariae. But it is known that other primate species may infect humans 
and have done so in the past - for example P. knowlesi (Singh et al. 2004). Although 
P. falciparum is the commonest species in the tropics and causes most of the malaria 
morbidity and mortality, P. vivax is an important infection in subtropical regions and 
can have a considerable impact on the economy (Harinasuta and Bunnag 1988). 
Although not the subject of this thesis, it is interesting that P. falciparum has evolved 
2 
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to be so virulent to the human host, in contrast to the other three species. Virulence 
throughout this thesis is defined as the damage done to the host. It is separate from 
studies defining virulence as high growth rates in rodent malaria models (Walliker et 
al. 1976). 
1.1.2.2 Plasmodium falciparum - life cycle 
The P. falciparum life cycle has both an asexual haploid stage in the human host and 
a sexual replication stage in the mosquito vector (figure 2). P. falciparum is 
transmitted by female mosquitoes of the genus Anopheles. The life cycle in a new 
human host starts with sporozoites being injected from the salivary glands ofthe 
vector, the mosquito (figure 2). The sporozoites travel to the liver and infect 
hepatocytes, where they will develop into schizonts. After 5-6 days an estimated 
30,000 merozoites are released from each schizont as a result of asexual fission. 
After being released from the liver the merozoites invade erythrocytes. 
Intraerythrocytic development takes approximately 48 hours, during which the ring 
stage parasites mature to pigmented trophozoites and schizonts. 
The mature stages (pigmented trophozoites and schizonts) are rarely seen in the 
peripheral circulation as they express variant surface antigens, which mediate 
adherence of the parasite infected red blood cell (iRBC) to endothelial cells 
(Sherman et al. 1993). This is known as cytoadherence and to date a number of 
different forms of cytoadherence of P. falciparum iRBC habe been described: the 
binding to endothelial cells, the binding to uRBC (known as rosetting), the binding 
of iRBC to other iRBC (known as autoagglutination) and finally, the binding to 
condroitin sulfate A in the placenta (Newbold et al. 1999). These different 
phenotypes, in particular binding to endothelial cells, leads to sequestration in blood 
vessels and organs, and prevents clearance by the spleen (Barnwell et al. 1983). 
Cytoadherence in small blood vessels of the brain, placenta and other major organs is 
thought to be a major factor involved in severe disease (Beeson and Brown 2002). 
3 
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At schizogony the merozoites are released, which reinvade new RBC to complete the 
asexual cycle. Ring stage parasites can alternatively develop into male or female 
gametocytes. These are ingested by the mosquito vector with the blood meal. It is in 
the vector that the sexual cycle of P. falciparum occurs. In the midgut of the 
mosquito the gametocytes develop into gametes, which fuse to form a zygote. These 
elongate into motile ookinetes, which then migrate through the midgut wall and 
round up as oocysts. The oocyst divides and matures over 7 to 15 days to finally 
produce sporozoites that migrate to the salivary glands, ready to complete the P. 
falciparum life cycle (Garnham 1988). 
Figure 2: 
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Figure 2: Overview of the malaria life cycle. Blue arrows indicate the stages in the 
human host and red arrows the stages of development in the mosquito host. The 
erythrocytic cycle is shown in B. Reproduced from Centres for Disease Control and 
Prevention (http://www.cdc.gov/malaria/biology/life —cycle.htm). 
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1.1.2.3 Malaria - the disease 
The clinical features in malaria result from the asexual blood stage of the infection. 
Most malaria infections cause fever, malaise, headache and lethargy, they are 
however not lethal. But in some cases severe disease develops with the main clinical 
features being unrousable coma, anaemia, respiratory distress and organ failure 
(Marsh and Snow 1997). Respiratory distress, caused by metabolic acidosis, alone or 
in connection with other symptoms has a particularly high fatality rate of around 
25% (Marsh and Snow 1997). To date no approved vaccines exist to protect from 
malaria and the spread of parasites resistant to anti-malarial drugs makes the 
treatment difficult (Walliker 2000). 
In areas of high transmission severe malaria is a feature seen mainly in young 
children, as increased exposure enhances immunity and so protects older children 
and adults from severe malaria and maternal antibodies protect infants (Gupta et al. 
1999b). However, immunity to P. falciparum is not known as sterile immunity as 
parasites are still frequently found in the blood of adults living in malaria endemic 
areas. Interestingly, the age at which different severe malaria pathologies occur 
varies, for example in Kenya the average age at which children present at hospital 
with severe anaemia is 22 months and for cerebral malaria is 40 months (Marsh 
1992; Marsh and Snow 1997). It is not understood why only a small proportion, that 
is around 2%, of P. falciparum infections result in severe malaria, and what the 
factors that may cause severe malaria are (Greenwood et al. 2005) (see below). 
In lower transmission areas, such as Southeast Asia, severe malaria is as likely to 
occur in adults as it will in children (Luxemburger et al. 1997) as the population does 
not build up a protective level of immunity. It is important to emphasise that severe 
malaria in adults much more frequently has different manifestations of the disease 
with renal failure being an often observed complication (Wailer et al. 1995; 
Luxemburger et al. 1997; Nacher et al. 2001). Cerebral malaria also occurs in adults 
with malaria and has a very high mortality rate of around 22% (White 1987). 
5 
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1.1.3 Factors affecting severe malaria 
1.1.3.1 Overview 
As discussed earlier on, severe clinical malaria occurs in only around 2% of infected 
individuals (Greenwood et al. 2005). To prevent severe malaria cases occurring it is 
necessary to understand the factors that may predispose an individual to develop 
severe malaria. The contribution of the different factors is currently unknown and is 
likely to vary with different locations and environments. The factors can be grouped 
into three categories: host factors, parasite factors and geographic and social factors 
(figure 3). 
Figure 3: 
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Figure 3: Many factors may lead to severe malaria as the outcome of an infection 
with P. falciparum. Factors are grouped as parasite, host and geographic and social 
factors. Adapted from (Miller et aL 2002). 
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1.1.3.2 Non-parasite factors 
The geographic and social and host factors encompass factors such as the availability 
of health care, maternal education levels, economic factors and political stability 
(Marsh 1992; Miller et al. 2002; Greenwood et al. 2005). Unfortunately, political 
instability has been named as one of the main reasons for the deterioration of malaria 
control (Greenwood et al. 2005). Host factors that have been associated with the 
outcome of a P. falciparum infection are age, previous exposure to the parasite and 
host genetics. Host genetics plays a major role and accounts for around 25% of total 
variation in the susceptibility of individuals to malaria disease in Kenya (Mackinnon 
et al. 2005b). Malaria resistance genes, such as the sickle cell anaemia gene, have 
reached higher frequencies in malaria endemic areas, where they provide protection 
from severe malaria (Haldane 1949). Interestingly, the sickle cell gene and the alpha-
thalassaemia polymorphisms, which are among the best known blood 
polymorphisms to confer protection from severe malaria, were found to only explain 
2.5% and 2% of the protection from severe malaria, respectively (Mackinnon et al. 
2005b). This indicates the complexity of the relationship, between host genetics and 
resistance to malaria. 
1.1.3.3 Parasite virulence factors 
In general parasite biology, parasite virulence has been described by theories looking 
at the trade-off between parasite virulence and host fitness. It is assumed that a 
parasite virulence factor will enhance the survival and/ or transmission of the 
parasite. The trade-off means that a virulence factor, though advantageous to the 
parasite, by definition will decrease host fitness or in other words increase 
pathogenesis (Anderson and May 1982). 
Differences in virulence between Plasmodium parasite strains have been shown in 
the past. The strongest evidence has been provided from rodent malaria models. It 
has been shown that different P. chabaudi strains differ in virulence and virulence 
can be selected for by passaging isolates through immune mice (Mackinnon and 
7 
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Read 1999). Furthermore, more virulent P. chabaudi strains out compete the less-
virulent strains and show enhanced transmission to the mosquito vector (Mackinnon 
and Read 2004a; de Roode et al. 2005a; de Roode et al. 2005b). There is also good 
evidence for differences in virulence of P. falciparum strains. Nearly 80 years ago, 
differences in virulence between P. falciparum strains were described: In the past, 
neurosyphilis was treated with fevers induced by carefully monitored malaria 
infections and it was found that "various geographical races [of P. falciparum] can 
be recognised as being distinct by their clinical virulence, immunological reactions 
and other biological properties" (James et al. 1932). 
Similarly, more recent work investigated the agglutination phenotypes of P. 
falciparum field isolates from children with severe or uncomplicated malaria. The 
aim was to further unravel whether isolates causing severe malaria express rare or 
commonly recognised surface antigens. In detailed studies the agglutination 
responses to variant surface antigens (VSAs) expressed on the surface of P. 
falciparum iRBC was examined. Parasite isolates taken from children of various ages 
and clinical manifestations were tested for agglutination by sera from the child the 
parasite isolate was collected from (homologous) and sera from a different 
individual (heterologous). It was found that the VSA expressed by isolates in 
children with severe malaria are commonly recognised by heterologous sera (Bull et 
al. 1998; Bull et al. 1999; Bull et al. 2000). Similar results were found by another 
group, again reporting the association of a high VSA recognition of parasite isolates 
with severe malaria (Nielson et al. 2002). This does not seem to be due to affected 
children being immuno-compromised with low antibody titres, as sera from children 
with severe malaria have similar antibody levels as children protected from severe 
malaria (Dodoo et al. 1999) and will agglutinate parasites isolated from other 
children (Bull et al. 1998). Therefore, it has been suggested that children who 
develop severe malaria have a 'gap' in their acquired VSA antibody repertoire (Bull 
et al. 1998) or lack the ability to maintain a broad profile of anti-VSA antibodies 
(Tebo et al. 2002). Independently of the disease status the occurrence of common 
isolates is inversely associated with age (Nielson et at. 2002), indicating that 
acquired-immunity may select for parasite isolates expressing rare VSA not yet seen 
Chapter 1: Introduction 
by the immune system. So acquired immunity may select against a commonly 
recognised, more virulent P. falciparum phenotype. This is supported by the fact that 
immunity may be gained after as little as one or two infections with P. falciparum 
(Gupta et al. 1999a). Further analysis of the age distribution of cerebral malaria led 
to the most plausible explanation being that a distinct antigenic type of P. 
falciparum, which is common, causes cerebral malaria and that these antigenic types 
induce strong strain-specific immunity and postnatal protection provides a relatively 
long period of protection (Gupta et al. 1999a). A possible VSA that is predicted to 
have a high switching rate during the initial stage of infection is P. falciparum 
erythrocyte membrane protein 1 (PfEMP1) (Gatton et al. 2003) (Roberts et al. 1992). 
So most children may encounter the common virulent strains or commonly expressed 
VSA during the time where they still have postnatal protection and can build up 
immunity towards them. The few children that are infected later will consequently 
develop severe malaria. These commonly recognised virulent strains may explain 
why parasitisation in non-immune travellers generally leads to disease and has a 
higher case-fatality rate (Marsh 1992) (Muhlberger et al. 2003). 
So the question is what makes the commonly recognised virulent strains so virulent? 
The clinical manifestations associated with human malaria are mainly due to the 
erythrocyte stage of the P. falciparum life cycle. Therefore, parasite virulence factors, 
associated with intraerythrocytic development are of particular interest. Potential P. 
falciparum virulence factors are drug resistance, cytoadherence, immune-
suppression, autoagglutination, growth as defined by the multiplication rate and RBC 
selectivity of isolates, invasion pathways used by the merozoite to enter the RBC and 
finally rosetting (Marsh 1992; Miller et al. 2002). I will talk about the latter three• 
virulence factors in more detail below as they were investigated in this study. The 
other factors, cytoadherence, immune suppression and autoagglutination will not be 
discussed here, but are the current focus of research by other groups (see (Urban et 
al. 1999; Roberts et al. 2000; Pain et al. 2001; Sherman et al. 2003)). 
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1.2 P. falciparum multiplication rate and selectivity index 
1.2.1 Parasite multiplication rate 
Parasite multiplication rate during the asexual cycle, as a measure of how many RBC 
are newly infected when a schizont bursts, is an intriguing subject. Generally it is 
assumed that 8-32 merozoites are released at schizogony (Garnham 1988). The 
multiplication rate indicates how many of these re-invade. Although a parasite 
multiplication rate (PMR) of 5-fold is often quoted for laboratory strains, how many 
merozoites reinvade in vivo is not well understood and experimental studies in vivo 
are difficult to design as P. falciparum infections require treatment to prevent the 
development of severe malaria. 
There are a few available estimates of parasite multiplication rates in vivo. One 
source has been derived from the meticulously collected data generated during 
neurosyphilis treatment programs early in the last century, where fevers induced by 
malaria parasites were used to cure neurosyphilis as described above. All Giemsa 
counts were regularly collected and carefully monitored, allowing a retrospective 
analysis of the parasite growth rates. From the available data the multiplication rate 
has been estimated to be around 9-fold during the expansion phase and interestingly 
to abruptly be reduced to a value of 1-fold or less by an unknown mechanism 
(Simpson et al. 2002). Unfortunately, no further references or informatidn was given 
in regards to this postulated decrease in the parasite multiplication rate and the 
proposed control mechanism (Simpson et al. 2002). Fever has been shown to effect 
density-dependent regulation of parasite growth in a non-immune host (Gravenor 
and Kwiatkowski 1998). Additionally, in this retrospective analysis it was shown 
that the PMIR varies across parasite strain and patient, even when patients are 
infected with the same parasite strain (Simpson et al. 2002). Vaccine studies have 
designed PCR based methods to investigate the early growth phase of the parasite in 
the volunteer, before any symptoms arise. These experiments are generally carried 
out with Caucasian volunteers being infected with a laboratory strain, such as 3137. 
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The measured multiplication rates have been estimated to be around 12-15-fold 
(Cheng et al. 1997; Lawrence et al. 2000; Bejon et al. 2005), but the peak 
parasitaemias in these early stages of the infection are very low (10 parasites per 
microL)(Lawrence 2000). Furthermore, there does seem to be considerable variation 
in the early growth rates in naïve individuals, ranging from around 2-fold to 30-fold 
(Bejon et al. 2005). It is important to note that these studies were carried out in 
malaria naïve individuals and none of the above studies characterised how the 
multiplication rate may change after the early expansion phase. A different approach 
that has been taken to study the parasite multiplication rate is to look in vitro at the 
first cycle of invasion of field isolates. This has been carried out in Thailand. 
In vitro multiplication rates of parasite isolates from Thai patients, diagnosed with 
uncomplicated malaria, multiplied at a mean invasion rate of 2.8 (Chotivanich et al. 
2000). However, in the same study, parasite isolates from patients with severe 
malaria had a multiplication rate of around 8-fold. This was significantly higher than 
the group of isolates from patients with uncomplicated malaria (Figure 4) and, 
provided evidence that more virulent isolates with faster growth rates may cause 
severe malaria. There is supporting data from rodent models, where P. chabaudi 
growth rates have been associated with the level of virulence caused to the host 
(Mackinnon and Read 1999; Mackinnon and Read 2003, 2004b). Whether severe 
malaria in children in Africa is also in part caused by P. falciparum isolates with 
high parasite multiplication rates is unknown. 
11 
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Figure 4: 
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Figure 4: Multiplication rate of Thai field isolates from patients diagnosed with 
uncomplicated (left hand) or severe (right hand) malaria. The median multiplication 
rates are 2.8 and 8.3 respectively. Adapted from (Chotivanich et aL 2000). 
1.2.2 RBC selectivity 
Further insight into parasite multiplication in vivo can be gained by understanding 
whether red blood cell (RBC) invasion is a random, unrestricted process, or whether 
some selection occurs, with only a subset of RBC being accessible for invasion. A 
preference to invade reticulocytes by a number of different Plasmodium species is 
well documented, for example P. berghei and P. vivax merozoites are known to have 
a large preference to invade reticulocytes (Ott 1968; Mons 1990). A careful study 
looking at the selectivity index (SI) of a range of different Plasmodia species 
confirmed these preferences and gave a good overview of the RBC selectivity of 
different Plasmodia species (Simpson et al. 1999). The SI is a measure of whether 
merozoites can invade all RBC randomly (figure 5). It is defined as the number of 
observed multiple-infected RBC in relation to the number expected by chance, as 
calculated with a Poisson distribution. A SI of 1 indicates random invasion. A SI, 
which is larger than 1, indicates that more multiple-infected RBC are seen than 
expected and that invasion is not random. Non-random invasion may be explained by 
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Figure 5: The selectivity index (SI) is a measure of merozoite invasion. If invasion is 
a random process (left side), then the number of multiple-infected RBC equals the 
expected number and the SI=1. If invasion is a non-random process (right side) and 
some of the RBC cannot be invaded (indicated by the thick black RBC membranes), 
then one will observe more multiple-infected RBC than expected and the SI>1. 
Importantly it was found that Thai P. falciparum isolates from patients with severe 
malaria were less selective than isolates from patients with uncomplicated malaria 
(Simpson et al. 1999). This correlated well with the PMR data from Thailand 
(Chotivanich et al. 2000). One may speculate that parasites that can invade a larger 
population of the RBC, that is they are less selective, and multiply at a higher rate, 
cause severe malaria. As far as I am aware neither the PMR nor the SI has been 
studied for field isolates from patients with severe malaria in Africa, where malaria is 
often highly endemic and mainly children are diagnosed with severe malaria. 
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1.3 P. falciparum invasion pathways 
1.3.1 Basic description of invasion 
Following from the question as to what proportion of RBC are invaded, as measured 
with the SI, it is also necessary to understand how merozoites invade erythrocytes. 
From video microscopy studies it is known that merozoites go through the stages of 
reversible attachment to a RBC, reorientation so that the apical end of the merozoite 
is in contact with the erythrocyte surface, tight junction formation and finally 
internalisation (figure 6). 
Figure 6: 
Irreveqst4e aflachment _- 	ar'cI junction formation 
Paritephorous vacuDe 
miUon mid Mwofl 
Initial aftachrrm" 
	
/. and reorientation 
rVII -0 ~ 
Figure 6: Merozoite invasion into the RBC comprises a number of steps. Adapted 
from (Chitnis and Blackman 2000). 
In contrast to P. vivax, which is restricted to erythrocytes expressing the Duffy blood 
group antigen and to reticulocytes, multiple pathways have been described for 
invasion by P. falciparum merozoites. In the following paragraphs I will first of all 
give a description of the parasite proteins that have been postulated to be involved in 
merozoite invasion, then move on to describe potential RBC receptors and finally 
group the pathways by their enzyme-sensitivity profile. 
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1.3.2 P. falciparum merozoite antigens 
1.3.2.1 The EBP protein family 
Identified originally in P. vivax, there is now a well-defined family of genes, known 
as the erythrocyte binding protein (EBP) family (also known as the ebi family or the 
DBL-EBL family). The EBP family encodes proteins involved in specific 
recognition of host cell receptors and invasion (figure 7). 
Figure 7: 
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Figure 7: Protein structure of the EBL protein family. Reproduced from (ToIla et at. 
2005). 
The genes are usually single-copy and have a multi-exon structure. The proteins 
generally have a tandem copy of the DBL domain in P. falciparum although the P. 
vivax protein only has one copy and the P. falciparum antigen MAEBL also forms an 
exception with a unique domain, which is more similar to AMA1 (Blair et al 2002). 
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The EBP gene family, because of the characteristic DBL domain, falls within the 
larger DBL superfamily. Another well-known DBL family are the var genes 
encoding PfEMP1 (P. falciparum erythrocyte protein 1), which mediates antigenic 
variation and cytoadhesion (discussed below under 1.4 Rosetting). The EBP family 
is distinct from the var genes as the exon structure differs; furthermore EBP proteins 
lack the integral membrane domain and the acid cytoplasmic tail (Peterson and 
Wellems 2000). 
As described the EBP family consists of several family members, which have largely 
been identified through the genome project (figure 7). EBA-175, the name 
originating as it is a 175 kDa rythrocyte binding antigen, was the first EBP protein 
identified in P. falciparum (Camus and Hadley 1985). EBA- 175 binds sialic acids 
and the backbone of glycophorin A for invasion (Sim et al. 1994). Recently, the 
binding domain has been found to form dimers in an antiparallel fashion. 
Dimerisation may occur when two EBA- 175 domains assemble around glycophorin 
A, which exists as a dimer on the erythrocyte surface (Tolia et al. 2005). PEBL (also 
known as EBA-165) was identified in the genome due to its close homology to EBA-
175, but is thought to be a transcribed pseudogene (Triglia et al. 2001). EBL-1 is also 
similar to EBA- 175, yet little is known about its possible role in RBC invasion 
(Peterson and Wellems 2000). BAEBL (also known as EBA-140 or EBP2) is another 
EBP family protein identified through its homology. Interestingly different RBC 
binding specificities were initially reported for BAEBL (Mayer et al. 2002; Narum et 
al. 2002), and it was found that there are four polymorphisms that lead to different 
RBC binding specificities (Mayer et al. 2002). Another EBP family protein, JESEBL 
(also known as EBA-181), has also been described to show different RBC binding 
and perhaps receptor specificity due to allelic polymorphism (Mayer et al. 2004). 
JESEBL is not essential for invasion and can be disrupted (Gilberger et al. 2003). 
1.3.2.2 The RBL protein family 
Two proteins mediate recognition of reticulocytes by P. vivax the reticulocyte 
binding protein 1 and 2 (PvRBP-1 and PvRBP-2). Orthologues to both of these 
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proteins have been identified in P. falciparum. This family forms a separate family 
from the EBP proteins and similarly has several family members. So far five proteins 
have been identified, of which one PfRh3 (P. falciparum reticulocyte binding protein 
homolog 3) is thought to be a pseudogene as no translated product has been found in 
asexual stage parasites (Taylor et al. 2001). PfRh2a and b, orthologues to PvRBP-2, 
were described first in 2000 (Rayner et al. 2000). Two more family members PIRh1 
and PfRh4 have also been identified (Taylor et al. 2002). Since then several studies 
have shown that different levels of these proteins may mediate different receptor 
specificities (Taylor et al. 2002; Duraisingh et al. 2003; Stubbs et al. 2005). 
Furthermore, although these genes were all thought to be single copy genes, it has 
been found that there are PfRhl gene amplifications in laboratory strains and that 
this may affect the invasion profile (Triglia et al. 2005). Most recently it has been 
described that PfRh4 activation may be involved in a pathway switch to sialic acid-
independent pathways (Stubbs et al. 2005). In this study, W2mef parasites either 
selected to grow on neuraminidase treated RBC or where EBA- 175 was disrupted 
had increased expression levels of PfRh4 and the pseudogene PEBL, which are 
located in a head-to-head orientation on chromosome 4 (Stubbs et al. 2005). 
Furthermore, as it was found that disrupting EBA- 175 led to the expression of PfRh4 
and sialic acid —independent invasion, this indicated some overlap of the PfRh and 
EBP protein family as independently of each other they can mediate parasite 
invasion, albeit by different invasion pathways (Stubbs et al. 2005). 
1.3.2.3 MSP1 
Another family of proteins are the merozoite surface proteins (MSPs), of which only 
MSP1, the best-characterised protein, will be discussed here (details to proteins 
MSP2 to MSP9 in: Tonhosolo et al. 2001; Mills et al. 2002; Oeuvray et al. 1994; 
Marshall et al. 1997; Marshall et al. 1998;Trucco et al. 2001; Black et al. 2001; 
Vargas-Serrato et al. 2002). MSP1 is highly abundant on the surface of merozoites 
(Blackman et al. 1991a; Blackman et al. 1991b). Although the exact function of 
MSP1 is unknown, there is considerable evidence for its role in invasion. Knockouts 
of MSP 1 are not possible, indicating that this protein is essential (Gaur et al. 2004). 
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Furthermore, antibodies to the protein can inhibit invasion (Blackman et al. 1990; 
Uthaipibull et al. 2001). In vivo evidence that MSP1 antibodies protect from severe 
malaria is slightly more conflicting with evidence for a protective effect of human 
MSP1 antibodies in some (Egan et al. 1999; John et al. 2004), but not all studies 
(Dodoo et al. 1999; Conan et al. 2004). The protein itself consists of a precursor, 
which is processed twice leaving a l9kDa C-terminus attached to the merozoite 
surface by a GPI-anchor (McBride and Heidrich 1987). MSP 1-19, as it is referred to, 
contains two EGF-like domains, indicating a possible role in receptor-ligand 
interactions (Holder and Blackman 1994). A possible receptor for MSP1-19 hasbeen 
suggested and will be discussed further below. 
1.3.2.4 AMA1 
Apical membrane antigen 1 (AMA 1) is another essential merozoite surface protein. 
This protein is expressed from a single copy gene at the schizont stage of the 
parasite, localised to the rhoptries and spread on the merozoite surface after schizont 
rupture (Narum and Thomas 1994). It is not possible to knock the gene out, 
demonstrating that it is essential for blood-stage growth (Triglia et al. 2000). 
Furthermore, antibodies to AMA1 can inhibit parasite invasion (Hodder et al. 2001), 
and antibodies to AMA1 are associated with protection from clinical disease (Polley 
et al. 2004). Although, there does seem to be a strong strain-specific component to 
this immunity as heterologous antibodies are not as effective at inhibiting parasite 
invasion (Kennedy et al. 2002; Healer et al. 2004; Malkin et al. 2005), which 
complicates the use of AMA! as a vaccine candidate (Malkin etal. 2005). 
1.3.2.5 Overview: 
Altogether the above description of P. falciparum invasion proteins shows an 
amazing complexity and it seems like numerous strategies have evolved to enhance 
the chance of successful invasion in the face of erythrocyte polymorphisms and host 
immune responses. Examples for the strategies to enhance successful invasion are 
the complexity of proteins that mediate invasion, as listed above, the different levels 
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of expression of invasion ligands, such as PfRh 1 and PfRh2aJ2b, and the evolution of 
allelic variants, such as seen for BAEBL and JESEBL. Furthermore, although the P. 
falciparum invasion proteins, which have been associated with specific invasion 
pathways, were described in the above paragraphs, there are a number of other 
proteins associated with merozoite invasion, such as the serine repeat antigen 
multigene family (SERA), glutamate-rich protein (GLURP) and subtilisin-like 
protein, which to date have not been associated with a specific invasion pathway and 
are described elsewhere (Li et al. 2002, Miller et al. 2002, Dziegiel et al. 1993, 
Blackman et al. 1998). 
1.3.3 Erythrocyte receptors 
Identifying possible receptors on erythrocytes is of course of major importance to 
understand merozoite invasion. Yet, despite numerous parasite proteins having been 
described as having a role in invasion, the number of receptors identified is still very 
limited. The main RBC receptors for P. falciparum merozoite invasion, which have 
been shown to mediate some of the invasion process or pathway, are the glycophorin 
proteins A, B and C (Pasvol and Wilson 1982; Dolan et al. 1994; Sim et al. 1994; 
Maier et al. 2003). Glycophorin A is highly abundant on the RBC surface, although 
its exact biological role is not clear. The glycophorins, as their name suggests, sugar 
residues on their extracellular domains and these contain sialic acid residues, which 
are important for binding of some of the parasite proteins. Two other described 
erythrocyte surface proteins, Band 3 and Kx, the latter being a blood group antigen 
which is not present on RBC of the McLeod phenotype, have been suggested to be 
involved in merozoite invasion (Goel et al. 2003; Kato et al. 2005). However, there 
is no strong evidence for those receptors. Finally, five other receptors that differ in 
regards to the invasion pathway they mediate are proposed to be present - they have 
been termed receptor A, E, X, Y and Z (Dolan et al. 1994; Rayner et al. 2001; 
Duraisingh et al. 2003; Gaur et al. 2003; Gilberger et al. 2003; Cortes et al. 2004). 
Besides their sensitivity to a number of enzymes (see below), little is known about 
these putative receptors. 
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1.3.4 Invasion pathways 
The receptors involved in invasion, as described above, were identified by looking at 
invasion into mutant erythrocytes or enzyme treated RBC. Enzymes, which are used 
to study invasion pathways are trypsin, neuraminidase and more recently 
chymotrypsin. Trypsin removes GPA, GPC and Receptor X (Pasvol et al. 1982, 
Maier et al. 2003, Dolan et al. 1994). Neuraminidase removes sialic acids, which are 
linked to glycoproteins on the RBC surface (Pasvol et al. 1982). Finally, 
chymotrypsin removes GPB, Band 3, Receptor E and Z (Dolan et al. 1994, Goel et 
al. 2003, Gilberger et al. 2003, Duraisingh et al. 2003). The invasion pathways 
identified to date with these enzymes are shown in table 1. Five different invasion 
profiles can currently be distinguished, and these may point to one or more invasion 
pathways. It is still unfortunately a relatively crude method, but a number of P. 
falciparum invasion characteristics have been established. The invasion phenotype of 
laboratory strains has been found to be stable (Binks and Conway 1999). Parasites 
can adapt to invade by a different pathway, either upon long-term culturing on, for 
example, neuraminidase treated RBC or when a particular parasite invasion ligand is 
disrupted or knocked out (Mitchell et al. 1986, Dolan et al. 1994, Stubbs et al. 2005). 
These findings indicate that P. falciparum can adapt to selective pressure induced by 
blood polymorphisms and similarly may be able to switch invasion pathways, if 
invasion-inhibitory antibodies target and inhibit a pathway. It would be interesting to 
study whether invasion-inhibitory antibodies do cause laboratory isolates to invade 
by a different pathway in vitro. 
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Table 1: Invasion profiles described for P. falclparum laboratory strains 
I Invasion Profile type 	I Parasite Ligand j RBC receptor I Reference 
Nms Ts CTR 	 EBA-175 GPA (Pasvol 1982)(Camus 1985)(Sim 1994). 
BAEBL GPC (Maier 2003)(Mayer 2003) 
NmSTR CT 	 ? GPB (Dolan 1994) 
JESEBL Receptor E (Gilberger 2003) 
NmSTRCTR 	 PfRhl 	 Receptor V 	 iaynerUu1RIrIgIla 2005) 
NmR Ts CT? - 	? Receptor x uoian 1 	4) 
Nm R TR CTS PfRh2b Receptor z (Duraisingh 2003) 
MSP1 Band 3 (Goel 2003) 
AMA1 KXb (Kato 2005) 
NmRT? CT? PfRh4 ? (Stubbs 2005)C 
a Invasion profile type abbreviations: Nm = neuraminidase, T = trypsin, CT = chymotrypsin, 
S = sensitive and R = resistant 
b Erythrocyte membrane protein, Kx (Kato 2005) 
c PfRh4 has so far only been associated with the sialic-acid independent pathway in some 
but not all sialic-acid independent laboratory P. falciparum isolates (Stubbs 2005) 
1.3.5 Field Isolate Data 
As it became possible to assess which invasion pathways are used by laboratory 
strains, this has also been taken to field studies. The first question to ask was whether 
field isolates use a large variety of invasion pathways or invade via one major 
pathway. This is of importance for any vaccines that are designed to target- merozoite 
antigens and inhibit invasion. To date three studies have looked at the invasion of 
field isolates into enzyme treated RBC (Okoyeh et al. 1999; Baum et al. 2003; Lobo 
et al. 2004). Okoyeh et al. found that out of 15 Indian isolates 12 could invade by an 
alternate invasion pathway to the EBA- 1 75/GPA pathway (Okoyeh et al. 1999). This 
was an important finding indicating that vaccines based on EBA-175 may not be 
efficient at inhibiting invasion and parasite growth. In contrast, the study on 38 
isolates in The Gambia concluded that a vaccine eliciting antibodies against EBA-
175 may be effective initially, as glycophorin A, which EBA- 175 binds to, was the 
primary receptor for the majority of the Gambian field isolates studied (Baum et al. 
2003). A large variety of invasion pathways were used by field isolates collected in 
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Brazil (Lobo et al. 2004). In the Brazilian study half of the isolates (7 of 14) invaded 
via the neuraminidase and trypsin sensitive pathway, although they conclude from 
studies with mutant erythrocytes, which lack glycophorin A, that 5 of those isolates 
still invade via an alternative pathway to the EBA-175/GPA pathway (Lobo et al. 
2004). Hence, these three studies gave an excellent insight into the invasion 
pathways used by P. falciparum in the field. However, no studies to date have looked 
at invasion pathways used by field isolates from patients diagnosed with severe 
malaria. 
1.4 P. falciparum rosetti ng 
1.4.1 Association with severe malaria 
Rosetting is a cytoadherence phenotype of Plasmodia, where RBC bind to the 
surface of iRBC (figure 8). It was first described in P. fragile (David et al. 1988) and 
subsequently was identified in P. falciparum (Handunetti et al. 1989). 
Figure 8: 
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Figure 8: Image of a rosette. 
The parasites are stained with ethidium bromide (red). 
Rosetting is one of the best-studied parasite virulence factors, and it has been 
repeatedly associated with severe malaria in Africa (Rowe et al. 1995) (Rowe et al. 
2002b) (Carlson et al. 1990) (Ringwald et al. 1993) (Kun et al. 1998) (Heddini et al. 
2001) (Pain et al. 2001) (Treutiger et al. 1992) (Newbold et al. 1997). Despite the 
22 
Chapter 1: Introduction 
fact that the rosetting frequency can only be assessed in vitro, there is evidence 
supporting the notion that rosettes form in vivo and may be a causative for malaria 
pathogenesis. First of all, it is convincing that the finding that isolates from patients 
with severe malaria rosette with a higher frequency than isolates from patients with 
mild malaria has been repeated numerous times (see above). Furthermore, in a 
malaria endemic region of Papua New Guinea there is an unusually high frequency 
of a gene, which is linked to a human blood group polymorphism that reduces 
parasite rosetting. This gene allele, leads to a decrease of the complement receptor 1 
(CR1) levels on RBC and is associated with protection from severe malaria 
(Cockburn et al. 2004). CR1 is a rosetting receptor, and lack of CR1 on RBC reduces 
the rosetting frequency (Rowe et al. 1997; Rowe et al. 2000). 
1.4.2 Molecular Basis of rosetting 
The parasite rosetting ligand is PfEMP1 (. falciparum rythrocyte membrane 
protein fl, a member of the DBL family. PfEMP 1 is expressed by var genes, of 
which 50 to 60 copies exist per parasite isolate (Su et al. 1995). It is thought to be the 
major parasite protein mediating variant surface antigens for immune evasion and 
cytoadherence, whether to endothelium lining the blood vessels (Newbold et al. 
1997), white blood cells (Urban et al. 1999), other iRBC causingautoagglutination 
(Roberts et al. 2000; Pain et al. 2001) or other RBC causing rosetting (Rowe et al. 
1997). The complex domain structure of the different PfEMP1 types allows this large 
variation in receptor recognition (Su et al. 1995). The DBLa domain has been shown 
to bind RBC to form rosettes (Rowe et al. 1997) and there is ongoing work to 
establish whether there is a conserved sequence over a large number of parasite 
strains to identify possible epitopes for vaccine design (Alex Rowe, personal 
communication). 
One identified RBC receptor involved in the formation of rosettes is CR1 on the 
RBC. RBC deficient in CR1 show a reduced rosetting phenotype compared to 
normal RBC (Rowe et al. 1997) and antibodies to CR1 can reverse rosetting of both 
laboratory strains and field isolates (Rowe et al. 2000). 1gM is also a required serum 
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factor, which has to be present at the time of rosette formation (dough et al. 1998a) 
and binds to the surface of rosetting iRBC (Rowe et al. 2002b). Other RBC receptors 
are CD36 (Handunnetti et al. 1992), heparan sulphate-like molecules (Chen et al. 
1998) and the ABO blood group sugars (Carlson and Wahigren 1992). The 
preference of rosette formation with blood group A RBC (Carlson and Wahigren 
1992; Rowe et al. 1995; Barragan et al. 2000) also associates rosetting with severe 
malaria, as blood group A has been independently associated with severe malaria 
(Fischer and Boone 1998; Lell et al. 1999; Pathirana et al. 2005) and also increased 
invasion rates of laboratory parasites (Chung 2005). 
1.4.3 Why rosette? 
The underlying mechanism associating the rosetting of P. falciparum isolates with 
severe pathological symptoms is unknown. Rosettes are found in other Plasmodia 
species, which do not cause severe malaria, so there must be something unique to P. 
falciparum. Previous work shows a possible involvement of rosettes in obstructing 
microvascular blood flow (Kaul et al. 1991; Dondorp et al. 2004) and it may be the 
formation of rosettes together with other cytoadherence phenotypes of P. falciparum, 
which cause severe malaria pathogenesis. Rosettes have also been associated with 
higher parasitaemia levels in the host (Rowe et al. 2002a), suggestive of rosetting 
somehow promoting parasite growth and/or survival. This has been shown not to be 
due to an increase in the parasite multiplication rate of rosetting isolates compared to 
non-rosetting isolates (Clough et al. 1998b). The correlation between rosetting and 
parasitaemia is not seen in children and adults with uncomplicated malaria (Rowe et 
al. 2002b) (Iqbal et al. 1993). Alternatively, the combination of rosetting and a high 
multiplication rate may lead to severe disease. The lack of any association between 
rosetting and the multiplication rate in vitro, does not rule out such an association 
occurring in vivo under conditions, where host immunity is present. Rosettes may 
enhance parasite survival by mediating immune evasion and is investigated in this 
study. 
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1.4.3 Rosetting as a mechanism to evade invasion inhibitory antibodies 
Rosetting may allow merozoites to directly target the attached RBC without 
exposure to serum antibodies (figure 9). In semi-immune and immune hosts parasite 
growth is inhibited by antibodies directed to merozoite surface antigens (Pasvol 
1982). An example is merozoite-surface-protein 1, the most abundant merozoite 
surface protein. Seropositive children have been shown to be more resistant to 
clinical malaria in several studies, and human antibodies inhibit parasite invasion in 
vitro (Egan et al. 1999). Although other studies show no correlation between MSP1 
antibody levels and protection from clinical malaria (Dodoo et al. 1999). If rosetting 
does allow merozoite release and RBC invasion without prolonged exposure to the 
host sera, the invasion inhibitory or growth inhibitory antibodies could not bind and 
be active, and higher invasion rates of rosetting parasites would be seen than non-
rosetting parasites in the presence of inhibitory antibodies. 
Figure 9: 
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Figure 9: Diagram showing how merozoites released from rosetting and non-
rosetting P. falciparum iRBC could be differentially inhibited by invasion-inhibitory 
antibodies. A) Rosetting might reduce the effect of invasion-inhibitory antibodies if 
merozoites invade directly into the RBC in rosettes, thereby avoiding prolonged 
exposure to antibodies in the host's plasma. B) Merozoites derived from non- 
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rosetting parasites would be exposed to antibodies in the plasma and hence would 
show lower invasion rates than merozoites from rosetting parasites. C) If merozoites 
from rosetting parasites do not preferentially invade the RBC in the rosette but are 
exposed to plasma antibodies in a similar way to merozoites from non-rosetting 
parasites, they would be expected to show reduced invasion rates in the presence 
of host antibodies. 
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1.5 Aim of Thesis 
Parasite factors that may contribute to the pathogenesis of severe malaria are not well 
understood. There is evidence from Thailand, that parasites with higher 
multiplication rates and a decrease in RBC selectivity may cause severe malaria in 
patients. However, it is unknown whether these results from Southeast Asia, where 
malaria transmission is low and severe malaria affects patients of all ages, are 
representative for Africa, where mainly children below 5 years of age have severe 
malaria and often some degree of immunity is present. This study concentrates on P. 
falciparum field isolates from children in two African study sites and addresses the 
following questions related to potential parasite virulence factors: 
Are parasite multiplication rate and selectivity index virulence factors 
associated with severe malaria in African children? (Chapter 2) 
Is the selectivity index affected by immune selection, host immunity, the 
day of infection and/or mosquito transmission in P. chabaudi? (Chapter 3) 
What are the invasion profiles of Kenyan clinical isolates from children 
with uncomplicated and severe malaria, and is there an association between invasion 
pathways and disease severity? (Chapter 4) 
4. Do rosettes protect from invasion-inhibitory immunity? (Chapter 5) 
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CHAPTER 2: Low multiplication rates of African Plasmodium 
falciparum isolates and lack of association of multiplication, 
rate and red cell selectivity with malaria virulence 
A version of this chapter has been submitted as: Deans, AM et al.. Low 
multiplication rates of African Plasmodium falciparum isolates and lack of 
association of multiplication rate and red cell selectivity with malaria virulence. 
American Journal of Tropical Medicine and Hygiene. In press 2005. 
2.1 Abstract 
Two potential malaria virulence factors, parasite multiplication rate (PMR) and red 
cell selectivity (measured as selectivity index, SI) were assessed in Plasmodium 
falciparum clinical isolates from Mali and Kenya. At both sites PMR were low 
(Kenya median 2.2, n=33, Mali median 2.6, n=61) and did not differ significantly 
between uncomplicated and severe malaria cases. Malian isolates from 
hyperparasitaemic patients had significantly lower PMR (median 1.8, n=19) than 
other Malian isolates (uncomplicated malaria median 3.1, n=23; severe malaria 
median 2.8, n=19, P=0.03, Kruskal Wallis). Selective invasion occurred at both sites 
(Kenya geometric mean S1 1.9, n=98, Mali geometric mean SI 1.6, n=104) and there 
was no significant association between the SI and malaria severity. Therefore, in 
contrast to previous results from Thailand, I found no association of PMR and SI 
with malaria severity in African children. This raises the possibility of differences in 
the mechanisms of malaria virulence between sub-Saharan Africa and Asia. 
2.2 Introduction 
There is a poor understanding of factors causing severe malaria, although host 
genetics, environmental determinants and parasite properties are all thought to play 
an important role (Miller et al. 2002). As far back as the early 20th century when 
malaria therapy was used to treat neurosyphilis, differences in Plasmodium 
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falciparum strain virulence were recognised (James et al. 1932). In parasite 
evolutionary theory, differences in strain virulence can be explained by the trade-off 
hypothesis, which describes how parasites evolve to balance the fitness advantages 
of high growth and transmission with the fitness cost of host death (Anderson and 
May 1982). In other words, parasites that grow faster transmit more efficiently, but 
are also more virulent to the host. The relationship between parasite growth rate and 
virulence has been shown in rodent malaria models with P. chabaudi (Mackinnon 
and Read 1999; Mackinnon and Read 2003, 2004). In human malaria, P. falciparum 
virulence was associated with in vitro parasite multiplication rate (PMR) in a study 
carried out in Thailand (severe malaria isolates median PMIR 8.3, uncomplicated 
malaria isolates median PMIR 2.8) (Chotivanich et al. 2000). Whether this 
relationship between PMR and virulence is seen in other malaria endemic countries 
is unknown. 
Further insight into parasite multiplication in vivo can be gained by understanding 
whether red blood cell (RBC) invasion is a random, unrestricted process, or whether 
some selectivity occurs, with only a subset of RBC being accessible for invasion. 
The selectivity index (SI) compares the observed number of multiple-infected RBC 
(containing more than one ring-stage parasite) to the number expected from a 
random Poisson distribution (Simpson et al. 1999). A SI of 1 indicates random, non-
selective invasion of RBC, whereas a SI of, for example, 2, indicates two-fold more 
multiple-infected RBC than expected by chance alone. Factors that may lead to non-
random invasion (SI>1) include parasite receptor preference, host RBC 
polymorphisms or host merozoite-agglutinating antibodies (Miller et al. 1984; 
Ramasamy et al. 1999; Ramasamy et al. 2001). A SI of <1 could occur if invasion by 
one merozóite rendered a RBC refractory to further invasion. 
In all human Plasmodium infections multiple-infected RBC occur (Simpson et al. 
1999). In P. vivax the S  is high (about 8), which reflects the preference of P. vivax 
for reticulocytes and young red blood cells (Simpson et al. 1999). In P. falciparum 
infections with parasitaemias above 2%, multiple-infected RBC are largely due to the 
high parasite load, and the SI is around 1 (Simpson et al. 1999). P. falciparum 
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infections with lower parasitaemias (<2%) show a tendency towards higher RBC 
selectivity, with a mean SI of 2.44 (Simpson et al. 1999). Importantly, after 
accounting for parasitaemia effects, red cell selectivity of P. falciparum isolates has 
been associated with disease severity in Thailand (Simpson et al. 1999). Severe 
malaria isolates show random, unrestricted invasion of RBC (geometric mean SI 
1.35), whereas uncomplicated malaria isolates show restricted, non-random invasion 
with a higher number of multiple-infected cells (geometric mean SI 2.31) (Simpson 
et al. 1999). 
Together with the PMR results (Chotivanich et al. 2000), the above data indicate that 
there may be more virulent isolates causing severe malaria in Thai patients due to 
rapid, unrestricted growth and subsequent high parasite burdens in the host. The 
influence of these factors on malaria severity in African children has not previously 
been studied. Therefore I investigated PMR and red cell selectivity in relation to 
malaria virulence in two diverse sites in Africa. 
2.3 Materials and Methods 
2.3.1 Parasite isolates 
Parasite isolates were collected from Bandiagara, Mali and Kilifi, Kenya. Malaria 
transmission is seasonal at both sites, with infective bites ranging from 20-60 per 
month in Mali (Lyke et al. 2004b) and 10-30 per year in Kenya (Kinyanjui et al. 
2004). In Mali there is a single malaria season every year (July-December), whereas 
in Kenya there are two malaria seasons per year (June-August and December-
February). The Malian samples were collected as part of the Bandiagara Malaria 
Project case-control study in which uncomplicated malaria controls were age-, 
residence- and ethnicity-matched to severe malaria cases (Lyke et al. 2003; Lyke et 
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al. 2004b). The WHO criteria for severe malaria were applied (World Health 
Organization 2000), although patients with hyperparasitaemia (>500,000 parasites 
per microlitre of blood) and no other symptoms or signs of severe disease were 
analysed as a separate group, as previous studies indicate a good prognosis for these 
children (Marsh et al. 1995; Lyke et al. 2003). Uncomplicated malaria cases were all 
those recruited into the study with fever and P. falciparum parasitaemia who did not 
have severe malaria or hyperparasitaemia (Lyke et al. 2003; Lyke et al. 2004a). In 
Kenya, children with cerebral malaria (unrousable coma with a Blantyre score 
prostration (inability to sit unaided or in babies, .to breast feed) or respiratory distress 
(abnormally deep breathing) were considered to have severe malaria. The simpler 
clinical definition applied in Kenya identifies approximately the same group of 
children at risk of life-threatening malaria as those identified by the more 
comprehensive WHO criteria (Marsh et al. 1995). In Kenya, uncomplicated cases 
were children with malaria presenting at hospital with no symptoms or signs of 
severe disease, who were treated as outpatients with oral therapy. Blood samples 
were collected after obtaining informed consent from the children's parents or 
guardians, and protocols were approved by ethical review boards in the UK, USA, 
Mali and Kenya. 
2.3.2 Parasite culture 
After collection the blood samples were spun down for 5min at 400g to remove the 
Buffy Coat layer. Subsequently, lymphocytes were removed from the blood samples 
by diluting the blood sample with incRPMI to 50% haematocrit and layering it over 
Sm! pre-warmed Lymhoprep (BioWhittaker). The sample was spun at 400g for 
20mm. After centrifugation the white blood cells were removed and the pellet 
washed twice in incRPMI. The Malian isolates were then frozen in glycerolyte and 
shipped to Edinburgh. The isolates were thawed as follows. The isolates were diluted 
in a series of salt solutions (0.2 ml of 12% saline added slowly, followed by 10 ml of 
1.8% saline followed by lOml of 0.9% saline/0.2% glucose) and washed in RPMI 
1640 medium (BioWhittaker) containing 2mM glutamine (BioWhittaker) 37.5mM 
Hepes (BioWhittaker), 20 mM glucose (Sigma) and 25 [tg/ml gentamicin (Gibco) 
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(incomplete RPMI). The cells were resuspended in complete RPMI (incomplete 
RPMJ supplemented with 10% human AB serum), gassed with 3% CO2, 1% 02,  96% 
N2 and incubated at 37 °C. Kenyan isolates were collected into heparinised tubes and 
put into culture within 12 hours of collection. Lymphocytes and the buffy coat were 
removed as described above, the RBC washed three times in incomplete RPMI and 
resuspended in complete RPMI, then gassed and incubated as above. Cultures were 
monitored by Giemsa (BDH) smears for 18-36 hours, and only those with normal 
morphology that matured to the schizont stage were included in the study. Thai 
samples were frozen and shipped to Edinburgh and then thawed and cultured in the 
same way as the Malian samples. 
2.3.3 Thin blood smears for selectivity index calculations 
Thin smears were prepared from blood collected from the patient on arrival at 
hospital and were stained with Giemsa. A subset of the slides for SI calculations are 
from the isolates used to collect in vitro PMR data. The remaining slides in both 
Kenya and Mali were collected from children recruited into other studies of factors 
affecting severe malaria (Rowe et al. 1995; Rowe et al. 2002; Lyke et al. 2004a). 
2.3.4 Selectivity Index 
300 ring-infected RBC were counted per slide and the number of rings in each RBC 
was recorded (Leica microscope). The parasitaemia was estimated as the proportion 
of RBC infected with at least one parasite from a count of 1000 RBC. The SI was 
calculated as described by Simpson et a! (Simpson et al. 1999). The observed 
number of multiple-infected RBC (i.e. 2 or more rings per RBC) was determined by 
counting. The expected number of multiple-infected RBC was determined with a 
Poisson distribution (e -l' f/x!), where li is (-ln(1-parasitaemia) and x is the number 
of parasites per erythrocyte (i.e 1, 2, 3, 4 or 5). These values were multiplied by the 
number of cells counted (i.e 300) to obtain the number of RBC with 1,2,3,4 or 5 
parasites per erythrocyte and therefore also the total number of expected multiple- 
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infected RBC. To obtain the selectivity index the number of observed multiple-
infected RBC was divided by the number of expected multiple-infected RBC. 
2.3.5 In vitro PMR assay 
The assay to determine PMR in the first cycle of in vitro culture was set up as 
described by Chotivanich et a! (Chotivanich et al. 2000). All parasites were cultured 
as described above until the mature schizont stage. The schizonts were enriched by 
centrifugation through Percoll. For this the schizonts were spun down for 2min at 
250g. The pellet was resuspended at 50% haematocrit in cRPMI and carefully 
layered over 5m1 pre-wrmed Percoll (Sigma). The Percoll concentration was 60% 
for Malian samples, but had to be adjusted to 55% whilst working in Kenya to enrich 
a pure schizont population. A 90% Percoll stock was prepared from Percoll (Sigma) 
and lOX RPMI (Sigma), for example to prepare 30ml of 90% Percoll, 27m1 Percoll 
were diluted with 3m1 of lox RPMI. From this stock the working concentrations 
were prepared with incRPMI, generally 1 Oml were prepared at a time, so for a 60% 
Percoll concentration 6.67ml of 90% Percoll were diluted with 3.33ml incRPMI. The 
sample was spun for 20min at 2000rpm. After centrifugation the schizont band, 
which is visible above the percoll layer as a dark brown layer, is separated from the 
RBC and younger iREC. The band is isolated and washed twice with 5m1 incRPMI 
for 2min at 250g. The schizont pellet is then resuspended in cRPMI and aliquoted 
into 5 1.5m1 Eppendorf tubes. The schizonts were diluted to 2% haematocrit and a 
control smear was made to check the parasitaemia. The samples were then adjusted 
to around 1% parasitaemia with normal group A (Malian samples) or group 0 
(Kenyan samples) red blood cells, each from one single healthy Caucasian donor 
respectively. To each of the 5 samples either control or enzyme-treated RBC (see 
chapter 4) were added. They were incubated in 96-well plates (Corning) at a volume 
of 50tl at 2% haematocrit with duplicate wells for each isolate. The 96-well plate 
was placed within a gas modulator chamber (Billups-Rothenberg) to allow culturing 
in 3% CO2,1% 02, 96% N2 for 24hrs at 37 °C. Thin blood films of the pre-invasion 
sample and the ring-invaded RBC after 24hrs were made and stained with Giemsa to 
determine the parasitaemia. At least 1000 RBC from each slide of the duplicate wells 
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per sample were counted. The PMR is the number of ring-infected RBC after 
invasion divided by the pre-invasion parasitaemia. The multiplication rate can also 
be calculated using the total number of ring-stage parasites present in all infected 
RBC after invasion (Chotivanich et al. 2000). Analysis of the data using total number 
of ring-stage parasites rather than the number of ring-infected RBC did not 
materially affect any of the results shown here; therefore only data referring to the 
number of ring-infected RBC are given. 
2.3.6 Rosetting 
Rosette frequency was assessed by staining an aliquot of culture suspension with 25 
tg/ml of ethidium bromide. A wet preparation of the stained culture suspension at 
2% haematocrit was viewed with a fluorescence microscope and the percentage of 
200 mature-infected erythrocytes binding 2 of more uninfected erythrocytes was 
counted (the rosette frequency). 
2.3.7 Statistical analysis 
Statistical analysis was done with StatView 5.0.1 software and Minitab 14.1. The 
power calculation was determined using S-plus software. Non-parametric tests 
(Mann-Whitney U or Kruskal Wallis) were used for most analyses due to the non-
normality of the data, and correlations were assessed by Spearman rank correlation. 
The PMIR data were square-root transformed to conform to normality and 
homogeneity of variance assumptions. They were then analysed using a general 
linear model for the effects of disease severity, parasitaemia, country of origin, and 
the interaction between disease severity and country of origin. Repeating the non-
parametric analysis of the PMR with parametric tests using the transformed data did 
not materially alter the results (data not shown). The SI data were normalised by log 
transformation. Geometric mean SI (95% confidence intervals) for disease severity 
groups were calculated and compared by one-way analysis of variance. Correlations 
with SI were assessed by simple regression. 
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2.4 Results 
2.4.1 Growth of field isolates in vitro 
During the field work in Kenya a total of 69 samples were collected, 34 from severe 
malaria patients and 35 from uncomplicated malaria patients. I found that nearly 
50% (16 samples) of isolates from severe malaria patients failed to grow to the 
mature trophozoite stage in culture. Whereas, only 2 isolates from mild malaria 
patients failed to grow in culture. This difference may partly be explained by 
previous drug treatment. Analysis of the severe malaria patients' medical files 
showed that 9 (56%) out of the 16 samples that failed to grow had been from patients 
who had had previous drug treatment. It is likely that this occurred in more cases, as 
there were a number of samples with no entry in this section of the medical file. In 
contrast of the 18 samples from children with severe malaria that grew only 4 (22%) 
children had previous drug treatment recorded. Unfortunately, for the samples from 
children with uncomplicated malaria there is no existing record on possible previous 
drug treatment. 24 samples could not be included in the study for other reasons; these 
were that the parasitaemias were too low by the schizont stage, contamination or due 
to schizont rupture prior to percoll isolation. I collected multiplication rate data for 
33 samples as described below. The Malian samples were collected as part of a large 
case-control study described elsewhere (Lyke et al. 2003; Lyke et al. 2004b). 
Samples selected for inclusion in this study generally had >1% parasitaemias, which 
grew well to the schizont stage. 
2.4.2 Clinical and laboratory details of patients in the PMR study 
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The laboratory data for the patients in the PMR study are shown in Table 1. Children 
with severe malaria tended to have higher parasitaemias, higher white blood cell 
counts and lower haemoglobin levels than children with uncomplicated malaria 
(Table 1). The Kenyan children with severe disease are younger than those with 
uncomplicated malaria; however, this age difference is not seen in the Malian dataset 
because age-matching was part of the study design (Table 1). The parasites from 
severe malaria cases showed higher rosette frequencies than those from 
uncomplicated malaria cases as described previously (Rowe et al. 1995; Rowe et al. 
2002), although this was not statistically significant in Kenya where the sample size 
was small (Table 1). Of the 13 Kenyan children with severe malaria, 3 had cerebral 
malaria, 5 had respiratory distress and prostration, 4 had prostration alone and 1 had 
respiratory distress alone. Of the 19 Malian children with severe disease, 5 had 
cerebral malaria, 10 had other neurological impairment (prostration, obtundation or 
repeated seizures), 2 had respiratory distress, 1 had severe anaemia and 1 • had 
jaundice. One Malian child with respiratory distress died, and all the other children 
survived. 
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Table 1: Laboratory data and parasite multiplication rates for patients 












All patients 33 	33(30) 8.7(2.6) 6.0(4.1) 13.7 1.3(0- 2.2(1.1-3.3) 
[30] [27] (12.0) 5.5) 
[27] [20] 
Uncomplicated 20 	44(35) 9.8(l.3) 4.0 (2.3) 9.0 1.0(0-3) 2.3 (1.2-3.6) 
[17] [14] (3.6) [12] 
[14] 
Severe   13 	20(11) 7.5(3.1) 9.1 (4.5) 18.8 3.3(0- 1.8 (1.0-2.9) 
(15.6) 19.3) 
[8] 
P-value' P0.02 P0.0125 P0.0001 P0.003 P0.32 P0.38 
Mali 
All patients 6.1 	39 (22) 9.6 (1.8) 8.2 (7.8) 14.0 7.0(0 - 2.6(1.8-3.5) 
(7.2) 17) 
[60] 
Uncomplicated 23 	40(22) 9.6 (1.5) 3.0(1.7) 13.2 2.0(0- 3.1 (2.3-4.4) 
(7.4) 12) 
[22] 
Severe 19 	34 (22) 8.7 (2.4) 7.3 (4.3) 15.7 14.0(9- 2.8 (2.1 7 3.5) 
(8.3) 24) 
Hyperparasitaemic 19 	42 (24) 10.4 15.4 13.1 5.0(2- 1.8 (1.2-2.7) 
(1.1) (9.4) (5.9) 20) 
P-value' 	 P0.54 	P0.04 	P<0.0001 	P0.48 	P0.003 	P= 0.27i p=0 03k 
'Number studied. 
b Mean (Standard deviation). 
Square brackets [] indicate n, where n differs due to missing data. 
d Pt: parasitaemia percentage of infected RBC in 1000 RBC counted. 
C  WBC: white blood cell count. 
rosette frequency (percentage of infected RBC binding 2 or more uninfected RBC in 200 
infected RBC counted). 
Median (Interquartile Range). 
hThe mean (standard deviation) values for additional biochemical tests in the severe cases are pH 7.34 
(0.15), bicarbonate 16.04 mmoIIL (5.90), lactate 5.03 mg/dL (3.56). These tests were not available 
for uncomplicated cases in Kenya or for any Malian samples. 
'Statistical analysis: All columns were analysed for the malaria severity groups by ANOVA or 
Student's t-test, except the RF and multiplication rates which were analysed by Mann-Whitney U test 
(Kenya) or Kruskal-Wallis test (Mali). 
severe versus uncomplicated (Mann Whitney U test). 
k severe, uncomplicated and hyperparasitaemia groups (Kruskal Wallis test). 
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2.4.3 Field isolate multiplication rates are not associated with disease 
severity in Kenya and Mali 
I measured the PMR in the first cycle of in vitro culture for 33 Kenyan and 61 
Malian field isolates. A power calculation indicated that in both Kenya and Mali I 
had >99% power to detect a difference in PMR between severe and uncomplicated 
isolates as large as that seen in the previous study in Thailand (Chotivanich et al. 
2000). With the sample size and variance shown here for Kenya (the smallest of the 
two studies), I had >90% power at a 5% error level to detect a difference in the PMR 
between severe and uncomplicated isolates as small as 1.8. 
In both Kenya and Mali the multiplication rates were low (Kenya median 2.2, Mali 
median 2.6, Table 1). In Kenya there was no significant difference in the PMR of 
isolates from severe malaria patients compared to the PMIR of isolates from 
uncomplicated malaria cases (P=0.38, Mann Whitney U, Figure 1A and Table 1). 
Similarly, in Mali there was no significant difference in the PMIR of severe malaria 
isolates compared to uncomplicated malaria isolates (P=0.27, Mann Whitney U, 
Figure lB and Table 1). Children with uncomplicated malaria had lower 
parasitaemia than children with severe malaria in both Kenya and Mali (Table 1), 
and parasitaemia was found to be significantly negatively correlated with PMR in 
both Kenya and Mali (Kenya: Rho=-0.397, P=0.025; Mali: Rho=-0.312, P=0.02; 
Figure 2). The data on the relationship between PMR and disease severity were 
therefore re-analysed after adjustment for host parasitaemia, and there was still no 
significant difference between the PMR of uncomplicated malaria isolates compared 
to severe malaria isolates (17 1 , 29 0343, P=0.56 and F 1 , 3 8=0.120, P=0.73 for Kenya 
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Figure 1: 
Figure 1: Parasite multiplication rates (PMR) of Kenyan (A) and Malian (B) P. 
falciparum isolates from children diagnosed with uncomplicated or severe malaria. 
Isolates from Malian children diagnosed with hyperparasitaemia (Hyperpt.) are 
shown as a separate group. Equivalent children with hyperparasitaemia and no 
other symptoms or signs of severe malaria do occur in Kenya, but they were not 
recruited due to the study design. The median PMR for each group is indicated by 
the closed circle and line. 
In Kenya the PMR of isolates from cerebral malaria cases (n=3, median 2.7) was not 
significantly different to the PMR of isolates from patients with other forms of 
severe disease (n=10, median 1.7, P=0.74, Mann Whitney U). Similarly, in Mali, the 
PMR of isolates from cerebral malaria cases (n=5, median 3.5) did not differ 
significantly from the PMR of isolates from other severe malaria cases (n=14, 
median 2.5, P=O. 17, Mann Whitney U). The number of isolates in the sub-categories 
of severe disease is small, and a larger study would be required to determine 
conclusively whether there are any significant differences in PMIR amongst isolates 
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I also studied patients in Mali with hyperparasitaemia (>500,000 parasites per 
microlitre of blood) but no other symptoms or signs of severe malaria. These patients 
can be classified as "severe" using WHO criteria (World Health Organization 2000), 
however, they have a very low mortality rate and should probably be considered as 
an intermediate category between severe and mild uncomplicated malaria (Marsh et 
al. 1995; Lyke et al. 2003). Patients with hyperparasitaemia also occur in Kenya, but 
were not recruited in the Kenyan study because its aim was to compare the most 
severely ill children to those with mild uncomplicated disease, rather than 
considering the intermediate category. I found that isolates from patients with 
hyperparasitaemia had significantly lower PMR (median 1.8) than isolates from 
other Malian severe and uncomplicated malaria cases (P=0.03, Kruskal Wallis, 
Figure lB and Table 1). The occurrence of lower PMR in isolates from patients with 
higher parasite burdens was also indicated by the negative correlation between 
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Figure 2: Scatter plots indicating the negative correlation between the PMR and host 
parasitaemia of P. falciparum isolates from Kenya (A, n=33) and Mali (B, n=61). 
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I also examined PMR in relation to three other variables: patient age as a possible 
indicator of host immunity, haemoglobin as an additional measure of disease severity 
and parasite rosette frequency (a known correlate of malaria virulence in African 
children) (Rowe et al. 1995; Rowe et al. 2002). The age and haemoglobin levels of 
the children and the parasite rosette frequency were not correlated with PMR in Mali 
(P=0.98, P=0.72 and P=0.64 respectively) or Kenya (P=0.29, P=0.78 and P=0.70 
respectively, Spearman rank correlation). 
The maximum PMIR seen in the Kenyan isolates was 6. 1, and in the Malian isolates 
was 8.9 (Figure 1). This is in contrast to the previous study from Thailand where 
more than half of the isolates from severe malaria patients showed between 8 and 25-
fold multiplication (Chotivanich et al. 2000). I used identical methods to those 
described in the Thai study, however, my results are so clearly different to those 
reported earlier that I decided to examine the possibility of a technical problem in the 
PMR assay. I therefore studied PMR in a small, blinded set of Thai isolates (gift 
from Dr. K. Chotivanich and Professor N. White, Mahidol University, Thailand). 
The PMR assay was set up using blood from the same Caucasian donor who was 
used for the Mali samples. Despite the small numbers studied, the Thai severe 
malaria isolates had a higher PMIR (median 7.7, (n=4: 1.4, 6.5, 9.0, 10.2) than the 
Thai uncomplicated malaria isolates (median 2.2 (n=4: 0.4, 2.2, 2.2, 3.5) as shown 
previously (Chotivanich et al. 2000). This difference in PMR between severe and 
uncomplicated Thai isolates was significantly greater than that found in the African 
samples (country* disease severity interaction: F 1 , 77=5.20, P=0.008). Thus, technical 
differences between studies are unlikely to explain the contrast between P. 
falciparum isolates from Thailand and Africa in the relationship between PMR and 
severe malaria. 
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2.4.4 Clinical and laboratory details of patients in the SI study 
The laboratory data for the children in the SI study are shown in Table 2. The severe 
malaria patients had lower haemoglobin levels, higher parasitaemias and higher 
white cell counts than the children with uncomplicated malaria. The parasite isolates 
from the severe malaria patients had significantly higher rosette frequencies than the 
parasite isolates from the uncomplicated malaria and hyperparasitaemic patients 
(Table 2). Of the 46 Kenyan children with severe malaria, 20 had cerebral malaria, 
11 had respiratory distress and prostration, 11 had prostration alone, 2 had 
respiratory distress alone and 2 were missing the clinical details on sub-category of 
severe disease. Of the 46 Malian children with severe malaria, 13 had cerebral 
malaria, 23 had other neurological impairment (prostration, obtundation or repeated 
seizures), 2 had respiratory distress, 5 had severe anaemia and 3 had jaundice. 6 
Malian and 3 Kenyan children with severe disease died, and there were no deaths 
amongst the uncomplicated malaria or hyperparasitaemic children. 
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Table 2: Laboratory data and selectivity index for patients included in the SI 
analysis in Kenya and Mali 
N 	Age bc Hbc Pt bd (%) WBC
bce 11cfg Selectivit 





All patients 98 	33 (26) 8.1 (2.5) 6.5 (6.1) 13.2 (13.1) 4.25 (1-13.5) 1.92 
[79] [74] [45] [62] (1.65- 
2.19) 
Uncomplicated 52 	40(27) 9.4(l.5) 4.2 (2.9) 9.0 (3.9) 1.5(0-7) 2.05 
[37] [32] [21] [31] (1.55- 
2.55) 
Severe   46 	27 (23) 7.0 (2.6) 9.0 (7.7) 16.9 6.5(2.5- 1.79 
[42] [42] (16.9) 17.5) (1.58- 
[24] [31] 2.01) 
P-value P0.02 P<0.0001 P<0.0001 P0.044 P0.009 P0.56 
2 
Mali 
All patients 	10 39 (24) 	9.0 (2.4) 	7.6 (7.0) 
4 
Uncomplicated 	33 38 (20) 	9.4 (1.7) 	3.3 (2.5) 
Severe 	46 38 (25) 	8.2 (2.9) 	6.9 (5.7) 
Hyperparasitaemic 	25 44 (25) 	10.2(l.5) 	14.8 (8.0) 
P-value' 	 P0.58 	P0.003 	P<0.0001 
13.9 (7.7) 12(2-22) 1.61 
[101] [98] (1.12- 
2.10) 
12.9 (6.3) 2(0-14.5) 1.86 
[32] (0.60- 
3.11) 
15.4 (9.3) 18.5(11.5- 1.55 
[45] 37) (0.86- 
[40] 2.25) 
12.3 (5.5) 5(2-19.5) 1.44 
[24] (1.21- 
1.67) 
P=0.19 P<0.0001 P=0.62 
'Number studied. 
b Mean (Standard deviation). 
C  Square brackets [] indicate n, where n differs due to missing data. 
Pt: parasitaemia (percentage of infected RBC in 1000 RBC counted). 
e WBC: white blood cell count. 
RF: rosette frequency (percentage of infected RBC binding 2 or more uninfected RBC in 200 
infected RBC counted). 
g  Median (Interquartile Range) 
h The mean (standard deviation) values for additional biochemical tests in the severe cases are pH 7.26 
(0.15) n=23, bicarbonate 13.97 mmol/L (5.85) n23 and lactate 6.91 mg/dL (4.35) n=23. These tests 
were not available for uncomplicated cases in Kenya or for any Malian samples. 
'Statistical comparison: All columns were analysed for the malaria severity groups by ANOVA or 
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2.4.5 Selectivity index of field isolates is negatively correlated with 
parasitaemia 
I examined thin blood smears from 98 Kenyan and 104 Malian children. The 
geometric mean SI (95% confidence interval, CI) was 1.92 (1.65-2.19) for Kenyan 
isolates and 1.61 (1.12-2.10) for Malian isolates, indicating non-random, selective 
invasion at both sites. The SI in both Kenya and Mali was negatively correlated with 
host parasitaemia, (Kenya r = -0.523, Mali r = -0.526, P<0.001 in both cases, Figure 
3). To allow direct comparison with previous data (Simpson et al. 1999), I grouped 
the S  into 4 categories (<2% parasitaemia; 2.1-5%; 5.1-10%; 10%-max, Figure 4). 
The <2% parasitaemia group had a significantly higher SI than the other parasitaemia 
groups in both Kenya and Mali (P< 0.02, Figure 4, Student's t test). 
Figure 3: 
Figure 3: Scatter plots indicating the negative correlation between the selectivity 
index (SI) and host parasitaemia of P. falciparum isolates from Kenya (A, n=98) and 
Mali (B, n=104). 
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Figure 4: 
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Figure 4: Geometric mean SI (95% Cl) of P. falciparum isolates separated by patient 
malaria severity (uncomplicated, black bars; severe, white bars; hype rparasitaemia, 
grey bars) and host parasitaemia group. Four samples with a SI of 0 (i.e. no 
multiple-infected cells) were excluded (2 Kenyan and 2 Malian). 
The SI was not correlated with age (P=0.63 and P=0.76), haemoglobin (P=0.49 and 
P=0.68) or parasite rosette frequency (P=0.95 and P=0.24 for Kenya and Mali 
respectively, simple regression). The latter result was of particular interest because I 
had hypothesised that rosetting might increase SI if it resulted in preferential 
invasion into the RBC forming the rosettes. The lack of correlation between rosetting 
and SI suggests that invasion is not targeted into the uninfected erythrocytes in 
rosettes, a finding that agrees with previous work (dough et al. 1998). 
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2.4.6 Selectivity index of field isolates is not associated with disease 
severity 
I examined whether the SI differed amongst isolates from children with 
uncomplicated or severe malaria or hyperparasitaemia (Figure 4 and Table 2). One-
way analysis of variance with parasitaemia grouping included as a covariate showed 
no significant difference in the SI of isolates from the different disease severity 
groups (F 1 , 93=0.14, P=0.71 and F 1 , 73=0.255, P=0.62 for Kenya and Mali 
respectively). There was also no significant difference between uncomplicated and 
severe cases if only parasitaemias below 5% were analysed in accordance with 
previous data from Thailand (data not shown) (Simpson et al. 1999). With my 
sample sizes and variance I had >97% power to detect a difference between severe 
and uncomplicated isolates equivalent to that measured in Thailand (Simpson et al. 
1999). 
In Kenya the SI of isolates from children with cerebral malaria (geometric mean 
1.72, 95% Cl 1.29 to 2.15, n=20) did not differ significantly fron the SI of isolates 
from children with other forms of severe disease (geometric mean 1.85, 95% CI 1.59 
to 2.11, n=26, F 1 , 44 0.53, P=0.47, ANOVA). Similarly, in Mali, the SI of isolates 
from children with cerebral malaria (geometric mean 1.23, 95% CI 0.88 to 1.58, 
n=13) did not differ significantly from the SI of isolates from children with other 
forms of severe disease (Mali geometric mean 1.70, 95% Cl 0.74 to 2.67, n=33, 
P=0. 18, F 1 ,43=1.894, P=0. 18, ANOVA). 
2.4.7 Multiplication rate in relation to the selectivity index 
I also looked at the relationship between SI and PMIR. In Kenya there was a negative 
correlation between SI and PMR (n=29, Rho= -0.410, P=0.03, Spearman rank 
correlation, Figure 5A). However, in Mali there was no significant correlation 
between the SI and PMR (n=60, Rho— 0.015, P=0.91, Spearman rank correlation, 
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PMR giving a negative correlation between SI and PMR as seen in Kenya (figure 
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Figure 5: Scatter plots indicating the relationship between the PMR and SI of P. 
falciparum isolates from Kenya (A, n=29) and Mali (B, n=60). These samples are the 
subset from the SI data shown in Fig. 3 for which there is corresponding PMR data. 
2.4.8 ABO blood group of the patient is not associated with PMR or SI 
of the parasite isolates 
I looked at the PMR and the SI of the field isolates in relation to the ABO blood 
group of the patient they were isolated from. This is of interest as individuals with 
blood group A and B are at a higher risk of severe malaria (Pathirana 2005). I saw no 
association between the PMIR and the patients' blood group in Mali (P0.21, Kruskal 
Wallis). In Kenya there was a trend that isolates taken from patients with blood 
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group 0 (median PMR: 2.73, IQR: 2.02 to 3.76, n=17) had a higher PMR then 
isolates taken from patients with blood group A (median PMR: 1.75, IQR: 0.48 to 
4.63, n7) (P=0.03, Kruskal Wallis). This result was confounded though by the fact 
that the blood group A patients had higher parasitaemias (mean: 9.71, standard 
deviation 7.02, n=10) than blood group 0 patients (mean: 5.07, stdev 3.67, n=20) 
(P=0.02, Fisher's PLSD). Analysing them together in a parametric test looking at the 
effect of the blood group on the PMIR (square-root transformed) and including 
parasitaemia, as a covariate, there is no significant effect of blood group (P=0.12, 
ANOVA). Furthermore I saw no association between the ABO blood type and the SI 
(P=0.42 and P=0.33, Kniskal Wallis, Kenya and Mali respectively). 
I could confirm previous findings that the ABO blood group of RBC is associated 
with the rosetting frequency of field isolates. I found that there was a higher rosetting 
frequency of Kenyan field isolates in blood group A (median: 10.5; range: 1 - 70, 
n=6) versus blood group 0 RBC (1.5, 0 - 16, n=17) (P=0.03, Mann Whitney U). 
Although I did not see a high RF in blood group B RBC ( 0, 0-7, n=3). The 
association between RF and blood group A provides more evidence that rosetting of 
iRBC is linked to severe malaria, as this blood group has been associated with an 
increased risk of severe malaria (Pathirana 2005, Lell 1999). 
2.5 Discussion 
In this study I assessed two indicators of P. falciparum invasiveness (PMR and SI) 
and determined the relationship of these factors to malaria severity. The PMIR 
measures parasite multiplication under standard conditions in the first cycle of in 
vitro culture, whereas the SI is determined from blood smears taken directly from 
patients. There was no significant difference in the PMIR and SI of isolates from 
severe malaria patients compared to isolates from uncomplicated malaria patients in 
two diverse sites in Africa. This lack of association with severe malaria is in contrast 
to previous studies on PMR and SI from Thailand (Simpson et al. 1999; Chotivanich 
et al. 2000). I was able to exclude technical differences as the source of this 
discrepancy in results, because a small, blinded study of Thai isolates in my 
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laboratory confirmed the previously published data (Chotivanich et al. 2000). The 
PMIR of the African isolates were mostly in the range of 1-6 fold (Figure 1), and are 
comparable to those of uncomplicated malaria isolates from Thailand (Chotivanich et 
al. 2000). However, isolates with high PMR in the 10-22 fold range characteristic of 
severe malaria cases in Thailand were absent from Africa. It seems extraordinary that 
many isolates in both Africa and Thailand should have such low PMR when every 
schizont produces approximately 24 merozoites. I only used healthy parasites that 
matured well for one cycle in culture for the PMR assays, however, I do not know 
how well the in vitro assay reflects PMR in vivo. The high PMR seen in Thai severe 
malaria isolates are in agreement with estimates of PMR in vivo from recent studies 
with the P. falciparum laboratory-adapted clone 3137 infecting European volunteers 
(Cheng et al. 1997; Lawrence et al. 2000; Bejon et al. 2005), and from retrospective 
analysis of data collected during neurosyphilis treatment programmes (Gravenor et 
al. 1995; Simpson et al. 2002). To my knowledge, there are no comparable data 
available for in vivo PMR using fresh clinical isolates, or from any parasite clones in 
semi-immune individuals. 
Why should there be a difference between Asia and Africa in the association of PMR 
and SI with parasite virulence? In Thailand (and most of Southeast Asia), malaria 
transmission levels tend to be low, there is little acquired immunity in the population, 
and severe malaria affects all age groups (Luxemburger et al. 1997). In contrast, in 
sub-Saharan Africa, malaria transmission tends to be moderate to high, older 
children and adults show partial immunity to malaria and severe disease mainly 
occurs in children under the age of 5 years. It is possible that the different levels of 
immunity to malaria in the two regions are responsible for the diverse results 
highlighted here. Partial immunity in African patients could delay the course of 
infection and lead to later presentation at hospital than Asian patients, by which time 
differences between isolates in PMR and SI may no longer be apparent. If such a 
scenario were true, one might expect African children experiencing their first malaria 
infections after maternally-acquired immunity has waned, to show higher PMR more 
typical of those seen in Thailand. However, there was no correlation between age 
and PMR in my study, and isolates from children between 6 and 12 months of age 
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who are unlikely to have had many previous malaria infections did not have higher 
PMR than isolates from older children (Kenya: infants, n=5, median PMR 1.5; older 
children, n=25, median PMR 2.3, P=0.52, Mann Whitney U. Mali: infants, n=4, 
median PMR 2.7; older children, n=57, median PMIR 2.6, P=0.79, Mann Whitney 
U). There was also no significant correlation between age and SI, and isolates from 
children in the 6-12 month age group did not show significantly higher SI than 
isolates from older children (Kenya: infants, n=13, geometric mean SI 1.77 (1.38-
2.16); older children n=66 geometric mean SI 1.86 (1.55-2.17), F 1 , 75=0.15, P=0.70, 
ANOVA. Mali: infants, n=8, geometric mean SI 1.70 (95% CI 0.06-3.34); older 
children, n=96, geometric mean SI L60 (1.08-2.12), F 100=0.05, P0.82, ANOVA). 
The small number of children in the 6-12 month age group at both sites reflects the 
relative rarity of severe malaria in children under 1 year of age in these areas. A 
prospective study with active surveillance would be required to determine 
conclusively whether parasites from African children experiencing their first malaria 
infection show higher PMR and lower SI than parasites from older children. 
An alternative explanation of my results is that parasites adapted to grow in semi-
immune populations in sub-Saharan Africa have evolved different mechanisms of 
virulence compared to those adapted to grow in non-immune populations in Asia. 
The growth of parasites within the host during the asexual blood stage depends upon 
the multiplication potential of the parasite and the host's ability to remove infected 
red cells. It is plausible that in Asia, in the absence of significant levels of immunity, 
virulent parasites reach high parasite burdens within the host by having high PMR. In 
Africa, parasites with high PMR may not be effective in reaching high parasite 
burdens because of the presence of invasion-blocking antibodies in many hosts. In 
this case, parasite properties contributing to avoidance of the host's immune system 
clearance mechanisms may be more important in helping a parasite to achieve high 
parasite burdens and produce high levels of sexual stages and so maximise its 
transmission and fitness. 
Whatever the explanation for the discrepancies between sub-Saharan Africa and Asia 
indicated by this study, my results do raise the possibility that different pathogenic 
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mechanisms of severe malaria may operate in parts of the world with different 
malaria transmission levels. This possibility is supported by studies of another 
potential virulence factor, rosetting, which is associated with severe disease in 
multiple sites in Africa (Carlson et al. 1990; Rowe et al. 1995; Kun et al. 1998), but 
not in Asia (Ho et al. 1991; Angkasekwinai et al. 1998). The hypothesis that Asian 
and African parasites differ in virulence properties could be tested in the absence of 
confounding effects of host immunity and host genetics by studying isolates 
infecting non-immune travelers. 
One striking finding from this study was that isolates from Malian patients with 
hyperparasitaemia had significantly lower multiplication rates than other Malian 
isolates (Figure 1 and Table 1). Additionally, there was a negative correlation 
between in vivo parasitaemia and PMR across all isolates from both Kenya and Mali 
(Figure 2). These results seem counterintuitive, as one might expect that isolates 
reaching high parasitaemia in vivo would have the highest multiplication rates rather 
than the lowest. Density-dependent mechanisms are thought to occur in vivo to 
prevent excessive expansion of parasite populations, and can be determined by the 
availability of host red cells, the presence of host immunity or by a down-regulation 
of parasite invasiveness (Reuner et al. 1997; Bruce et al. 2000; Tyler et al. 2001; 
Bruce and Day 2003). My data are consistent with P. falciparum having the ability to 
down-regulate its multiplication rate in order to avoid overwhelming the host. I am 
not aware of any other experimental evidence to support such an idea, however, it is 
plausible that switching of invasion pathways (Dolan et al. 1990; Soubes et al. 1997; 
Cowman et al. 2000; Reed et al. 2000; Gaur et al. 2004) could potentially underlie 
such a process. It would be of great interest to examine the relationship between 
particular invasion pathways and parasite PMR and SI, and to determine whether the 
PMR and SI are stable properties of each isolate or can vary in response to external 
stimuli. An initial study found no association between invasion pathways and SI in 
Gambian field isolates (Baum et al. 2003). An alternative interpretation of the 
finding that isolates from hyperparasitaemic patients have very low PMIR is that 
slowly multiplying parasites may do less damage to their hosts and therefore are able 
to reach high parasitaemias without causing the type of life-threatening disease 
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manifestations seen in the severe malaria group. 
Could the relationship between PMR and in vivo parasitaemia explain the differences 
between African and Thai isolates? The interaction between parasitaemia and PMR 
was not commented upon in the Thai study, and the parasitaemias of the patients 
were not shown. However, high parasite burdens equivalent to those seen in Africa 
are not uncommon in Southeast Asia; therefore I think it unlikely that differences in 
parasitaemia levels explain the diverse results from the two areas. In the current 
study I have carried out additional analysis on the subset of samples with 
parasitaemias of less than 5%, and on all data after adjustment to take into account 
host parasitaemia effects. In both cases, there is no significant association between 
disease severity and PMIR and SI in African children. 
One similarity between Thai and African isolates is that red cell selectivity is highest 
at low parasitaemias, with isolates from patients with a parasitaemia of <2% having 
significantly higher SI than other groups (Figures 3 and 4). It may be that parasites 
with restricted invasion (high SI) are unable to reach high parasitaemias. A parallel 
to this occurs in P. yoelii, where virulent strains that invade normocytes reach higher 
parasitaemias than avirulent strains that have a strong reticulocyte preference 
(Walliker et al. 1976; Swardson-Olver et al. 2002). An alternative explanation for 
the high SI at low parasitaemia is that the presence of host anti-merozoite antibodies 
could lead to partial blocking of invasion and keep the parasitaemia low, while also 
agglutinating merozoites and increasing the number of multiple invasions (Miller et 
al. 1984). 
In this study I have found no evidence to support a role for high parasite 
multiplication or lack of red cell selectivity as virulence factors in African children, a 
finding that contrasts sharply with previous work from Southeast Asia (Simpson et 
al. 1999; Chotivanich et al. 2000). It may be that other virulence factors such as 
rosetting (Carlson et al. 1990; Rowe et al. 1995; Kun et al. 1998) and platelet-
mediated clumping (Pain et al. 2001) play a major role in parasite virulence in sub-
Saharan Africa, whereas PMR and red cell selectivity are more important in Asia. If 
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distinct pathogenic mechanisms do underlie severe malaria in different parts of the 
world, this could have implications for the development of new strategies to treat and 
prevent severe disease. The differences in pathogenic mechanisms of severe malaria 
in regions of varying malaria transmission in both Africa and Asia are therefore 
worthy of further study. 
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CHAPTER 3: RBC selectivity is not associated with virulence 
in P. chabaudi infections 
3.1 Abstract 
Red cell selectivity was studied in P. chabaudi infections with three congenic P. 
chabaudi strains: CWO, N-lines and I-lines, which differ in their virulence to the 
host. The experimental design allowed me to look at the effects of parasitaemia, 
strain virulence, host immunity, course of infection and mosquito transmission on the 
selectivity index '(SI). Invasion by P. chabaudi was found to be very unselective 
(geometric mean SI 1.17). There was no significant association of the SI with 
mosquito transmission (P=0.41), host immunity (P=0.94) or strain virulence (P=0.65, 
P0.25 and P0.35, pre-mosquito transmission, post-mosquito transmission naïve 
mice and post-mosquito transmission immunised mice respectively). The SI was 
overall negatively associated with parasitaemia (P=0.01), whereas this association 
was more strongly seen later during the infection. Independently of parasitaemia 
there was an increase in RBC selectivity from day 9 to day 14 of the infection 
(P=0.02, pre-mosquito transmission). The findings indicate that P. chabaudi 
virulence is not related to RBC selectivity. Furthermore, the interesting relationship 
between the time course of the infection and the SI reported here, is worth further 
investigation. 
3.2 Introduction 
The selectivity index (SI) is a measure of the red blood cell preference during 
merozoite invasion. It is defined as the observed number of multiple-infected RBC 
relative to that expected by chance. A SI of 1 implies RBC invasion to be completely 
random in terms of RBC selectivity, whereas deviations from 1 imply that the 
invasion process is selective, due to restriction of invasion into a subset of cells. RBC 
selectivity may be driven by both host factors and parasite factors ((Simpson et al. 
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1999), chapter 2). It has been mainly studied in P. falciparum isolates as described in 
the previous chapter (chapter 2) (Simpson etal. 1999; Chotivanich et al. 2000; Baum 
et al. 2003), but has been measured for a few other Plasmodia species (Simpson et 
al. 1999). The SI had only been studied in relation to virulence for P. falciparum 
isolates in Thailand (Simpson et al. 1999; Chotivanich et al. 2000), where it was 
found that parasites isolated from patients with severe malaria were less selective 
with lower SI than isolates from patients with uncomplicated malaria. The work 
presented in chapter 2 followed on. from the Thai study to look at the SI of P. 
falciparum isolates from Mali and Kenya. In contrast to the previous findings from 
Thailand, there was no association between the SI and malaria severity of clinical 
isolates from African children. A full discussion of the possible reasons for the 
different findings in Africa compared to Asia are presented in the previous chapter. 
Whether these differences are driven by host factors, such as host immunity levels, 
the time of sampling the parasites, or intrinsic parasite variation, it is clear that more 
questions arose than were answered. Hence further work is needed to examine the 
complex relationship between SI and malaria virulence. 
I decided to continue my work on the selectivity index of Plasmodia in relation to 
virulence in a different species - P. chabaudi. This species, a rodent malaria, is used 
frequently as a laboratory model to study Plasmodia virulence evolution - for 
example the effects of passaging, immune selection and strain competition 
(Mackinnon and Read 2003, 2004a; de Roode et al. 2005; Mackinnon et al. 2005a). 
P. chabaudi is a rodent model for P. falciparum malaria sharing some of the 
infection characteristics such as the cytoadherence properties of iRBC (discussed in 
(Mackinnon and Read 2004b)). The advantage of using this system here is the fact 
that the infection characteristics and virulence traits have been well studied and there 
are less confounding variables than there are when working with P. falciparum field 
isolates. An example of the course of infection of a P. chabaudi infection can be seen 
in figure 1, typically the peak parasitaemia occurs around day 7-9 after which the 
parasitaemia decreases until it is very low at day 14. The design of the study 
described here allowed me to look at differences in selectivity between unpassaged 
and passaged lines from the same ancestral strain with known differences in their 
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virulence to the host. The lines were derived from an avirulent ancestral line, CWO, 
and had been passaged through either naïve mice (N-lines) or immunised mice (I-
lines). Furthermore, the same lines were transmitted through mosquitoes. It has been 
previously reported (Mackinnon and Read 2004a) that passaging both through naïve 
and immunised mice led to an increase in virulence of the lines, with the I-lines 
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Figure 1: Schematic representation of the infection profile of naïve (solid line) or 
immunised mice (dashed line) infected with P. chabaudi. The parasitaemia (%) over 
the days 5 to 15 post-infection are shown. Adapted from (Mackinnon and Read 
2003). 
I hoped to gain insight into the possible factors driving RBC selectivity by looking at 
the SI of these congenic P. chabaudi lines: CWO, N-lines and I-lines. The first 
question I could address is whether in P. chabaudi infections there is a relationship 
between the SI and parasite virulence. One may expect that virulent clones are less 
selective as this has been reported previously for P. yoelii, where the virulent clones 
can invade normocytes (Walliker 1976), and for P. falciparum in Thailand (Simpson 
1999). Similarly it is possible to address whether mosquito transmission may affect 
the SI. Mosquito transmission has been shown to decrease virulence of P. chabaudi 
lines and lead to an increase of another known virulence factor, rosetting 
(Mackinnon et al. 2005). If there were a relationship between the SI and virulence, 
one would expect an increase in SI after mosquito transmission as virulence 
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decreases. Another question is whether the SI changes over the time-course of an 
infection. During the infection, the host mounts an immune response to the asexual 
stages of P. chabaudi and immunity may have an effect on the SI. Finally with this 
experimental design I could also look at the SI in naïve versus immunised mice. 
Parasitaemia-limiting factors in the immunised mice may be expected to lead to an 
increase in SI of the parasite lines. The results of this study are presented below. 
3.3 Materials and Methods 
3.3.1 Experimental design 
The experimental design for generating the lines has been described in detail 
elsewhere (Mackinnon and Read 2004a) and is shown in figure 2. In brief, two lines 
of P. chabaudi were selected from the ancestral avirulent line (CW-0, referred to 
here as CWO) by serial passaging through either naïve mice (N-lines) or immunised 
mice (1-lines) (mice: female C57131/6J, 7-10wk old). Immunised mice had been 
immunised with 104  parasites of a different clone, ER, on average 3 weeks prior to 
their use in the experiments detailed here (Mackinnon 2004). The N- and I-lines 
consisted of 5 independent sublines (figure 2A) and these had each been passaged 
once through mosquitoes. In the experiments reported here, for the pre-mosquito 
transmission experiments two mice were infected per subline giving a total of 10 
mice for the N- or I-lines, and a further five mice were infected with the ancestral 
line (CWO) (figure 213: 1). For the post-mosquito transmission experiments the 
sublines were transmitted once through Anopheles stephensi mosquitoes. As for the 
pre-mosquito transmission experiments, two mice were infected per subline and five 
mice were infected with the ancestral line (figure 213:2). 5 mice were also infected 
with the ancestral line, which had not been transmitted through the mosquito (not 
shown in figure). Furthermore, in the post-mosquito experiments both naïve and 
previously immunised mice were infected with the three P. chabaudi lines as 
described above (figure 213:2). Within this dataset the effect of host immunity on the 
SI could be compared for day 7. The analysis was limited to day 7, as the 
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parasitaemia in the immunised mice was too low to accurately assess the SI later in 
the infection. For the pre-mosquito experiment the SI was counted from slides made 
on day 7, 9, 11 and 14 of the infection and for the post-mosquito in naïve mice 
experiment the SI was counted from slides made on day 7, 9 and 11 of the infection. 
The pre- and post-mosquito experiments were separate experiments done at different 
times and comparisons for a mosquito transmission effect are not strictly valid. 
Within the post-mosquito experiment it was possible to analyse the effect of 
mosquito transmission on the CWO line, as 5 mice were infected with the ancestral 
line as described above. There were two repetitions of the pre- and post-mosquito 
experiments. 
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Figure 2: Schematic overview of the experimental design. 
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3.3.2 Selectivity index 
The slides included in this study were prepared on days 7, 9, 11 and 14 of the study. 
They are thin smears stained with Giemsa. Generally 300 ring-infected RBC (iRBC) 
were counted per slide (Leica, 100x magnification, brightfield) and the number of 
rings in each RBC was recorded. In some cases due to lower parasitaemias less than 
300 iRBC were counted, the minimum though being 100 iRBC counted. The SI was 
calculated as described previously (Simpson et al. 1999) Briefly, the number of 
observed multiple-infected RBC (i.e. 2 or more rings per RBC) was divided by the 
number of expected multiple-infected RBC. The latter was calculated according to a 
Poisson distribution, where lambda is (-ln(l-parasitaemia). The parasitaemia was 
counted as proportion of infected RBC per 500 RBC by Dr M. Mackinnon. The 
proportion of reticulocytes was counted on the Giemsa stained slide as reticulocytes 
are recognisably larger than RBC and stain a slightly darker shade of blue. This 
measure gave the proportion of reticulocytes out of all red blood cells. The red blood 
cell count was measured by flowcytometry (Coulter Electronics, Luton, UK). 
3.3.3 Statistical analysis 
All statistical analyses were done with Statview 5.0.1. The analyses were done with 
an ANOVA, using the log-transformed SI and log-transformed parasitaemia. The 
three experiments - pre-mosquito, post-mosquito in naïve mice and post-mosquito 
in immunised mice - were analysed independently for the main effects of line and 
day of infection. They were then pooled to look at the effects of treatment (naïve or 
immunised mice) or mosquito transmission (pre- or post-mosquito transmission). 
Here, the results from the minimal model are shown where non-significant effeôts 
and interactions were removed from the analyses. Significant interactions are 
described in the results. All analyses were carried out with and without including the 
log(pt) as a covariate. Furthermore, all analyses were repeated excluding all 
parasitaemias that were <1% to allow for the bias of errors in parasitaemia counting 
at low densities (see below). Correlations between SI and the variables proportion of 
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reticulocytes and RBC count were made with a non-parametric Spearman rank 
correlation of raw data (SRC). 
3.4 Results 
3.4.1 The SI is associated with parasitaemia 
There was a negative correlation of the SI with parasitaemia (P0.01, Rho=-0.173, 
SRC, figure 3A) when all data points were analysed together. A correlation between 
the SI and parasitaemia was seen previously for P. falciparum (see chapter 2) and 
other studies (Simpson et al. 1999) and is mainly due to the high SI at the lower 
parasitaemias. Interestingly here, as is visible from the figure, the parasitaemia was 
not associated with the SI on all days - with day 7 being an exception - this is 
discussed in more detail below. To examine the effect of parasitaemia on the SI, all 
of the analyses described below were performed with and without adjustment for 
parasitaemia. 
I considered the possibility that the high SI at the lower parasitaemias may be due to 
counting error in parasitaemia. The method of calculating the SI from a ratio means 
that the SI is particularly sensitive to deviations from the real parasitaemia at lower 
parasitaemias. This is because the expected number of multiple-infected RBC will be 
very small at low parasitaemias, and then even 1 observed multiple-infected RBC 
can create a large SI. This is illustrated in figure 3B. I calculated the number of 
multiple-infected RBC one would expect to see if the SI=1.173 over the range of 
parasitaemias that were included in this study. (The SI=1.173 is the mean SI from 
my data from samples above 5% parasitaemia, so excluding any bias in the SI at the 
lower parasitaemias.) I then increased and decreased the parasitaemia by a set 
amount (in this case by both 1% parasitaemia or 0.1% parasitaemia), keeping the 
number of multiple-infected RBC constant, and recalculated the SI. The new SI that 
one obtains, if the parasitaemia is over- or underestimated, are shown in the figure 
3B in red lines (1% parasitaemia) and blue lines (0.1% parasitaemia). This highlights 
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the problem that the SI is liable to change more in an upward direction at the lower 
parasitaemias if there is an error in the parasitaemia, thereby introducing, on average, 
a positive bias in SI at low parasitaemias. Included in the graph are also the actual 
data points from my work with P. chabaudi (figure 3B). Although the possibility of a 
parasitaemia induced error was considered many data points lay beyond the error 
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Figure 3: Scatterplot of the SI against the parasitaemia, showing the data for all three 
experiments. In plot A the days of infection are indicated by separate symbols (day 7: purple 
circles, day 9: red squares, day 11: violet triangles, day 14: orange diamonds). In plot B 
besides the data (counts: black circles) the SI calculated for errors in parasitaemias (1 %pt 
error red lines; 0.1% pt error blue lines) are indicated. See results for more details. 
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3.4.2 SI is not related to clone virulence 
At all time points I had data for three parasite lines: CWO, N-lines and I-lines (figure 
4A,B,C), although in the pre-mosquito dataset I only had data from 8 CWO samples, 
compared to 66 and 68 slides for the I- and N-lines. The geometric mean (95% CI) 
for the three lines in the pre-mosquito data set was 1.411 (0.623-2.199), 1.169 
(1.021-1.317) and 1.214 (0.966-1.462) for CWO, N-lines and I-lines respectively. 
There was no significant line difference between the three parasite lines when all 
days were analysed in either the pre-mosquito data set (F2, 1 39=0.43, P=0.65), the 
post-mosquito in naïve mice data set (F 2,49=1.44, P=0.25) or the post-mosquito in 
immunised mice data set (F 2, 12=1.23, P=0.33). This was also the case if the 
parasitaemia or alternatively if only parasitaemias above 1% parasitaemia were 
included in the analyses (not shown). 
I also looked at the effect of line on the SI on the individual days of infection (see 
figure 4 A,B,C). There was no difference on any of the days between the SI of the 
CWO, N-lines or I-lines in the pre-mosquito data set (F 2,37=0.24, P=0.79; F2,3 7=2.09, 
P=0.14; F 2 , 34=3.03, P=0.06 and F 2 , 22=0.69, P=0.52 for day 7, 9, 11 and 14 
respectively). The trend on day 11 is due to parasitaemia differences between the 
lines and is not maintained if parasitaemia is included in the analysis (F 2,3 1 =1.10, 
P=0.35). Similarly, only on day 11 is there a significant difference in the SI of the 
three lines after mosquito transmission (F 2 , 18=0.02, P=0.99; F2,20=1.02, P=0.38 and 
F2 , 5= 15. 11, P=0.003 for day 7, 9 and 11 respectively). Again this can be explained by 
differences in the parasitaemias (F 1 ,3=1.94, P=0.26), although only the CWO and I-
lines were compared in this analysis as the N-lines had to be excluded as there was 
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Figure 4: SI (left panel) and parasitaemia (right panel) of the three P. chabaudi 
lines: CWO (white bars), Wine (blue bars) and I-line (red bars). The SI was 
counted for pre-mosquito transmission infections in naïve mice (A) and post-
mosquito infections in both naïve (B) and immunised mice (C). The x-axis 
shows the day of the infection on which the slides were prepared. The mean 
and 1 standard error are shown. 
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Furthermore, I compared the non-passaged ancestral line (CWO) versus the passaged 
lines that had evolved to be more virulent (N- and I-lines, grouped as Non-CWO). 
There was no significant difference in either the pre-mosquito or post-mosquito data 
set (17 1 ,40=031, P=0.40 and F 1 , 50=1.85, P=0.18, respectively). 
3.4.3 Mosquito transmission and the selectivity index in P. chabaudi 
The experimental design allowed me to compare the selectivity index of the P. 
chabaudi isolates before and after mosquito transmission. I was interested in this as 
previously it has been shown that mosquito transmission can reduce virulence and 
increase the rosetting frequency of isolates (Mackinnon et al. 2005). The overall SI 
before mosquito transmission was 1.201 (geo. mean, 1.063 - 1.343, 95% confidence 
interval, n=142) and post-mosquito transmission in naïve mice was 1.115 (0.725 - 
1.505, n=52). There was no significant effect of mosquito transmission on the 
selectivity index (F 1 , 1 92=0.68, P=0.41) (figure 4 A,B). This was significant if the 
parasitaemia was included in the analyses (F 1 , 1 90=13.08, P=0.0004), but there was 
also a strong interaction as the parasitaemia was considerably lower after mosquito 
transmission (parasitaemia x MT [pre/post mosquito] interaction: 1 7 1,19o=11-11, 
P=<0.001), which makes the results hard to interpret. There was no effect of 
mosquito transmission on the RBC selectivity if the line was included in the analysis 
[i.e. CWO, I, N] (F1,1900.40, P=0.53). As the compared datasets were from 
experiments carried out at different times and therefore not strictly comparable, I 
also analysed an in-built pre- and post-mosquito transmission control for the CWO 
line. In the experimental design the ancestral line was included in the same 
experiment as the mosquito transmitted CWO line allowing a direct comparison of 
the effects of mosquito transmission. There was no significant difference between the 
SI before or after mosquito transmission of the ancestral line CWO (F 1 ,290.47, 
P=0.50). Thus the decrease in virulence of P. chabaudi lines after mosquito 
transmission (Mackinnon et al. 2005) cannot be explained by an increase in RBC 
selectivity. 
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3.4.4 The SI over the course of the infection 
The selectivity index was measured at multiple time-points during the infection as 
seen in figure 4 (left panel). The corresponding parasitaemias can be seen in the right 
hand panel (figure 4). I had data from day 7, 9, 11 and 14 for the pre-mosquito 
transmission infection. For post-mosquito transmission experiments, I had data for 
day 7, 9 and 11 in naïve mice, and only for day 7 of the infection in immunised mice 
because thereafter, parasitaemias were too low to obtain counts for SI calculations. 
The effect of the day of infection on SI varied between the pre- and post-mosquito 
groups and therefore is discussed separately below. 
In the pre-mosquito data there was no day effect on the SI (F 3 , 134 1 .84, P=0.14, 
figure 4A). If parasitaemia was included in the model, the day of infection was 
significantly associated with the SI (F 3 , 134 6.87, P=0.0002), but there was a 
significant interaction of the parasitaemia with the day of the infection (Day x 
parasitaemia interaction: F 3 , 134r8.52, P<0.0001) (figure 4A, right panel). Further 
investigation found that the interaction between the day of the infection and the 
parasitaemia was explained by a lack of a correlation between the SI and 
parasitaemia on day 7 in contrast to the negative correlation on the other days 
(P=0.13, P=0.002, P=0.003, P=0.0003, SRC, Day 7, 9, 11 and 14 respectively). 
Excluding day 7 from the model when looking at the effect of day of infection and 
parasitaemia on the SI removed the significant interaction of the two terms (Day x 
parasitaemia interaction: F 2 , 96 0.820, P=0.44). Nevertheless, the day of infection still 
had a significant effect on the SI (F 2 ,96=3.868, P=0.02), thus indicating that there is a 
day effect. As can be seen in figure 4A, the SI increases over time, with the 
exception of day 11. 
In the post-mosquito data set there was a significant effect of the day of infection on 
the SI (F2,49=7.03, P=0.002, figure 4B). If parasitaemia was included in the analysis 
there was no day effect on the SI (F 2 ,462.47, P=0.1) and there was no interaction 
between the parasitaemia and the day of infection. The high SI seen on day 11 of the 
post-mosquito naïve mice data set was due to very low parasitaemias on that day of 
67 
Chapter 3: RBC selectivity in P. chabaudi infections 
the infection (see above). When all parasitaemias below 1% were excluded from the 
analyses then there was no day effect on SI in either the pre-mosquito or post-
mosquito data set (F 3 , 1 3i1.53, P=0.21 and F 2,47=1.96, PO.l5, respectively). 
3.4.5 The SI in naïve compared to immunised mice 
I looked at the SI of the selected N-lines and I-lines when grown in naïve versus 
immunised mice (figure 4 B,C). Only data for day 7 of the infection in immunised 
mice were available for this comparison because the parasitaemias were too low later 
in the infection. Although the parasitaemia was considerably lower in the immunised 
mice, there was no difference in the SI between the naïve and immunised mice 
(F 1 , 34=0.01, P=0.94) (figure 413,C). The parasitaemia was not included in the analysis 
as there was no association between the SI and the parasitaemia on day 7 
(Rho=0.033, P=0.84, SRc). 
From the graphs (figure 4) one can see that the low parasitaemia on day 7 of the 
infection post-mosquito in immunised mice does not lead to the same larger mean 
and variance in SI as it does on both day 11 of the post-mosquito in naïve mice and 
day 14 in the pre-mosquito data set (figure 4). These may be considered to be 
roughly equivalent in terms of immunity, as supported by their similar parasitaemias, 
though different in the stage of the infection. This raises the question as to whether 
the high SI is more likely to occur at a later stage in the infection when possibly 
strain-specific immunity, anti-merozoite antibodies or some other parasitaemia-
limiting factor is present. To address this, I repeated the above analysis but compared 
the day 7 post-mosquito data in immunised mice to the results from day 11 in naïve 
mice (post-mosquito). The parasitaemia between these two groups did not differ 
(F 1 ,24=0.07, P=0.79). However, there was a significant difference in the SI between 
the two groups (F 1 , 21 =5.62, P=0.03). This was also the case if the parasitaemia was 
included in the analysis (Immune/naïve: F 1 , 20=8.08, P=0.01 and log(Pt): 17 1 ,20=12.53, 
P=<0.01). If parasitaemias below 1% were excluded from this analysis then there 
was a significant difference when parasitaemia was included in the analysis 
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(Immune/naIve: F1, 18=4.766, P=0.04 and log(Pt): F 1 , 18=4.21, P=0.06), but there was 
no effect when parasitaemia was not included in the analysis (F 1 , 1 9=1 .654, P=0.22). 
3.4.6 The SI is not associated with RBC count or the proportion of 
reticulocytes 
I found a weak correlation between the SI and the RBC count on the day the SI was 
counted (Rho=O. 188, P=0.03, SRC, figure 5A), but the latter is strongly correlated 
with the parasitaemia (Rho=-0.440, P=<0.0001, SRC). When parasitaemia was 
included in the analysis there was no correlation between the SI and the RBC count 
(F 1 , 139=0.30, P=0.59). Furthermore, looking at the effect of both the RBC count on 
the day of count and the day of the infection, there was no effect of the RBC count 
on the SI (F i , 137=2.40, P=0.12, ANOVA). There was no correlation between the SI 
and the proportion of reticulocytes present in the mouse blood (Rho=0.170, P=0.19, 
SRC, figure 5B). There was also no association if the day of infection was included 
in the analyses (F 1 ,55=2.23, P=0.14). This was expected, as P. chabaudi does not 
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Figure 5: Scatterplots showing that there is no correlation between the SI and 
either ABC count (A) or the proportion of reticulocytes (B). The points are 
separately labeled for the day of the infection (day 7: purple circles, day 9: red 
squares, day 11: violet triangles, day 14: orange diamonds). 
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3.5 Discussion 
I looked at the SI in congenic P. chabaudi lines that differed in virulence to address a 
number of questions as described earlier: i) Is the SI related to clone virulence? ii) 
Does mosquito transmission affect the SI of the three parasite lines? iii) Does the SI 
change over the time course of the infection? and iv) Does immunity affect the SI?. 
The following results were found. The three lines, CWO, I-lines and N-lines that 
were looked at differ in their virulence (Mackinnon and Read 2004a), but no 
significant difference in the SI in relation to virulence was seen. Similarly, there was 
no difference in the SI between the ancestral CWO line and the passaged lines. In 
accordance with these findings mosquito transmission did not change the SI of the 
congenic parasite lines. There was an effect of the day of infection on the SI. In the 
post-mosquito data set, the change of the SI over the days of infection could be 
explained with parasitaemia. The lower parasitaemias in the later days of the 
infection (day 11) were negatively associated with high SI. In the pre-mosquito data 
set the relationship between the day of infection and parasitaemia with the SI is more 
complex. There is a significant effect of both parasitaemia and the day of infection 
on the SI. The pre-mosquito and the post-mosquito data set show the same negative 
relationship of the SI with parasitaemia and/or day respectively, the general result 
being an increase in SI over time. Furthermore I found that P. chabaudi growing in 
naïve or immunised mice did not differ in their selectivity. I saw no correlation 
between the SI and the proportion of reticulocytes, which is expected as P. chabaudi 
does not have a reticulocyte preference and shows a low overall selectivity. There 
was also no correlation between the SI and the RBC count when adjusted for RBC 
parasitaemia. 
It is an unexpected finding that the SI of the three different lines is so similar, 
particularly on day 7 before the changes in parasitaemia occur, and this both before 
and after mosquito transmission. I had expected that CWO would be the most 
selective line of the three as it is the least virulent of the three lines, and that 
passaging to create the N- and I-lines may lead to a decrease in selectivity along with 
the increase in virulence. Virulence of these lines was defined by minimum RBC 
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count, but there was also a positive relationship between maximum parasitaemia and 
virulence (Mackinnon and Read 2004a) and I was trying to identify whether that may 
be in part due to decreased RBC selectivity. The results though show no difference in 
SI between the lines and there is no evidence to support the hypothesis that P. 
chabaudi virulence is associated with RBC selectivity. 
The underlying mechanisms of the virulence phenotypes of different P. chabaudi 
clones are not well understood. It is known that peak parasitaemia in an infection is 
positively correlated with the level of virulence caused to the host (Mackinnon 1999, 
Mackinnon 2003) and the early replication rates between N- and I-lines (M. 
Mackinnon, personal communication). There may be other factors, besides the 
asexual replication rate, which allow the more virulent strains to reach higher peak 
parasitaemias, persist for longer in the host and cause more damage to the host. Other 
mechanisms explaining how the different P. chabaudi clones cause more or less 
damage to their host are being elucidated. It is currently being studied whether the 
different clones trigger different levels of immunopathology, in terms of for example. 
cytokine production (e.g. TNFalpha) in the host (Grainne Long, personal 
communication). This follows from previous work where hosts with different 
susceptibility to P. chabaudi infections show different immune responses (Cross and 
Langhorne 1998) and higher TNFalpha levels have been correlated with severe P. 
falciparum malaria (Allan et al. 1995). 
How do my findings match the previous work looking at the association between 
field isolate SI and virulence in P. falciparum? In Thailand clinical isolates from 
severe malaria patients had lower RBC selectivity than isolates from uncomplicated 
malaria cases (Simpson et al. 1999). In my work, however, the SI of Malian and 
Kenyan field isolates was not associated with malaria severity in children (chapter 
2). Similarly to the results with African P. falciparum, in the rodent model described 
in this chapter, there was no association between SI and the three congenic P. 
chabaudi lines, which have been shown to differ significantly in their virulence to 
the host. Thus, the studies with P. falciparum and P. chabaudi are inconsistent with 
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the Thai results, where it was found that the SI is lower in P. falciparum isolates that 
cause severe malaria and are hence more virulent. 
There are of course limitations to the P. chabaudi model. The SI of this Plasmodia 
has, to my knowledge, not been studied before, although it is known that P. chabaudi 
does not have a reticulocyte preference (Jarra and Brown 1989). It is important to 
note that the SI of P. chabaudi is very low with a geometric mean of 1.167 (1.035 - 
1.299 95% CI, n=209). The SI for P. falciparum is higher with a mean around 1.7 
(see chapter 2). This may have important implications for the interpretation of the 
present results. As RBC selectivity is already very low in the ancestral line, CWO, 
then that may explain why no further reductions in selectivity in the passaged, more 
virulent N- and I-lines, is seen. It is possible that the adaptation of P. chabaudi from 
its natural host into mice has selected for isolates that can invade all RBC 
unselectively. It would be interesting to know what the SI of P. chabaudi is in its 
natural host the thicket rat, Thamnomys rutilans. Due to its low SI, P. chabaudi is not 
a good model to study RBC selectivity. There are other rodent models available; one 
for example is P. berghei, which has been shown to have a very high SI of 25.9 
(Simpson et al. 1999). P. berghei is known to have a strong reticulocyte preference, 
which has also been shown to vary in different hosts (Ott 1968; Mons 1990). 
Similarly the selection for more virulent P. yoelii lines has shown that parasites 
become more virulent by becoming less selective and invading normocytes (Walliker 
et al. 1976), which would indicate a change in the SI. However, these models more 
accurately reflect P. vivax, which has a stronger reticulocyte preference than P. 
falciparum (Mons 1990). 
In the P. chabaudi model the low parasitaemias mainly occur later in the infection 
and these are associated with higher selectivity. Interestingly though, it can be seen 
from the data in figure 4, that low parasitaemias in CWO on day 7 (figure 4A) and in 
all lines on day 7 in immunised mice (figure 4C) do not seem to associate with 
higher SI. Thus this raises the possibility that low parasitaemias are less likely to be 
associated with higher SI earlier in the infection, than later in the infection, i.e. day 
11 or 14. This suggests that during the infection, strain-specific immunity, anti- 
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merozoite antibodies or other parasitaemia-limiting factors -generate the negative 
relationship between parasitaemia and higher SI. I investigated this by comparing the 
SI of P. chabaudi on day 7 of the infection in the immunised mice versus the SI of P. 
chabaudi on day 11 in the naïve mice (figure 413,C). I found that these two groups 
did not differ statistically in their parasitaemia, but did differ significantly in their SI. 
This suggests that for a similar parasitaemia range, the SI is higher at a later stage in 
the infection. As the low parasitaemias are not associated with the higher SI on day 7 
of the infection in immunised mice, one may conclude that the immunity generated 
by previous immunisation with a heterologous strain does not affect RBC selectivity. 
One may postulate that strain-specific immunity may affect RBC selectivity. Strain-
specific immunity is known to play an important role in controlling P. chabaudi 
infections (Mota et al. 2001; Martinelli et al. 2005). Following from these findings it 
would be interesting to look in particular at low parasitaemia infections over the 
time-course of an infection to further investigate whether the association between 
low parasitaemias and higher SI generally occurs later in the infection. 
Finally, a correlation between the SI and the parasitaemia was seen. As in my 
previous chapter (chapter 2) and in previous work (Simpson et al. 1999), this is 
mainly due to the higher SI at low parasitaemias (roughly below 2% parasitaemia). I 
considered whether the bias in the SI at low parasitaemias might partly be due to 
errors in counting and the method for calculating the SI, which is based on a ratio of 
the observed multiple-infected RBC divided by the expected multiple-infected RBC. 
I showed this with a theoretical calculation of SI for a set number of multiple-
infected RBC and a change in parasitaemia by either 1% or 0.1%. The latter is very 
likely to occur at any parasitaemia. An error of 1% is less likely to occur, but may be 
possible. In this study the results fall beyond an error of 1% and therefore are likely 
to be explained by a biological effect rather than an error in counting the 
parasitaemia (figure 313). Although this is only the first attempt to explain why the 
association between the SI and parasitaemias is seen, it will be important to try and 
sort out to what extent the SI at the lower parasitaemias is due to parasitaemia errors 
versus being a real effect. This could be analysed in a careful study both controlling 
for parasitaemias and accurately quantifying the low parasitaemias by other means 
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such as real-time PCR, which could also give a better understanding of the SI at low 
parasitaemias over the course of an infection as discussed above. 
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4.1 Abstract 
Invasion of RBC by P. falciparum occurs by multiple pathways, which can be 
studied by looking at invasion into enzyme treated RBC. Although most research to 
date has focused on laboratory strains, a small number of studies have looked at the 
invasion profile of field isolates from outpatients. As yet, there are no reports on the 
invasion pathways used by field isolates from patients with severe malaria. Here I 
looked at the invasion profiles of 31 Kenyan isolates from children with 
uncomplicated or severe malaria. There was considerable variation in regards to the 
invasion pathways used, the majority of isolates (23/31) invade by a neuraminidase 
resistant, trypsin sensitive pathway. The molecular basis of this pathway has not been 
clearly defined. There was an equal distribution of the isolates from children with 
uncomplicated or severe malaria across the different invasion profiles. Furthermore, 
the isolates from children with severe malaria did not significantly differ in their 
inhibition by the different enzyme treatments compared to isolates from children 
with uncomplicated malaria (P>0. 1, all enzymes, Mann Whitney U). This work 
shows that there is no association between invasion profiles and malaria severity and 
that the majority of Kenyan isolates invade by a different pathway than described for 
Brazilian (Lobo 2004) or Gambian (Baum 2003) field isolates. This indication of 
geographical differences in the preferred invasion pathway used by P. falciparum 
isolates may have an important implication for vaccine design. 
4.2 Introduction 
Erythrocyte invasion by merozoites is a crucial step during the intra-erythrocytic 
asexual cycle of P. falciparum. This stage of the parasite infection causes an 
estimated 500 million clinical malaria cases per year (Snow et al. 2005) and 
understanding the parasite's biology is important to identify new drugs and vaccines. 
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Four key stages of invasion have been described: merozoite attachment to the 
erythrocyte, apical reorientation, tight-junction formation and finally erythrocyte 
invasion. The molecular basis of these processes is not well understood. It is now 
clear that in contrast to P. vivax, which requires the Duffy antigen for invasion, 
multiple pathways mediate erythrocyte invasion by P. falciparum merozoites (Gaur 
et al. 2004). Invasion pathways have been identified by looking at the invasion of 
merozoites into mutant erythrocytes (Pasvol and Wilson 1982; Hadley et al. 1987) 
and by removing RBC surface receptors with enzyme treatments (Mitchell et al. 
1986; Perkins and Holt 1988; Dolan et al. 1994; Binks and Conway 1999), the 
commonly used enzymes being neuraminidase, trypsin and chymotrypsin. 
Neuraminidase removes sialic acids from the RBC surface. Invasion into these RBC 
defines whether a parasite isolate is sialic-acid dependent or independent. Trypsin 
cleaves protein at lysine or arginine residues (Stryer 1995) and removes surface 
glycoproteins such as glycophorin A (GPA) and glycophorin C (GPC). 
Chymotrypsin has a different specificity to trypsin cleaving at tyrosine, tryptophan, 
phenylalanine and methionine residues (Stryer 1995) and removes for example 
glycophorin B (GPB). 
Invasion profiles of various laboratory P. falciparum strains have been defined by 
studying invasion into enzyme treated RBC. Isolates are termed dependent or 
sensitive if invasion is decreased after a specific enzyme treatment, e.g. an isolate 
that does not invade a neuraminidase treated RBC invades via a sialic-acid dependent 
or neuraminidase sensitive pathway. Similarly if invasion of an isolate is not 
decreased by a specific enzyme treatment they are termed resistant or independent. 
A number of invasion profiles have been described as shown in table 1 and they are 
briefly discussed below. 
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Table 1: Invasion profiles described for P. falciparum laboratory strains. 
Invasion Profile type' I Parasite Ligand 	I RBC receptor 	I Reference 
NmT8 CTR 	 EBA-175 	 GPA 	
(Pasvol 1982)(Camus 
1985) (Sim 1994) 
BAEBL 	 GPC 	 (Maier 2003)(Mayer 2003) 
Nm S TR CT 	 ? 	 GPB 	
(Dolan 1994) 
JESEBL 	 Receptor E 	 (Gilberger 2003) 
NmS TR CTR 	 PfRhl 	 Receptor Y 	
kriaplut euv I)IIIII 
2005) - 
Nm R TS CT? 	 ? 	 Receptor  
Nm R  TR  CT8 	 PfRh2b 	 Receptor z 	
(Duraisingh 2003) 
MSP1 Band 3 	 (Goel 2003) 
AMA1 	 Kxb (Kato 2005) 
N mAT? CT? 	 PfRh4 	 ? 	
(Stubbs 2005) 
a Invasion profile type abbreviations: Nm = neuraminidase, T = trypsin, CT = chymotrypsin, 
S = sensitive and R = resistant 
b Erythrocyte membrane protein, Kx (Kato 2005) 
c PfRh4 has so far only been associated with the sialic-acid independent pathway in some 
but not all sialic-acid independent laboratory P. falciparum isolates (Stubbs 2005) 
The best-defined and characterised profile is a neuraminidase and trypsin sensitive, 
yet chymotrypsin resistant invasion phenotype. This invasion pathway is mediated 
by GPA as the erythrocyte receptor and EBA- 175 as the parasite ligand (Camus and 
Hadley 1985; Sim et al. 1994). Another receptor-ligand interaction defined by this 
enzyme profile is mediated by the ligand BAEBL binding to GPC (Mayer et al. 
2002; Maier et al. 2003). The next invasion profile is a neuraminidase sensitive, 
trypsin resistant and chymotrypsin sensitive invasion phenotype. This invasion 
profile has been described for the receptor GPB, which is trypsin resistant, but the 
parasite ligand remains unknown (Dolan et al. 1994) The same invasion profile 
could point to an invasion pathway via the unknown receptor E and the parasite 
ligand, JESEBL (Gilberger et al. 2003). A neuraminidase sensitive and trypsin 
resistant, yet chymotrypsin resistant invasion profile is mediated by interactions 
between the unknown RBC receptor Y and the P. falciparum protein PfRhl (Rayner 
et al. 2001; Triglia et al. 2005). A neuraminidase resistant and trypsin sensitive 
profile has been described for the unknown receptor X, which so far has no known 
ligands (Dolan et al. 1994). Finally another described invasion profile shows 
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resistance to both neuraminidase and trypsin, yet sensitivity to chymotrypsin 
treatment of the RBC. There are two described pathways that fit this invasion profile. 
The first describes an undefined parasite ligand interacting with an unknown receptor 
Z in a sialic-acid and trypsin independent manner (Duraisingh et al. 2003). Another 
speculative pathway is an interaction between the RBC protein band 3 and MSP1 on 
the merozoite surface (Goel et al. 2003). Furthermore a possible interaction between 
the P. falciparum protein AMA! with the erythrocyte membrane protein, Kx, has 
been described (Kato et al. 2005), although in this case the proposed interaction only 
occurs after trypsin treatment indicating that prior modification of the protein is 
necessary. Most recently it has been described that PfRh4 activation may be involved 
in a pathway switch to sialic acid-independent pathways (Stubbs et al. 2005). In this 
study, W2mef parasites either selected to grow on neuraminidase treated RBC or 
where EBA- 175 was disrupted had increased expression levels of PfRh4 and the 
pseudogene PEBL, which are located in a head-to-head orientation on chromosome 4 
(Stubbs et al. 2005). Switching of P. falciparum laboratory isolates when selected on 
neuraminidase treated RBC had been described previously (Mitchell et al. 1987, 
Dolan et al. 1990) indicating how parasites can adapt to emply different invasion 
pathways under selective pressure. There are also multiple allelic types of two P. 
falciparum proteins, BAEBL and IESEBL. The different allelic types mediate 
different erythrocyte-binding specificities to enzyme treated erythrocytes when the 
recombinant regions containing the different polymorphisms are expressed on 
transfected cells (Mayer et al. 2002; Mayer et al. 2004). However, although the 
presence of BAEBL and JESEBL allelic types has been confirmed in field isolates 
(Lobo et al. 2004), they may not be functionally important as the allelic types have 
not been associated with different invasion profiles in field isolates (Lobo et al. 
2004). 
Blood group antigens may also be associated with invasion, as a recent paper 
described higher invasion rates for laboratory P. falciparum strains into Al type 
RBC (Cheng et al. 2005). Blood group antigens are surface immunodominant sugars 
on the outside of the RBC membrane. Although there are a large number of blood 
group antigens (see Reid and Lomas-Francis 1997) only a few of them are of 
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particular interest here: the ABO blood group system and the MNS blood group 
system. The ABO blood group system contains the A and B antigens. These two 
antigens are defined by specific sugar residues added to the H antigen precursor, 
more specifically the addition of a N acetyl galactosamine to form the A antigen and 
a galactose residue to form the B antigen (Reid and Lomas-Francis 1997). These 
antigens are carried on glycoprotein molecules, such as band 3. The ABO blood 
group antigens are highly abundant. The MNS blood group system are found on the 
above described glycoproteins GPA and GPB (Reid and Lomas-Francis 1997). These 
proteins have been directly associated with P. falciparum invasion pathways as 
detailed above. 
The description of the above invasion pathways is based on work with laboratory-
adapted P. falciparum strains. The results for each strain are consistent across 
laboratories indicating that the invasion phenotype is stable (Dolan et al. 1994; Binks 
and Conway 1999), with the exception of a report showing different invasion profiles 
for two 3D7 lines (Cortes et al. 2004). Following from the work on laboratory 
isolates there has been recent interest to study the invasion phenotypes of field 
isolates to understand the RBC invasion process in human P. falciparum infections. 
This is of particular relevance for vaccine design to blood-stage antigens, which may 
target specific invasion pathways. To date there are three studies looking at the 
invasion profiles of field isolates collected in India, The Gambia and Brazil 
respectively (Okoyeh et al. 1999; Baum et al. 2003; Lobo et al. 2004). These studies 
have reported on the invasion profiles of field isolates invading neuraminidase or 
trypsin treated RBC (Okoyeh et al. 1999; Baum et al. 2003) or neuraminidase, 
trypsin or chymotrypsin treated RBC (Lobo et al. 2004). Overall large variation 
between the invasion pathways used was found for all sites, although there generally 
seems to be one preferred invasion profile employed by the majority of isolates from 
each study site. 12 out of 15 Indian isolates used an alternative pathway to the EBA-
175/GPA pathway (Okoyeh et al. 1999). Whereas, in both The Gambia and Brazil 
the neuraminidase and trypsin sensitive invasion profile was the predominant one 
(30/38 isolates in The Gambia and 7/14 isolates in Brazil) (Baum et al. 2003) (Lobo 
et al. 2004). Furthermore, in contrast to the conclusions from the study in The 
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Gambia that the majority of isolates invade through the EBA-175/GPA pathway, the 
Brazilian study challenges the notion that the neuraminidase and trypsin sensitive 
invasion profile indicates invasion by the EBA-175/GPA pathway, as they show that 
5 of the 7 Brazilian isolates with this phenotype can invade RBC, which lack GPA 
(Lobo et al. 2004). 5 out of 14 Brazilian isolates were trypsin resistant, which is an 
unusual phenotype (Lobo et al. 2004). 
All of the above studies were based on field isolates collected from patients with 
uncomplicated malaria (Okoyeh et al. 1999; Baum et al. 2003; Lobo et al. 2004). I 
was interested in the invasion profiles of isolates collected from severe malaria 
patients. Parasite isolates from severe malaria patients have been .associated with 
high multiplication rates and a decreased RBC selectivity in Thailand (Simpson et al. 
1999; Chotivanich et al. 2000) and it is unknown whether isolates from patients with 
severe malaria may use a specific invasion pathway or possibly a larger range of 
invasion pathways than isolates from patients with mild malaria. In this chapter the 
invasion profile of Kenyan field isolates collected from children diagnosed with 
either uncomplicated or severe malaria is reported and the association between 
invasion profile and disease severity is examined. 
4.3 Materials and Methods 
4.3.1 Parasite isolates 
Parasite isolates were collected from Kilifi, Kenya. At this site, malaria transmission 
is seasonal (June to August and December to February), with infective bites ranging 
from 10-30 per year (Kinyanjui et al. 2004). Children with cerebral malaria 
(unrousable coma with a Blantyre score 2), prostration (inability to sit or in babies, 
to breast feed) or respiratory distress (abnormally deep breathing) were considered to 
have severe malaria. The clinical definition identifies approximately the same group 
of children at risk of life-threatening malaria as those identified by the more 
comprehensive WHO criteria (Marsh et al. 1995). Uncomplicated cases were 
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children with malaria presenting at hospital with no signs of severe disease, who 
were treated as outpatients with oral therapy. Blood samples were collected after 
obtaining informed consent from the children's parents or guardians, and protocols 
were approved by ethical review boards in the UK and Kenya. The isolates were 
collected into heparinised tubes and processed within 12 hours of collection. 
Lymphocytes and the huffy coat were removed, the RBC washed three times in 
incomplete RPMI and resuspended in complete RPMI. The parasites were cultured in 
3%CO2, 1%02, and 96%N2 at 37°C. Cultures were monitored by Giemsa smears for 
18-36 hours, and only those with normal morphology that matured to the schizont 
stage were included in the study. 
Thin smears were prepared from blood collected from the patient at arrival at 
hospital and were stained with Giemsa. 
4.3.2 Selectivity Index 
300 ring-infected RBC were counted per slide and the number of rings in each RBC 
was recorded. The SI was calculated as described in detail by Simpson et 
al.(Simpson et al. 1999) Briefly, the number of observed multiple-infected RBC (i.e. 
2 or more rings per RBC) was divided by the number of expected multiple-infected 
RBC. The latter was calculated according to a Poisson distribution, where lambda is 
(-ln(1-parasitaemia). The parasitaemia was counted as proportion of infected RBC 
per 1000 RBC. 
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4.3.3 Parasite culture 
The parasites studied were P. falciparum clone 7G8 (Hadley et al. 1987) and strain 
M. Parasites were cultured in complete RPM! (cRPMI: RPMI 1640 (BioWhittaker) 
plus 25mM HEPES (BioWhittaker), 2mM glutamine (BioWhittaker), 25mM glucose 
(BioWhittaker), 25.tg/ml gentamicin (Gibco) and 10% pooled human AB serum) at 
1-2% haematocrit in 0+ RBC at 37°C with 3%CO2, 1%02, and 96%N2 at 37°C. 
Laboratory strains were synchronised by sorbitol (Sigma) lysis (Lambros and 
Vanderberg 1979). Incomplete RPM! (incRPMI) contains the following: RPM! 1640 
plus 25mM HEPES, 2mM glutamine, 25mM glucose and 25.tgIml gentamicin. 
4.3.4 Donor erythrocytes 
Donor RBC for the work with Kenyan field isolates were collected from a Caucasian 
donor (0+). 1 Omi whole blood were collected into 2m1 acid citrate dextrose (ACD, 
Gibco), mixed to prevent coagulation and stored at 4°C for a maximum of two 
weeks. Before use the white blood cells were removed by layering 6ml of whole 
blood over 5m1 lymphoprep (Axis Shield) and centrifuging for 20minutes at 400g. 
This results in a clean RBC pellet with all white blood cells in the layers above. The 
packed RBC were washed twice with lOml incRPMI, resuspended at 50% 
haematocrit and used within one week. 0+ RBC for experiments with laboratory 
strains were from the Blood Transfusion Unit. They were treated as described above. 
4.3.5 Enzyme preparation 
Frozen aliquots of trypsin (Sigma), chymotrypsin (Sigma) and the soybean trypsin 
inhibitor (Sigma) were prepared. For these the enzymes were dissolved in incRPMI 
to the required concentrations: trypsin (T, lmg/ml), chymotrypsin (1mg/mi) and 
soybean trypsin inhibitor (STI , 0.5mg/mi). They were then frozen in imi aliquots at 
-20°C. The neuraminidase ( Vibrio cholerae, Caibiochem) was reconstituted in dH20 
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and stored at 4°C following manufacturers instructions. Another supply of 
neuraminidase (Vibrio cholerae, Roche) was stored at 4°C. 
4.3.6 Enzyme treatment 
The enzyme treatment is based on previous protocols as described (Baum et al. 
2003). An aliquot of each of the required enzymes was thawed. A tube with 50mU 
neuraminidase in lml incRPMI was prepared and one control with 1 m incRPMI. To 
each tube (control, neuraminidase, chymotrypsin, trypsin) lOOj.tl packed cell volume 
of donor RBC were added. The tubes were incubated on a rotating wheel 
(ThermoDenley Cell Mixer) for ihour at 37°C. After that time all samples were 
washed once with imi incRPMI and then soybean trypsin inhibitor was added to the 
trypsin and chymotrypsin samples to inhibit the enzyme. IncRPMI was added to the 
control and neuraminidase sample. The samples were incubated on a rotating wheel 
for 10 minutes at room temperature. The samples were washed three times before 
resuspending the RBC at 50% haematocrit in incRPMI. The enzyme treated RBC 
were stored at 4°C and used for a maximum of one week after which the samples 
were freshly prepared. 
4.3.7 Agglutination of enzyme treated RBC 
A 20 .tl sample of each of the different RBC samples was diluted in 200tl 0.9% 
NaCl (Sigma). 40tl of the 5% haematocrit sample of each was added to the same 
volume of anti-M antibody (Biotest Uk Ltd), anti-S antibody (Biotest Uk Ltd) or 
Peanut (Arachis hypogaea) lectin (Sigma, reconstituted in PBS and stored in aliquots 
at -20°C) in Pyrex tubes. The samples were mixed and the tubes covered with 
parafllm. The samples were incubated for 5minutes (anti-S antibody) or 30 minutes 
at room temperature (anti-M antibody and PNA lectin). The anti-S antibody samples 
were centrifuged for 1 minute at 150g before the agglutination was assessed. To 
check for agglutination the pellets were gently dislodged, the agglutination assessed 
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by eye and the following scores given: one large agglutinate (++), small agglutinates 
(+), no agglutinates (-). 
4.3.8 Invasion pathway assay 
The assay to determine PMR in the first cycle of in vitro culture was set up as 
described (Chotivanich et al. 2000). All parasites were cultured as described above 
until the mature schizont stage. The schizonts were enriched by centrifugation 
through 55% Percoll (Sigma). The enriched schizonts were washed twice and 
adjusted to around 1% parasitaemia with normal group 0+ red blood cells and 
enzyme-treated red blood cells, from one single healthy Caucasian donor. They were 
incubated in 96-well plates (Corning) at a volume of 50d at 2% haematocrit with 
duplicate wells for each isolate. The 96-well plate was placed within a gas modulator 
chamber (Billups-Rothenberg) to allow culturing in 3%CO2, 1%02, and 96%N2 for 
24hrs at 37°C. Thin blood films of the pre-invasion sample and the ring-invaded 
RBC after 24hrs were made and stained with Giemsa to determine the parasitaemia. 
At least 1000 RBC from each slide of the duplicate wells per sample were counted. 
The PMR is the number of ring-infected RBC after invasion divided by the pre-
invasion parasitaemia. Invasion inhibition was measured as (100 - ((Enzyme-treated 
PMRlcontrol PMIR)xlOO)). In a few cases no ring-iRBC were seen and the invasion 
inhibition was measured as 100%. Where the PMR into enzyme-treated RBC was 
higher than into control RBC the invasion inhibition is given as a negative value, due 
to an increase in invasion. 
4.3.9 Statistical analysis 
All statistical tests on the Kenyan field isolate data were non-parametric tests as the 
data were non-normally distributed. To calculate the median and interquartile range 
and for statistical analyses any negative invasion inhibition results were counted as 0. 
The Mann-Whitney U test or Kruskal Wallis test were used to look for differences 
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between two or more groups respectively. Correlations between the selectivity index 
(SI) and the invasion inhibition data were carried out with a Spearman Rank 
Correlation. 
4.4 Results 
4.4.1 Controlling for enzyme treatment of RBC by agglutination 
I used two different methods to control for the enzyme treatment of the RBC for my 
study of the invasion pathways of Kenyan field isolates. Firstly, removal of epitopes 
from the RBC surface by the enzymes can be checked with two monoclonal 
antibodies and a lectin. The two monoclonal antibodies, anti-M and anti-S, recognise 
epitopes that are trypsin and chymotrypsin sensitive respectively. The peanut lectin 
will only agglutinate neuraminidase treated RBC. Table 2 shows the agglutination 
profile. After trypsin treatment the anti-M antibody does not agglutinate the RBC, 
whereas RBC treated with chymotrypsin are not agglutinated by the anti-S antibody. 
This shows the specificity of the two enzymes used. Furthermore agglutination of the 
RBC by the peanut lectin, PNA, was only observed after neuraminidase treatment. It 
is worth noting that upon neuraminidase treatment the anti-M and anti-S antibodies 
do not agglutinate the RBC as the epitopes recognised carry sialic acid residues (Sim 
et al. 1994). 
Table 2: Agglutination of RBC after enzyme treatment 
Enzyme Treatment 	Anti-M antibody 	Anti-S antibody 	 PNA8 
Control - 	 ++ 	 ++ 	 - 
Neuraminidase 	 - 	 - ++ 
Chymotrypsin 	 ++ 	 - 	 - 
Trypsin (1 mg/ml) 	 - 	 ++ 	 - 
a PNA, peanut (Arachis hypogaia) lectin 
•7G8 
• Dd2 
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4.4.2 Controlling for the enzyme treatment of RBC with P. falciparum 
laboratory strains of a known invasion phenotype 
Invasion pathways have been studied mainly with laboratory isolates to date. It is 
known that most laboratory strains have a stable invasion phenotype, which has been 
demonstrated in different laboratories. A good overview of this is given in Binks et 
al. (Binks and Conway 1999). For studies with field isolates a number of laboratory 
isolates are included in the study for comparative purposes (Baum et aL 2003; Lobo 
et al. 2004). I looked at the invasion phenotype of two laboratory isolates, 7G8 and 
Dd2. These two strains were selected as they show different profiles (Binks and 
Conway 1999). 7G8 is sialic-acid independent - invasion into RBC by this isolate is 
highly inhibited by trypsin (80 - 95% inhibition compared to the control) and to a 
much lesser degree by neuraminidase (30 - 40%). Dd2 on the other hand is highly 
inhibited by neuraminidase (90 - 100%), but less so by trypsin (50%). I did three 
independent experiments with these two isolates the results of which can be seen in 
figure 1. 
Inhibition of Invasion of 7G8 and Dd2 











Nm 	 Ct 	 T 
Enzyme 
Figure 1: Invasion inhibition (mean + 1SE) of two laboratory strains, 7G8 (blue) and 
Dd2 (red), following enzyme treatment of RBC. The enzyme treatments are listed on 
the X-axis and concentrations were as follows: Nm=neuraminidase 50mU/ml, 
Ct=chymotrypsin 1 mg/ml and T=trypsin 1 mg/ml. 
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The invasion profiles seen in regards to neuraminidase and trypsin treated RBC 
matched those predicted, which confirmed that both the enzyme treatment and the 
invasion assay were giving results comparable with previous research. Unfortunately 
little is known about the chymotrypsin invasion phenotype of parasites, as there has 
only recently been an interest in this pathway. 
4.4.3 Invasion profiles of Kenyan P. falciparum isolates 
The invasion profiles of 31 Kenyan isolates were examined (table 3). These isolates 
were a subset of those studied in chapter 2. Invasion inhibition by three different 
enzyme-treatments of RBC was measured: treatment with neuraminidase (Nm, 
50mU/ml), chymotrypsin (CT, 1mg/mi) and trypsin (T, lmg/ml). 
The invasion inhibition of Kenyan field isolates into Nm treated RBC varied from - 
32.4 (indicating an increase in invasion) to 100% inhibition (i.e. no ring iRBC were 
counted), with a median inhibition of 12.8%. The inhibition into CT treated RBC 
ranged from -66.7 to 100%, with a median inhibition of 62.8%. Invasion into trypsin 
treated RBC varied from 28 to 100%, with a median inhibition of 89.1%. 
The invasion profiles of the field isolates were defined by their Nm, CT and T 
invasion inhibition. Inhibition above 50% compared to the control was defined as 
sensitive and below 50% was defined as resistant according to the common 
definition (Baum et al. 2003; Lobo et al. 2004). The Kenyan isolates showed 6 out of 
a possible 8 phenotype combinations. Eighteen of the Kenyan isolates showed a 
neuraminidase resistant and chymotrypsin and trypsin sensitive profile (table 3). This 
profile matches the profile of 7G8. Five of the Kenyan isolates were neuraminidase 
and chymotrypsin resistant and trypsin sensitive. Three of the Kenyan isolates were 
sensitive to all enzymes: neuraminidase, chymotrypsin and trypsin. Three of the 
isolates showed no sensitivity to chymotrypsin and were neuraminidase and trypsin 
sensitive - this being the predominant invasion profile in a sample of Brazilian 
isolates and Gambian isolates (although the chymotrypsin sensitivity is unknown for 
the Gambian isolates) (Lobo et al. 2004) (Baum 2003). One isolate showed the same 
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Table 3: Invasion profile of Kenyan field isolates 
% Inhibition compared to control 
Invasion in RBC treated with: 
Profile type 
Isolat& 
Nm CT T 
(50mU/mI) (1mg/mi) (1mg/mi) 
NmR TS CTS 
7G8 33.3(19.2) 58.2 (7.5) 80.7 (5.5) 
6 U 9.3 62.8 86.1 
7 U 12.8 76.6 83.0 
8 S 7.1 78.6 78.6 
9 S -32.4 90.1 97.2 
10 S 0 73.2 87.8 
11 U 49.1 59.7 75.4 
12 S -22.8 62.9 85.7 
13 U 8.5 56.3 95.8 
14 U 1.1 56.5 89.1. 
15 U 12.5 58.3 79.2 
16 S 0 92.9 92.9 
17 U 7.5 64.2 79.1 
18U 42 94 88 
19 U 17.0 59.6 85.1 
20 U 10.3 92.3 92.3 
21 S 23.5 70.6 94.1 
22 S 33.3 55.6 92.6 
23 U 29.6 77.8 77.8 
NmR TS CTR 
1 U 13.8 43.1 100 
2 U 8.9 48.2 91.1 
3 S -13.2 42.1 89.5 
4 S 6.3 -66.7 100 
5 U -23.6 28.3 94.4 
NmTCT 
29 S 100 90.2 82.5 
30 U 56.0 100 100 
31 U 56.1 63.4 100 
Nms Tr, CTR 
26 S 75.2 30.2 96.0 
27 U 100 31.5 100 
28 U 58.0 38.6 81.3 
NmS TR CTR 
Dd2 89.2 (10.2) 11.1(30.5) 47.6 (16.9) 
25 U 58.5 8.3 28.6 
NmR TR CTS 
24 S 16 100 28 
a The disease severity of the host, from whom the parasite was isolated, is 
indicated beside the isolate number as S=severe malaria and U=uncomplicated 
malaria. The laboratory strains 7G8 and Dd2 are indicated in italics, for these two 
strains the mean of three experiments and the standard deviation are shown. 
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profile as the laboratory strain Dd2 and was neuraminidase sensitive and 
chymotrypsin and trypsin resistant. Finally, one isolate was resistant to both 
neuraminidase and trypsin treatment, but was sensitive to chymotrypsin treatment. 
There are two more profiles, which are theoretically possible, but were not seen in 
this study: no isolates were resistant to neuraminidase, chymotrypsin and trypsin 
treatment and no isolates had a neuraminidase sensitive, chymotrypsin sensitive and 
trypsin resistant profile. 
The invasion inhibition following neuraminidase treatment of RBC was lower than 
in previous studies (Okoyeh 1999, Baum 2003, Lobo 2004). This was investigated 
further to consider any possible problems with the neuraminidase used for the assay. 
15 frozen isolates of samples used in the original study were received from Kenya. 
Of these 5 grew after thawing in Edinburgh and could be used in an invasion assay 
using a different neuraminidase supply to control for enzyme problems. Comparing 
the invasion inhibition by neuraminidase of these 5 isolates in the experiments 
carried out in Kenya (10.3% median, 0% to 32.8% interquartile range) I found that 
although when repeating the work the inhibition was slightly higher (33% median, 
16.4% to 44.7% IQR) there was no significant difference (P=0. 18, Mann Whitney U) 
and even in the repeat experiments the inhibition is still strikingly lower than from 
previous reports (The Gambia 62% median invasion inhibition, Brazil 70% median 
invasion inhibition (Baum et al. 2003; Lobo et al. 2004). 
4.4.4 Invasion profiles and malaria severity in Kenyan isolates 
Previous studies looking at invasion pathways used by field isolates have been 
carried out with isolates taken from uncomplicated malaria patients that were 
outpatients. It is unknown whether isolates from severe malaria patients may invade 
by a specific invasion pathway. I looked at field isolates taken from children 
diagnosed with either uncomplicated or severe malaria, to compare the invasion 
inhibition into enzyme treated RBC of the two groups. 19 of the isolates were from 
children with uncomplicated malaria. The mean age (months) was 46.3 (34.9, 
standard deviation) and the mean haemoglobin level was 9.8 (gIdL, 1.3 standard 
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deviation). 12 of the isolates were from children with severe malaria. The mean age 
of the severe malaria children was 19.6 (11.2) and their mean haemoglobin level was 
7.7 (3.1). The severe malaria patients were diagnosed with the following symptoms: 
3 cerebral malaria, 4 prostration and respiratory distress, I respiratory distress, 1 
prostration and severe anaemia and 3 prostration only. As seen in table 3 the isolates 
from either group showed a similar distribution amongst the recorded invasion 
profiles (table 3). The median inhibition compared to the non-enzyme treated control 
of isolates from patients with uncomplicated or severe malaria for each of the 
enzyme-treatments is shown in figure 2. The inhibition did not differ between the 
uncomplicated and severe malaria isolates for any of the enzyme treatments (P>0.1, 
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Figure 2: Invasion inhibition (%) of Kenyan field isolates from children with mild (dark 
grey bars) or severe malaria (light grey bars). The RBC were treated with 
neuraminidase (Nm, 50mU/ml), chymotrypsin (CT, 1 mg/ml) and trypsin 
concentration (T, 1 mg/ml). The median plus the 3d  Quartile is shown. 
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4.4.5 Invasion profiles and ABO blood group type in Kenyan isolates 
Independently from malaria severity, I found there was a significant difference in 
neuraminidase sensitivity between isolates taken from patients of different ABO 
blood group types (figure 3). 17 isolates had been isolated from patients with blood 
group 0, 6 from patients with blood group B and 5 five from patients with blood 
group A. The single sample from a patient with blood group AB was excluded from 
this analysis and for two samples the blood group data was missing. It was found that 
isolates from patients with blood group B were more highly inhibited by 
neuraminidase treatment of RBC with a median inhibition of 44.7% (23.5 to 58.0 
IQR, n=6) compared to 7.1% (3.1 to 34.4 IQR, n=5) and 9.3% (0 to 23.3 IQR, n=17) 
for blood group A and 0 respectively (P=0.02, Kruskal Wallis). This would indicate 
that isolates growing in the B blood group type are more dependent on sialic acid for 
invasion of 0 type RBC (the donor used for all experiments was group 0). No other 
patient variable (age, parasitaemia, haemoglobin levels or white blood cell count) 
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Figure 3: Invasion inhibition (%) into neuraminidase treated RBC of Kenyan field 
isolates from children with the ABO blood group A (n=5), B (n=6) or 0 (n=17). The 
median inhibition ( 31 Quartile) is shown. 
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4.4.6 Invasion profiles and the selectivity index. 
I determined the selectivity index (SI) for the isolates included in this study for a 
larger study described elsewhere (Deans et al., chapter 2). The geometric mean SI for 
the samples included in this study was 1.78 (1.43 - 2.13, 95% confidence interval) 
and there was no significant difference between the SI for isolates from 
uncomplicated and severe malaria patients (P0.97, Mann Whitney U). SI was not 
correlated with the level of inhibition for any of the enzyme treatments (P>0.1, 
Spearman Rank Correlation). No other parasite variable (parasite multiplication rate 
or rosetting frequency) was found to be associated with the level of invasion 
inhibition by enzyme treatment of the RBC. 
4.5 Discussion 
In this chapter the invasion of Kenyan field isolates into erythrocytes treated with 
three different enzymes was examined in order to assess the invasion pathways used 
in natural malaria infections. 6 out of 8 possible invasion profiles were seen, 
indicating that P. falciparum field isolates in Kenya use a variety of invasion 
pathways. In contrast to previous studies from The Gambia and Brazil (Baum et al. 
2003; Lobo et al. 2004), but in accordance with a study from India (Okoyeh et al. 
1999), it was found that the neuraminidase- and trypsin-sensitive, chymotrypsin-
resistant pathway characteristic of EBA- 1 75/GPA-mediated invasion was rare in 
Kenyan field isolates, where only 3/31 showed this profile (Table 3). 
Because the Kenyan isolates showed less neuraminidase sensitivity than expected 
from previous reports (Baum et al. 2003; Lobo et al. 2004), I repeated the 
neuraminidase inhibition assay with a smaller number of samples using a 
neuraminidase enzyme from a different supplier. The low level of inhibition of 
invasion into neuraminidase treated RBC was confirmed using the new enzyme, 
showing that this finding is not due to technical problems with the assay. In addition 
the work from Dr Susana Nery (a collaborator from Dr David Conway's group who 
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is examining gene expression profiles in the same isolates as I have studied), has 
shown that the neuraminidase inhibition levels of the original isolates correlates with 
EBA-175 expression levels determined by quantitative RT-PCR (Susana Nery, 
personal communication). The EBA175 levels are negatively correlated with PfRh4 
in Kilifi field isolates (Susana Nery, personal - communication) and as PfRh4 
expression is associated with the switch to sialic-acid independent invasion (Stubbs 
et al. 2005) this may be a predominant invasion pathway used by Kenyan isolates. 
However, the full role of Rh4 in invasion of these isolates is not clear, and the 
invasion profile of PfRh4-mediated invasion has not yet been described. 
There may be selective pressure leading to the high sialic-acid independence and 
lack of use of the EBA-175/GPA pathway by field isolates collected in Kilifi. One 
may hypothesis that across geographical regions there are different preferences for 
which invasion pathway is mainly used. Another example is the fact that the 
Brazilian isolates showed a significantly reduced sensitivity to trypsin than expected 
from previous results, particularly as a relatively high trypsin concentration was used 
(Lobo et al. 2004). In Brazil 5 out of 14 field isolates are trypsin resistant compared 
to 2 out of 31 Kenyan field isolates. Similarly the measured sensitivity to 
chymotrypsin varied between our study and the previous report from Brazil, with 
only one 1 of 14 Brazilian isolate reported as chymotrypsin sensitive (Lobo et al. 
2004), whereas 22 out of 31 Kenyan isolates were sensitive to chymotrypsin 
treatment. To further study the variability of invasion pathways from different 
regions it would be ideal to carry out a large study looking at the invasion profiles of 
field isolates collected from multiple geographical locations, but analysed together 
using one blood donor. This way one would be able to more accurately address to 
what extent variability in the invasion profiles exists across different study sites. As 
blood polymorphisms are common and glycophorin A and B are thought to be 
amongst the fastest evolving human proteins (Baum et al. 2002; Wang et al. 2003), 
one can imagine how blood polymorphism effects may shape the invasion pathway 
preference of field isolates from different geographical regions. 
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Regional differences in the invasion profiles that the majority of isolates use may 
have important implications for bloodstage vaccines, which target antigens involved 
in invasion pathways. For example a vaccine to EBA-175, which may block the 
EBA- 1 75/GPA pathway, may not be as effective in Kenya as it would be in The 
Gambia, as the majority of Kenyan isolates were found to invade by a different 
pathway. Furthermore, the large redundancy of invasion pathways used by field 
isolates indicates that a bloodstage vaccine may not inhibit P. falciparum invasion 
and growth, but may instead select for parasites, which invade by different 
mechanisms. 
The majority of the Kenyan isolates (23/31) fell within two invasion profiles defined 
as neuraminidase resistant and trypsin sensitive, which is a not very well defined 
pathway described solely by the involvement of a potential receptor X (Hadley et al. 
1987; Dolan et al. 1994). Furthermore, specific allelic types of the merozoite 
antigens BAEBL and JESEBL have been described to have a neuraminidase resistant 
and trypsin sensitive erythrocyte binding profile (Mayer et al. 2002; Mayer et al. 
2004) in addition to their main invasion pathway as shown in table 1, although this 
association between specific allelic types and invasion pathways has not been 
supported by field isolate data (Lobo et al. 2004). The finding that the putative 
pathway involving receptor X occurs commonly in natural infection argues that 
further research to delineate this pathway should be considered a priority. 
Three other Kenyan isolates showed neuraminidase, trypsin and chymotrypsin 
sensitivity. Such an invasion profile has not been described previously, partly 
because chymotrypsin has not been used frequently in the past to describe invasion 
phenotypes. Possibly a pathway exists where the receptor is sensitive to both 
enzymes (trypsin and chymotrypsin) and is sialic acid dependent. Alternatively, these 
three isolates may only invade efficiently through a number of pathways and 
removing any of the different pathways by enzyme treatment reduces invasion by 
more than 50%. 
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Two further invasion profiles were seen. A neuraminidase sensitive, trypsin and 
chymotrypsin resistant profile was seen, the same invasion profile seen for the 
laboratory strain DO. This sialic-acid dependent profile has been described for the 
PfRhl - Receptor Y interaction (Rayner et al. 2001; Triglia et al. 2005). And finally 
a neuraminidase and trypsin resistant, yet chymotrypsin sensitive profile was seen, 
indicating a possible invasion preference through the PfRIi2b ligand binding to 
receptor Z (Duraisingh et al. 2003) and/or the suggested MSP- 1 binding to band 3 
pathway (Goel et al. 2003). As expected, no isolates exhibited independence from 
known invasion pathways and were all sensitive to at least one of the enzyme 
treatments. And no isolates invaded by the neuraminidase and chymotrypsin 
sensitive, yet trypsin resistant pathway, as described for the parasite ligand JESEBL 
and its potential receptor E (Gilberger et al. 2003). 
Whether growth in a certain blood group affects the invasion profiles of a parasite is 
unknown, despite some evidence for differences in ABO types in regards to some 
membrane surface characteristics. It has been found that specific sialic acids were 
associated with different ABO blood groups, although these only made up a small 
part of the more commonly shared surface sialic acids (Bulai et al. 2003). Similarly, 
it has been shown that there are more high affinity EGF binding sites on blood group 
A RBC compared to the other ABO blood groups (Engelmann et al. 1992). For the 
Kenyan isolates I saw a significant difference in the level of inhibition by 
neuraminidase treatment depending on the ABO blood group of the host that the 
parasites were isolated from (P=0.02, Kruskal Wallis), with isolates from patients 
with blood group B type being most highly inhibited by neuraminidase than isolates 
from patients with blood group A or 0. In addition, the three isolates that were 
sensitive to all three enzyme treatments (described above) were all isolated from 
hosts with a non-0 blood group type (two from a blood group B and one from a 
blood group A type) and may have been less sensitive to enzyme treatment if they 
had invaded enzyme treated blood group A or B erythrocytes. Evidence for potential 
differences in invasion into different ABO blood group types was shown in a recent 
publication, where it was found that P. falciparum laboratory strains can invade Al-
type RBC at higher invasion rates than other blood groups (Chung et al. 2005). It has 
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also been shown that both higher levels of rosetting and severe malaria are associated 
with blood group A (Rowe et al. 1995; Lell et al. 1999; Pathirana et al. 2005). It 
remains unclear whether the results seen here may only have occurred by chance as 
the sample size is small and the study was not designed to look at the invasion 
inhibition in regards to host ABO blood group type, but these findings together with 
the above described studies indicate that this deserves further investigation. It would 
be interesting to look at invasion profiles of laboratory or 'field isolates when 
invading different ABO blood group types, and also after selecting parasites to grow 
in different ABO blood group types and then studying their invasion into the same 
and different ABO blood group types. 
The work described in this chapter is the first study looking at the invasion profiles 
of field isolates collected both from children with uncomplicated malaria and with 
severe malaria. I found that the isolates from both groups showed the same invasion 
profiles and there was no significant association between invasion profile and disease 
severity. In this study, the sample size was relatively small with only 12 isolates from 
children with severe malaria. So one cannot rule out that a difference may have been 
seen in a larger study and further work is required. Yet, the lack of association 
between invasion profile and disease severity is consistent with the finding that with 
the same isolates, there was no significant difference in the multiplication rates 
between isolates from children with uncomplicated or severe malaria contrasting 
with previous results from Thailand ( chapter 2, (Chotivanich et al. 2000)). Due to 
the strong association between parasite multiplication rate and disease severity in 
Thailand, a study looking at the invasion profiles of Thai field isolates, to examine 
whether the high multiplication rates displayed by isolates from patients with severe 
malaria can be associated with overall less sensitivity to enzyme treatment of 
erythrocytes or a specific preferred invasion profile, may provide further insight. 
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CHAPTER 5: Plasmodium falciparum: rosettes do not protect 
merozoites from invasion-inhibitory antibodies 
A version of this chapter has been submitted as: Deans, AM & Rowe, JA. Plasmodium 
falciparum: rosettes do not protect merozoites from invasion-inhibitory antibodies. 
Journal of Experimental Parasitology. In press 2005. 
5.1 Abstract 
Rosetting is a parasite adhesion phenotype associated with severe malaria in African 
children. Why parasites form rosettes is unknown, although enhanced invasion or 
immune evasion have been suggested as possible functions. Previous work showed that 
rosetting does not enhance parasite invasion under standard in vitro conditions. I 
hypothesised that rosetting might promote invasion in the presence of host invasion-
inhibitory antibodies, by allowing merozoites direct entry into the erythrocytes in the 
rosette and so minimising exposure to plasma antibodies. I therefore investigated 
whether rosetting influences invasion in the presence of invasion-inhibitory antibodies to 
MSP-1. I found no difference in invasion rates between isogenic rosetting and non-
rosetting lines from two parasite strains, R29 and TM284, in the presence of MSP-1 
antibodies (P=0.62 and P=0.63, Students t-test, TM284 and R29 respectively). These 
results do not support the hypothesis that rosettes protect merozoites from inhibitory 
antibodies during invasion. The biological function of rosetting remains unknown. 
5.2 Introduction 
The binding of infected red blood cells (iRBC) to uninfected red blood cells (RBC) is a 
Plasmodium falciparum adhesion phenotype known as rosetting. P. falciparum field 
isolates vary in the extent to which they form rosettes, and high levels of rosette 
formation have been strongly associated with severe malaria in African children in 
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numerous studies (e.g., (Carlson and Wahlgren 1992; Ringwald et al. 1993; Rowe et al. 
1995). A human polymorphism associated with deficiency of the RBC rosetting receptor 
Complement Receptor One (CR1) that reduces rosetting (Rowe et al. 1997), has been 
shown to confer protection from severe malaria in a malaria endemic region (Cockburn 
et al. 2004), thus providing more evidence for an association between rosetting and life-
threatening malaria. 
How rosetting may contribute to the development of severe malaria is not understood. 
Other Plasmodium species that infect humans form rosettes (Udomsanpetch et al. 1995; 
Angus et al. 1996; Lowe etal. 1998) but do not typically cause the same severe malaria 
symptoms as P. falciparum. Obstruction of the microvasculature and impairment of 
blood flow by rosettes has been shown in an ex vivo model (Kaul et al. 1991), and it is 
likely that rosettes aggravate the pathologies caused by cytoadherence of iRBC by 
further blocking the microvasculature (Nash et al. 1992); Cytoadherence, where iRBC 
bind to the endothelium lining the blood vessels (reviewed in (Newbold et al. 1999), is a 
parasite property unique to P. falciparum among the human Plasmodium species, which 
may explain why rosetting is not associated with severe malaria in P. ovale, P. malariae 
or P. vivax. Rosetting also occurs in several rodent and primate plasmodia such as P. 
chabaudi (Mackinnon et al. 2002), P. fragile (David et al. 1988), P. coatneyi (Kawai et 
al. 1995) and P. cynomolgi (Handunnetti et al. 1989). The widespread occurrence of 
rosetting in a variety of plasmodium species suggests that it may have an important 
biological function, however this function is currently unknown. 
Rosetting in P. falciparum field isolates has been positively associated with host 
parasitaemia in African children (Rowe et al. 2002). It had been postulated that the 
function of rosetting could be to facilitate merozoite invasion (Wahlgren et al. 1989), 
which would promote high asexual blood stage parasitaemias in the host. However, 
experiments with a culture-adapted laboratory strain PA 1 showed conclusively that there 
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was no difference in invasion rates between the isogenic rosetting and non-rosetting 
parasites in this strain (dough et al. 1998). 
I hypothesised that increased invasion of rosetting parasites may only occur in the 
presence of host immunity, when rosettes could potentially act as an immune evasion 
mechanism by shielding the merozoites from host invasion-inhibitory antibodies. It is 
plausible that merozoites released from a rosetting iRBC may be able to reinvade the 
neighbouring RBC without prolonged exposure to host antibodies in the plasma, as 
indicated in Figure 1A. Merozoites from non-rosetting parasites would be exposed to 
plasma antibodies that could inhibit their invasion (Figure 113). If this were the case, one 
would expect rosetting parasites to have higher invasion rates than isogenic non-
rosetting parasites in the presence of invasion inhibiting antibodies. In order to test this 
hypothesis I compared the invasion rates of isogenic rosetting and non-rosetting parasite 
lines of two culture-adapted P. falciparum strains in the presence of invasion-inhibitory 
antibodies to MSP1 (merozoite surface protein one) (Singh et al. 2003). 
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Figure 1: 
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Figure 1: Diagram showing how merozoites released from rosetting and non-rosetting 
P. falciparum iRBC could be differentially inhibited by invasion-inhibitory antibodies. A) 
Rosetting might reduce the effect of invasion-inhibitory antibodies if merozoites invade 
directly into the RBC in rosettes, thereby avoiding prolonged exposure to antibodies in 
the host's plasma. B) Merozoites derived from non-rosetting parasites would be 
exposed to antibodies in the plasma and hence would show lower invasion rates than 
merozoites from rosetting parasites. C) If merozoites from rosetting parasites do not 
preferentially invade the RBC in the rosette but are exposed to plasma antibodies in a 
similar way to merozoites from non-rosetting parasites, they would be expected to show 
reduced invasion rates in the presence of host antibodies. 
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5.3 Materials and Methods 
5.3.1 Parasite culture 
The parasites studied were P. falciparum clone R29 (derived from the IT strain)(Roberts 
et al. 1992) and strain TM284 (Scholander et al. 1996). R29 and TM284 are 
genotypically distinct and express different PfEMP 1 variants (Rowe et al. 
1997)(J.A.Rowe unpublished data). Parasites were cultured in complete RPMI (cRPMI: 
RPM! 1640 plus 25mM HEPES, 2mM glutamine, 25mM glucose, 25g/ml gentamicin 
and 10% pooled human serum) at 1-2% haematocrit in 0+ RBC at 37°C with 3%CO2, 
1%02, 96%N2. Parasites were synchronised by sorbitol lysis (Lambros and Vanderberg 
1979). To select for isogenic rosetting and non-rosetting parasite lines the cultures were 
selected using plasmagel flotation (Pasvol et al. 1978; Rowe et al. 1997). Following 
suspension in plasmagel solution, the rosetting trophozoite stage parasites settle to the 
bottom with the RBC pellet and the non-rosetting trophozoite stage parasites float in the 
upper layer above the RBC pellet. The non-rosetting upper layer was carefully removed 
and both layers were washed and then returned to culture. Repeated plasmagel selections 
over 1-2 weeks results in rosetting lines with >65% rosette frequency and non -rosetting 
lines with <6% rosette frequency. 
5.3.2 Invasion assays 
Synchronous trophozoite stage parasite cultures were diluted to approximately 1% 
parasitaemia with RBC and resuspended in cRPMI at 2% haematocrit. 50pJ samples 
were set up in quadruplicate or triplicate wells in a 96-well flat-bottom plate (Corning). 
The wells immediately surrounding the samples had been prepared to contain lOOp 1 
incomplete RPMI to prevent dehydration during the assay. The plate was placed in a gas 
modulator chamber and gassed with 3%CO2, 1%02, 96%N2 for 3minutes before being 
placed at 37°C for 24 hours. From the remaining sample, pre-invasion smears were 
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made to count the exact pre-invasion parasitaemia on a Giemsa-stained thin smear. After 
24 hours, Giemsa-stained thin smears were made from all wells and the parasitaemia 
was assessed by counting 1000 RBC. The invasion rate is the post-invasion parasitaemia 
divided by the pre-invasion parasitaemia. 
Invasion inhibition assays were carried out using rabbit polyclonal IgG to MSP1-42 
(Singh et al. 2003). In initial experiments a monoclonal antibody to MSP 1 (McBride 
and Heidrich 1987; Blackman et al. 1990), two other rabbit polyclonal antibodies to 
MSP 1 (gift from Dr Mike Blackman) and a rabbit polyclonal IgG to AMA-i (gift from 
Dr Allan Saul) were tested, however, none of these reagents gave significant inhibition 
of invasion with R29 or TM284. For the assays with the anti-MSP1-42 antibody, the 
starting cultures were diluted to 0.9-1.3% parasitaemia with RBC and resuspended to 
2% haematocrit with no added antibody (control) or a final concentration of 1.5 mg/ml 
of anti-MSP 1 IgG. Assays were set up and invasion rates assessed as described above, 
with triplicate wells for each antibody and control. For shaking invasion assays the 96-
well plate in the modulator chamber was rotated at 150-160rpm during the 24 hour 
incubation period (Orbital shaker, Brunswick Scientific). To ensure that the invasion 
inhibitory antibody did not disrupt rosettes, samples of the rosetting parasites were 
incubated with the MSP1-42 antibodies at the above concentrations for 30 minutes at 
37°C and then the RF was assessed. 
5.3.3 Assessment of rosette frequency 
A 200p1 aliquot of culture suspension containing mature pigmented trophozoite stage 
parasites was stained with 25tWml ethidium bromide for Sminutes at 37°C. 15d of 
culture suspension was placed on a microscope slide and covered with a coverslip. The 
stained sample was viewed with a 40x objective using a Leica fluorescence microscope 
with both UV and brightfield light to allow visualisation of both iRBC and RBC 
simultaneously. 200 iRBC were counted and scored for rosetting, with a rosette being 
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defined as an iRBC binding two or more RBC. The percentage of the 200 iRBC in 
rosettes is termed the rosette frequency (RF). For the invasion assays, rosetting cultures 
had a RF of above 65% and non-rosetting cultures had a RF of less than 6%. 
5.3.4 Statistical analysis 
Statistical analysis was done with Statview 5.0.1 software. The invasion rates of isogenic 
rosetting and non-rosetting parasites were analysed with a paired Students West, paired 
by experiment to control for variations in invasion due to RBC donor, human sera and 
other factors. The percentage inhibition of invasion by the MSP1-42 antibody of 
rosetting and non-rosetting parasites was analysed with a Students t-test. 
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5.4 Results 
5.4.1 Invasion rates of isogenic rosetting and non-rosetting parasites 
I firstly set out to investigate whether isogenic rosetting and non-rosetting parasite lines 
derived from R29 and TM284 differed in their invasion rates under standard in vitro 
culture conditions. Over seven (TM284) or eight (R29) experiments, there was no 
significant difference in the invasion rates of the isogenic rosetting and non-rosetting 
lines (Table 1, P=0.86 and P=0.21, Paired Students t-test, TM284 and R29 respectively). 
I did find that TM284 has a higher invasion rate ( 6.6 mean (2.0 standard deviation)) 
than the parasite strain R29 (4.4 (1.6) (P=0.03, Students t-test (only R-)). 
Table 1: Parasite rosette frequency and invasion rate for two isogenic rosetting 
and non-rosetting parasite strains 
Strain R° N RFb Invasion Ratec 	Paired ttestd 
R+ 7 74(4.8) 6.7(1.6) 	 P=0.86 
TM284 
R- 7 3(2.4) 6.6 (2.0) 
R+ 8 77(8.3) 5.3 (1.8) 	 P=0.21 
R29 
R- 8 2(1.6) 4.4(1.6) 
8  R represents the rosetting phenotype: R+ is selected for rosetting and R- is selected to not form 
rosettes in culture 
b  Rosette Frequency counted as % iRBC binding two or more uninfected RBC; Mean (standard 
deviation) 
C  Invasion rate is the number of ring-1RBC from triplicate or quadruplicate wells from each 
experiment after 24 hr invasion divided by the starting schizont parasitaemia; Mean (standard 
deviation) 
d  Paired t-test for the invasion rate of the isogenic R+ and R- cultures paired by experiment to 
account for variations due to RBC age, RBC donor, human sera and other factors. 
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5.4.2 Identification of an invasion-inhibitory antibody 
To examine the hypothesis that rosetting may support invasion in the presence of host 
invasion-inhibitory antibodies (figure 1A and B), I had to identify antibodies that would 
inhibit the invasion of non-rosetting parasites. Invasion-inhibitory antibodies are often 
described in the literature and are used as a tool to identify P. falciparum proteins, which 
may be involved in the RBC invasion process. As generating antibodies was beyond the 
scope of this PhD project, I obtained several antibodies as gifts (see methods) and tried a 
range of antibody concentrations to check for invasion inhibition. The maximum 
inhibition seen with the different antibodies is shown in figure 2. I did not get a 
significant inhibition of invasion for four antibodies. Two rabbit polyclonal antibodies to 
MSP1 did not inhibit invasion of both R29 and TM294 at a 1/100 or 1/400 dilution of 
the rabbit sera in one experiment (data not shown). In three experiments with TM284 a 
1/10 dilution of the same polyclonal antibodies increased invasion by roughly 10% and 
13% (Rb-01 and Rb-03, Figure 2). An AMA1 polyclonal antibody did not inhibit 
invasion of R29 at three different concentrations (0.3, 0.6 and 1.25mg/mi) and at the 
highest concentration (1 .25mg/mi) inhibited invasion by only 16% in one experiment 
(figure 2). The inhibition was not significant compared to the control (P=0.57, Students 
t-test). The murine monoclonal antibody mAb 12.8, which has been shown to be an 
invasion-inhibitory antibody (Blackman et al. 1990; Guevara Patino et al. 1997), was 
tested in 5 experiments at a concentration of 0.5mg/mi on R29 and TM284 respectively. 
mAb 12.8 inhibited invasion by 16% and 18.4% in R29 and TM284 respectively (figure 
2), but this was not significant compared to the control with no added antibody (P=0.74 
and P=0.20, R29 R- and TM284 R- respectively, Students t-test). 
The only antibodies to significantly inhibit invasion by more than 20% was a rabbit 
poiyclonai antibody to MSP1-42 (Singh et al. 2003) (P=0.02 and P=<0.001, R29 R- and 
TM284 R- respectively, Students t-test, figure 2). This antibody was therefore used to 
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study invasion inhibition in isogenic rosetting and non-rosetting parasites as described 
below. 
Figure 2: 
Invasion inhibition of non-rosetting parasites (R-) 
by a panel of antibodies 
40 




 1Rb-01I 	1Rb-031 	AMA1 (R29) mAb 12.8 	mAb 12.8 	MSP1-42 	MSP1-42 





Figure 2: Invasion inhibition by a panel antibodies tried on either R29 or Tm284 as 
indicated in the brackets. Invasion inhibition was measured on non-rosetting parasites 
in an invasion assay as described in the methods. % Mean inhibition of invasion is 
relative to the control invasion rate. Details for the individual antibodies: RbOl and Rb03 
were used at a 1/10 dilution in 3 experiments with Tm284. AMA1 was used at 
1.25mg/mi in 1 experiment on R29. mAb12.8 was used at 0.5mg/mI in 5 experiments 
with both R29 and Tm284. MSP1-42 was used at 1.5mg/mI in two experiments with 
both R29 and Tm284. 
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5.4.3 Invasion rates of isogenic rosetting and non-rosetting parasites in 
the presence of antibodies to MSP-1 
To examine the hypothesis that rosetting may support invasion in the presence of host 
invasion-inhibitory antibodies (Figure 1 A and B), I studied the invasion rates of isogenic 
rosetting and non-rosetting parasites in the presence of antibodies to MSP 1-42 (Singh et 
al. 2003). In two experiments with both TM284 and R29, I found that the percentage 
inhibition of invasion in the presence of the MSP 1-42 antibodies did not differ between 
the isogenic rosetting and non-rosetting parasites (Table 2, P=0.62 and P=0.63, Students 
t-test, TM284 and R29 respectively). The mean inhibition of invasion for rosetting 
parasites was 33.0% (95% confidence interval 25.5% to 40.5%) and for non-rosetting 
parasites was 31.8% (95% confidence interval 26.3% to 37.3%). 
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Table 2: Invasion inhibition of isogenic rosetting and non-rosetting 
P. falclparum parasites from two strains 
Strain 	Exp. 	R a 	RFb 	Invasion Ratec 	Inhibition  
Control MSP-1 Ab 
R+ 70 7.4(1.2) 4.9 (0.1) 33.3 
1 
R- 2 6.8 (1.4) 4.7 (0.3) 30.2 
TM284 
R+ 68 9.0 (1.2) 6.2 (0.9) 31.2 
2 
R- 0 8.7 (0.2) 5.2 (0.7) 40.2 
R+ 76 5.1 (1.2) 3.8 (0.3) 24.4 
1 
R- 0 2.5 (0.3) 1.8 (0.2) 28 
.R29 
R+ 76 5.9 (0.3) 3.4 (0.2) 42.9 
2 
R- 0 4.3(l.2) 3.1 (0.3) 28.9 
a R represents the rosetting phenotype: R+ is selected for rosetting and R- is selected to not form 
rosettes in culture 
b Rosette Frequency counted as % iRBC binding two or more uninfected RBC 
C  Invasion rate is the mean (standard deviation) number of ring-iRBC from triplicate wells after 24 
hr invasion divided by the starting schizont parasitaemia 
d Percent inhibition of invasion of the isogenic R+ and R- parasites in the presence of the MSP-1 
antibody compared to the control invasion rate. There was no significant difference in the 
inhibition between the R+ and R- parasites (P=0.62 and P=0.63, Students t-test, TM284 and R29 
respectively). 
To ensure that my results were not due to rosettes being disrupted by the invasion-
inhibitory antibodies, I assessed the effect of the MSP 1-42 antibodies on rosetting. For 
both R29 and TM284 I found that the rosette frequency did not change in the presence 
of the MSP1-42 antibodies (R29: control with no antibody 48% RF, 1.5mg/mi MSP1-42 
52% RF; TM284: control with no antibody 83% RF, 1.5mg/mi MSP1-42 84% RF). 
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In the invasion inhibition experiments (Table 2), the data show a trend towards rosetting 
R29 parasites having higher overall invasion rates than R29 non-rosetting parasites in 
the control cultures without added antibodies. However, as shown in Table 1, an 
analysis of a larger number of experiments does not support a significant difference in 
invasion rates between these isogenic lines. 
5.4.4 Invasion inhibition of shaking cultures 
In addition, I attempted to examine the inhibitory effect of the MSP 1-42 antibodies on 
R29 and TM284 cultures under shaking conditions. However, in two experiments with 
TM284 no inhibition of invasion was seen when the cultures were shaken rather than 
static (P=>0.50, both R+ and R-, Student's t-test, figure 3). I therefore could not repeat 
the above experiments under shaking conditions. 
Figure 3: 
Figure 3: Lack of invasion inhibition of isogenic rosetting (R+) and non-rosetting (R-) 
Tm284 parasites by the antibody MSP-42 (1.5mg/mi) under shaking conditions. The 
mean (+ standard deviation) of two experiments, each with triplicate wells, is shown. 
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5.5 Discussion 
In this chapter I show that rosettes do not protect from invasion-inhibitory antibodies. I 
also confirmed the previous findings of Clough et al. that rosetting does not enhance 
invasion (Clough et al. 1998). This had been shown for one parasite line, PAl, and I 
repeated the findings with R29 and TM284. 
The experiments were complicated at first by the fact that it was necessary to identify an 
antibody that inhibited the invasion of the two P. falciparum strains under investigation. 
Antibodies to the merozoite surface antigens MSP1 and AMA1 are known to inhibit 
invasion and have been associated with protection from clinical malaria (John et al. 
2004; Polley et al. 2004). I tested a range of antibodies to MSP-1 and AMA-i to find a 
suitable antibody for these experiments, but found it difficult to identify a reagent giving 
significant invasion inhibition of R29 or TM284 non-rosetting parasites as shown in 
figure 2. There may be two reasons for this. First of all the merozoite surface antigens 
MSP 1 and AMA 1, to which the antibodies were generated, are polymorphic and the 
invasion-inhibitory effects of these antibodies may therefore by strain-specific. The 
MSP1 monoclonal antibody mAb 12. 10, which was generated by the same group as the 
mAb 12.8 used here, showed 72% inhibition of the T9-94 strain and only 50% inhibition 
of invasion of the T9-96 strain at a concentration of 0.5mg/mi (Blackman et al. 1990). In 
addition human antibodies isolated from a malaria endemic region, which recognise the 
EGF1 domain in MSP1-19 similar to the mAbl2.8, did not show any invasion-inhibitory 
activity (Chappel et al. 1994). In regards to AMA 1, antibodies to either 3D7 or W2mef 
both inhibited the homologous strain by around 60-80% but the heterologous strain by 
only around 20% similar to my findings (Healer et al. 2004). Another study also 
reported less inhibition of invasion of heterologous P. falciparum strains by AMA1 
antibodies (Kennedy et al. 2002) and antibodies elicited by AMA1 in a Phase I vaccine 
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trial rarely inhibited invasion by more than 20% (Malkin et al. 2005). From my findings 
and the above reports, it is apparent that one would need to generate strain specific 
antibodies against R29 or TM284 antigens to see a maximum inhibition of invasion, but 
that lay beyond the scope of this PhD project. 
Although I believe the above explains the lack of invasion inhibition, as a second reason 
I cannot rule out problems with a decrease in activity of the antibodies due to storage or 
the shipping since they were generated. Reproducing invasion inhibition results may be 
a problem as a decrease in invasion-inhibitory activity by an antibody used by the same 
research group on the same homogenous strain has been described, which provides 
further evidence for problems with reproducibility of invasion-inhibitory effects (Healer 
et al. 2004). 
Despite those initial problems, it was possible to identify a rabbit polyclonal antibody to 
MSP1-42 (Singh et al. 2003) that gave a significant inhibition of invasion. The 
inhibition with MSP 1-42 was not as high as it had been shown with this antibody on the 
3D7 strain, for which 69% inhibition was reported (S.Mahanty, personal 
communication) and was not maintained under shaking conditions (see results 3.4). 
However, in the static. invasion assays the inhibition was significant compared to the 
control sample for both R29 and TM284 (figure 2, Table 2). Therefore this antibody was 
suitable for experiments to determine if rosettes protect from invasion-inhibitory 
antibodies. 
I found that rosetting and non-rosetting parasites were inhibited to the same degree by 
the MSP1-42 antibody for two parasite strains, R29 and TM284 (P=0.63 and P=0.62, 
respectively, Table 2). I showed that this was not due to the disruption of rosettes, as the 
rosettes were stable in the presence of MSP1-42. This indicates that rosettes do not 
protect merozoites from invasion-inhibitory antibodies as hypothesised in Figure 1A, but 
rather that rosetting parasites are inhibited by invasion-inhibitory antibodies to the same 
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extent as non-rosetting parasites (Figure lB and IC). It is unclear whether rosettes are 
stable during schizogony or whether they break apart before the schizonts rupture. My 
results point towards the latter being the most likely possibility. This suggestion is 
consistent with previous findings showing that the RBC forming the rosette are not 
preferentially targeted during invasion (dough et al. 1998). This result is important as 
the biological function of the rosetting phenotype is so far unknown. In addition it has 
potential implications for vaccine research as my findings do not support any evidence 
that rosettes may protect parasites from invasion-inhibitory antibodies generated by 
blood-stage vaccines. 
Although I found no evidence to support the hypothesis that rosettes protect merozoites 
from invasion-inhibitory antibodies, it is yet to be determined whether rosettes may 
affect the interactions of iRBC with other components of the host's immune system. 
Contact-dependent activation of natural killer cells - an important first line in innate 
immunity against P. falciparum - has been reported (Artavanis-Tsakonas et al. 2003), 
and this activation may not occur if uninfected RBC surround the iRBC. Contrary to 
this, binding of iRBC to dendritic cells has been shown to modulate the function of 
antigen-presenting cells to possibly delay an immune reaction (Urban et al. 1999), so 
rosetting may prevent the binding of iRBC to receptors on the surface of dendritic cells 
and may promote dendritic cell activity. Furthermore, rosettes may shield the iRBC from 
phagocytosis by macrophages and neutrophils. It will be interesting to compare natural 
killer cell activation, dendritic cell modulation and phagocytosis of rosetting and non-
rosetting parasites in an attempt to understand the biological function of rosetting. 
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6.1 Summary 
The focus of my study was to investigate potential P. falciparum virulence factors 
that may contribute to the pathogenesis of severe malaria. The work involved 
looking at virulence factors in field isolates from two distinct regions in Africa, 
looking at RBC selectivity in the P. chabaudi model and furthermore studying the 
rosetting phenotype in laboratory strains. I made the following findings: 
Parasite multiplication rate and selectivity index are not associated with 
malaria severity in Africa. 
Selectivity index is not associated with parasite virulence in the P. 
chabaudi model. There does seem to be a day effect on SI. 
There is no significant difference between invasion pathways of Kenyan 
field isolates from patients with uncomplicated or severe malaria. 
Rosetting does not protect iRBC from invasion-inhibitory antibodies. 
A full discussion of my findings can be found at the end of each chapter. Here I will 
discuss how my findings link together and where this leaves future research. 
6.2 Severe malaria - Africa and Asia 
Understanding what causes severe malaria is crucial to develop better drugs and 
vaccines in the future. Multiple factors may predispose an individual to severe 
malaria (Miller et al. 2002; Greenwood et al. 2005), yet there is little understanding 
of the precise contribution of different factors in the pathogenesis of severe malaria. 
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This study looked at a number of parasite virulence factors in relation to malaria 
severity in Africa and the following conclusions can be drawn: There is no evidence 
for differences between P. falciparum parasites that are isolated from children with 
uncomplicated or severe malaria in regards to their multiplication rates or their RBC 
selectivity, contrasting previous results from Thailand (Simpson et al. 1999; 
Chotivanich et al. 2000). This is not the first report where there is a discrepancy 
between findings from Africa and Asia in relation to a P. falciparum phenotype, as 
rosetting has been strongly associated with severe malaria in Africa (Carlson et al. 
1990; Rowe et al. 1995; Kun et al. 1998), however the same is not the case in Asia 
(Ho et al. 1991; Angkasekwinai et al. 1998). Although further studies are needed to 
investigate why the results from Asia and Africa differed, one may conclude that in 
Africa parasite virulence factors other than the parasite multiplication rate or RBC 
selectivity may be associated with the development of severe malaria. Results from 
the work described here further support rosetting as a virulence factor associated 
with severe malaria (chapter 2 and A. Rowe, personal communication), but there are 
also other virulence factors such as autoagglutination and cytoadherence, which may 
play an important role. 
I found no association between the SI and malaria severity of P. falciparum 
infections in Kenya and Mali. Several reasons for this were discussed (chapter 2), 
two of which were first that it is due to host immunity, as in Africa the population 
rapidly builds up a level of semi-immunity to the parasite and children above 5 years 
rarely develop severe malaria. Second, I postulate that a low level of immunity may 
delay the onset of clinical symptoms and, hence, the time until presentation at the 
hospital. Intriguingly, when studying the SI in the P. chabaudi model I did not see an 
association between virulence and the SI, but there is an indication that the SI may 
change over the time-course of the infection. This may be driven by strain-specific 
immunity or other host responses to the infection over time. Although tentative, this 
may explain differences seen between Thailand and Africa. One may hypothesise 
that Thai patients with severe malaria have no acquired immunity to P. falciparum 
and are at an early stage in the infection, comparable to day 7 in the P. chabaudi 
model, and parasites from these patients show low RBC selectivity (Simpson et al. 
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1999). Whereas, the Thai mild malaria patients are controlling the parasite growth 
and increasing RBC selectivity, comparable to a later day in the P. chabaudi model 
and hence a higher SI than isolates from Thai patients with severe malaria. In 
African children, where some immunity is present, possibly delaying the time until 
presentation at the hospital, in children that both develop uncomplicated or severe 
malaria the selectivity index is higher, comparable to a later day in the P. chabaudi 
model, similar to the Thai uncomplicated patients. It would be very interesting to 
look at a birth cohort in Africa to examine the SI in the first infection when host 
immunity should be very low. As these cohorts are sometimes followed for many 
years, one could look at the SI in later infections as well. Although there is the 
complication that due to maternal antibodies the infants experiencing their first 
infection may not be regarded as naïve in terms of immunity to malaria. 
Due to the above mentioned difficulties, a good way to compare Asian and African 
parasite isolates in regards to their PMR and SI would be by studying parasites 
isolated from non-immune Caucasian travellers who return to the UK and develop 
malaria. Such a study design could eliminate variables such as differences in host 
genetics, immunity levels, previous drug treatment, previous malaria infections, and 
time of presentation to the hospital. Furthermore, as the assays for parasites from 
both Africa and Asia could be carried out by the same laboratory this would remove 
any across laboratory variation. There are of course limitations and one problem may 
be the smaller number of travellers returning from Asia who develop severe P. 
falciparum malaria. The question is of course what may one expect to see? If there 
are genuine differences in PMR between Asian and African parasites, then one may 
expect to see a significant difference in PMIR between the two groups. If the low 
PMR seen in Africa is because of host immunity, then one may expect to see high 
PMR of isolates from travellers returning from African malaria endemic locations, 
that are similar to the high PMR of isolates from patients with severe malaria in 
Africa (Chotivanich et al. 2000). At the same time, it would be possible to look at 
other parasite virulence factors such as rosetting and autoagglutination. 
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A very different approach to study differences in PMR is to identify genes associated 
with high PMIR. One method used to address this topic is linkage group selection 
(Martinelli et al. 2005) and there is currently an ongoing project using this method to 
identify genes linked with a higher growth rate phenotype in P. chabaudi (Naomi 
Gadsby, personal communication). Any identified genes, could be used to find P. 
falciparum homologues. It would then be possible to look at the expression of these 
genes in both Thai and African isolates to see if there is a genetic difference between 
the high PMR Thai isolates and the low PMR Thai and African isolates. 
An unexpected result described in chapter 2 was the finding that parasites from 
children diagnosed with hyperparasitaemia had the lowest PMR. This group of 
patients are themselves very interesting as they are able to harbour such high parasite 
infections, yet do not show any signs of severe malaria. This group may be 
invaluable for identifying which parasite factors one should target for a drug design 
or vaccine that will prevent severe malaria. One may of course argue that these are 
children, who are on their way to develop severe malaria, but there are a number of 
strong reasons to believe they truly form a separate category. First of all, they are 
relatively old and have high haemoglobin levels (chapter 2). The mortality rate of 
children with hyperparasiteamia is very low at only 0.01% compared to an overall 
mortality rate of 8.7% of children with severe malaria in the same population (Lyke 
et al. 2003). They do not have as high rosette frequencies as parasites from children 
with severe malaria (chapter 2 and A. Rowe, personal communication). Also, when 
looking at the blood group information of the parasites collected in Mali, severe 
malaria is associated with blood group A (A. Rowe, personal communication), yet 
the hyperparasitaemia children show a similar distribution of the blood groups as the 
uncomplicated malaria patients. The blood group distributions of both the 
uncomplicated and the hyperparasitaemia children differ from the distribution of the 
children, which have severe malaria (A. Rowe, personal communication). An 
ongoing study looking at the var genes, which are expressed in the Malian children, 
has also found that the var genes expressed by children with uncomplicated malaria 
are distinct from the var genes expressed by parasites from children with severe 
malaria (Helen Kyriacou, personal communication). One may speculate that 
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parasites, which can develop high parasitaemias in the host without severe pathology 
symptoms, express an 'avirulent' PfEMP1 type. This 'avirulent' PfEMP1 type may 
be associated with binding to certain receptors, possibly CD36 rather than receptors 
such as ICAM1, which may facilitate the development of severe malaria. Functional 
studies looking at the binding specificities of this 'avirulent' PfEMIP 1 type compared 
to for example the variant surface antigens associated with severe malaria could 
address this question. It may also be associated with decreased PMR as shown in this 
study. As far as I am aware, there has not been any association between any PfEMP 1 
types and PMR described to date. Unfortunately, in this study the invasion pathways 
of the Malian isolates were not investigated, but it may be worth following up which 
invasion pathways parasites isolated from patients with hyperparasitaemia use. 
The work described here looking at the invasion pathways of parasites from children 
with uncomplicated and severe malaria in Kenya showed no significant difference 
between the two groups. This may not be so surprising as there was no significant 
difference between the PMR of these two groups. Although independently of PMR, 
there could have been a difference in invasion pathways used by isolates from 
children with uncomplicated or severe malaria. Invasion pathways may not link to 
parasite virulence, but it still remains to study the invasion pathways used by 
parasites with high PMIR in Thailand, where such clear differences in PMR between 
uncomplicated and severe malaria patients were seen (Chotivanich et aL 2000). 
6.3 Plasmodium chabaudias a model to study RBC selectivity 
In the P. chabaudi model it was found that there is no association between the SI and 
parasite virulence. This supports my finding from Africa and as described in more 
detail above may indicate that the differences in SI found for Thai isolates may have 
been due to other factors, such as time in the infection, rather than being an intrinsic 
parasite virulence factor. This is the first report of a SI for P. chabaudi. Overall, I 
found RBC selectivity to be low, as expected for a parasite that does not have a 
preference for reticulocytes or young RBC. P. chabaudi may provide a good model 
for further study of the SI over the course of the infection and for the identification of 
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host factors that may lead to an increase in SI later in infection, as it is possible to 
monitor the infections over time. Such a study could provide evidence to test the 
hypothesis outlined above that the differences in results from Southeast Asia and 
Africa in regards to the SI and malaria severity, are due to the timing or patients 
presentation at hospital. 
6.4 Severe malaria - rosetting as a virulence factor 
In this study I found rosettes do not protect .merozoites from invasion inhibitory 
antibodies. A relationship between rosetting and malaria severity has been 
demonstrated in Africa, yet how rosettes contribute to the development of severe 
malaria is unknown. A previous study (dough et al. 1998) and work presented in 
this thesis, where rosetting of neither laboratory strains (chapter 5) nor field isolates 
(chapter 2) were associated with higher PMR, show that rosetting does not enhance 
parasite growth per Se. Rosetting is though positively correlated with parasitaemia in 
vivo indicating that rosettes may have some effect on parasite growth or survival in 
the host (Rowe et al. 2002). I tested the hypothesis that rosettes may protect 
merozoite invasion from invasion-inhibitory antibodies and so maintain a higher 
growth rate in the presence of host immunity. I could not find evidence to support 
this hypothesis (chapter 5). It now remains to be investigated whether rosettes may 
protect from other forms of host immunity - such as phagocytosis, activation of 
natural killer cells or other contact-dependent immune suppression mechanisms. 
6.5 Conclusions 
The results described in this thesis emphasise that there is still a lot to be learnt about 
P. falciparum virulence factors. I showed that results found in Africa are not the 
same as Thai infections and that a virulence factor other than parasite multiplication 
rate or RBC selectivity may play an important role in the development of severe 
malaria in Africa. Other virulence factors, such as rosetting or autoagglutination, are 
known, but how they may be associated with severe malaria is not well understood. 
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Possibly they maintain parasite growth in the host, where some degree of acquired 
immunity may be present. I investigated this hypothesis for rosetting, but found that 
rosettes do not protect merozoite invasion from invasion-inhibitory antibodies. So 
the function of rosetting remains to be investigated further. The invasion pathways 
used by parasite isolates were found to be diverse, but there was no indication that 
the invasion profile is a virulence factor as there was no significant difference in 
invasion profiles between isolates from uncomplicated and severe malaria patients. 
Finally, these findings have serious implications for future research and malaria 
intervention strategies. Will a vaccine disrupting rosettes protect children in Africa 
from severe malaria, yet not affect the severe malaria pathologies in Asia? And vice 
versa, antibodies that inhibit the rapid growth of parasites may be protective in Asia, 
however still leave the individual at risk in Africa? Future work will be required to 
address these questions. 
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Abstract 
Rosetting is a parasite adhesion phenotype associated with severe malaria in African children. Why parasites form rosettes is 
unknown, although enhanced invasion or immune evasion have been suggested as possible functions. Previous work showed that roset-
ting does not enhance parasite invasion under standard in vitro conditions. We hypothesised that rosetting might promote invasion in the 
presence of host invasion-inhibitory antibodies, by allowing merozoites direct entry into the erythrocytes in the rosette and so minimising 
exposure to plasma antibodies. We therefore investigated whether rosetting influences invasion in the presence of invasion-inhibitory 
antibodies to MSP-1. We found no difference in invasion rates between isogenic rosetting and non-rosetting lines from two parasite 
strains, R29 and TM284, in the presence of MSP- I antibodies (P = 0.62 and P = 0.63, Student's I test, TM284 and R29, respectively). 
These results do not support the hypothesis that rosettes protect merozoites from inhibitory antibodies during invasion. The biological 
function of rosetting remains unknown. 
© 2005 Elsevier Inc. All rights reserved. 
Index Descriptors and Abbreviations. Plasmodiumfalciparum; Rosetting; Invasion inhibition; Immune evasion; Rosette formation; Erythrocyte invasion; 
RBC, red blood cells; iRBC, infected red blood cells; cRPMI, complete RPMI; RF, rosetting frequency; MSP-1, merozoite surface protein I; AMAI, api-
cal membrane antigen I 
Introduction 
The binding of infected red blood cells (iRBC) to unin-
fected red blood cells (RBC) is a Plasmodium falciparum 
adhesion phenotype known as rosetting. P. falciparum field 
isolates vary in the extent to which they form rosettes, and 
high levels of rosette formation have been strongly associ-
ated with severe malaria in African children in numerous 
studies (e.g., Carlson and Wahlgren, 1992; Ringwald et al., 
1993; Rowe et al., 1995, 2002b). A human polymorphism 
associated with deficiency of the RBC rosetting receptor 
Complement Receptor 1 that reduces rosetting (Rowe 
et al., 1997), has been shown to confer protection from 
severe malaria in a malaria endemic region (Cockburn 
Corresponding author. Fax: +44 131 650 6564. 
E-mail address: Alex.Rowe@ed.ac.uk  (J.A. Rowe). 
0014-4894/$ - see front matter © 2005 Elsevier Inc. All rights reserved. 
doi: 10.10 16/j.exppara.2005.l 1.007 
et al., 2004), thus providing more evidence for an associa-
tion between rosetting and life-threatening malaria. 
How rosetting may contribute to the development of 
severe malaria is not understood. Other Plasmodium spe-
cies that infect humans form rosettes (Angus et al., 1996; 
Lowe et al., 1998; Udomsanpetch et al., 1995) but do not 
typically cause the same severe malaria symptoms as 
P. falciparum. Obstruction of the microvasculature and 
impairment of blood flow by rosettes has been shown in 
an ex vivo model (Kaul et al., 1991), and it is likely that 
rosettes aggravate the pathologies caused by cytoadher-
ence of iRBC by further blocking the microvasculature 
(Nash et al., 1992). Cytoadherence, where iRBC bind to 
the endothelium lining the blood vessels (reviewed in 
Newbold et al., 1999), is a parasite property unique to 
P. falciparum among the human Plasmodium species, 
which may explain why rosetting is not associated with 
severe malaria in P. ovale, P. malariae or P. vivax. Roset-
ting also occurs in several rodent and primate plasmodia 
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uch as Plasmodium chabaudi (Mackinnon et al., 2002), 
'lasmodium fragile (David et al., 1988), Plasmodium coal-
eyi (Kawai et al., 1995). and Plasmodium cynomolgi 
Handunnettj et al., 1989). The widespread occurrence of 
osetting in a variety of plasmodium species suggests that 
osetting may have an important biological function. 
owever this function is currently unknown. 
Rosetting in P. falciparuni field isolates has been posi-
vely associated with host parasitaemia in African children 
Rowe et al., 2002a). It had been postulated that the func-
on of rosetting could be to facilitate merozoite invasion 
Wahlgren et al., 1989), which would promote high asexual 
lood stage parasitaemias in the host. However, experi-
tents with a culture-adapted laboratory strain PAl 
iowed conclusively that there was no difference in inva-
on rates between the isogenic rosetting and non-rosetting 
rasites in this strain (Clough et al., 1998). 
We hypothesised that increased invasion of rosetting 
rasites may only occur in the presence of host immunity, 
hen rosettes could potentially act as an immune evasion 
.echanism by shielding the merozoites from host invasion-
hibitory antibodies. It is plausible that merozoites 
leased from a rosetting iRBC may be able to reinvade the 
ghbouring RBC without prolonged exposure to host 
itibodies in the plasma, as indicated in Fig. IA. Merozo-
s from non-rosetting parasites would be exposed to 
asma antibodies that could inhibit their invasion 
ig. 1B). If this were the case, one would expect rosetting 
Lrasites to have higher invasion rates than isogenic non-
setting parasites in the presence of invasion inhibiting  
antibodies. To test this hypothesis, we compared the inva-
sion rates of isogenic rosetting and non-rosetting parasite 
lines of two culture-adapted P. falciparum strains in the 
presence of invasion-inhibitory antibodies to MSP- I (mero-
zoite surface protein one) (Singh et al., 2003). 
2. Methods 
2.1. Parasite culture 
The parasites studied were P. falciparum clone R29 
(derived from the IT strain) and strain TM284 (Rowe et al., 
1997). R29 and TM284 are genotypically distinct and 
express different PfEMPI variants (Rowe et al., 1997 and 
unpublished data). Parasites were cultured in complete 
RPM! (cRPMI: RPMI 1640 plus 25mM Hepes, 2mM glu-
tamine, 25mM glucose, 25.tg/ml gentamicin, and 10% 
pooled human serum) at 1-2% haematocrit in 0 RBC at 
37°C with 3% CO 21 1 % 02, and 96% N2. Parasites were syn-
chronised by sorbitol lysis (Lambros and Vanderberg, 
1979). To select for isogenic rosetting and non-rosetting 
parasite lines, the cultures were selected using plasmagel 
flotation (Pasvol et al., 1978; Rowe et al., 1997). Following 
suspension in plasmagel solution, the rosetting trophozoite-
stage parasites settle to the bottom with the RBC pellet and 
the non-rosetting trophozoite-stage parasites float in the 
upper layer above the RBC pellet. The non-rosetting upper 
layer was carefully removed and both layers were washed 
and then returned to culture. Repeated plasmagel selections 
over 1-2 weeks result in rosetting lines with >65% rosette 
A 	Rosetting (R+) 	B Non - Rosetting (A -) 	C Rosetting (R+) 
00)" 
0 ,~ ,n 
=I =t= = 
O 0 	0 	0 
O~ L O~ 0 
1. Diagram showing how merozoites released from roselting and non-rosetting P. falciparwn iRBC could be differentially inhibited by invasion-inhib-
y antibodies. (A) Rosetting might reduce the effect of invasion-inhibitory antibodies if merozoites invade directly into the REC in rosettes, thereby 
ding prolonged exposure to antibodies in the host's plasma. (B) Merozoites derived from non-rosetting parasites would be exposed to antibodies in 
plasma and hence would show lower invasion rates than merozoites from rosetting parasites. (C) If merozoites from rosetting parasites do not prefer-
ally invade the RBC in the rosette but are exposed to plasma antibodies in a similar way to merozoites from non-rosetting parasites, they would be 
.'cted to show reduced invasion rates in the presence of host antibodies. Our results indicate that merozoites released from rosetting parasites are inhib-
to the same extent as merozoites released from non-rosetting parasites (B and Q. 
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frequency and non-rosetting lines with <6% rosette 	2.4. Statistics 
frequency. 
2.2. Invasion assays 
Synchronous trophozoite-stage parasite cultures were 
diluted to approximately 1 6/6 parasitaemia with RBC and 
resuspended in cRPMI at 2% haematocrit. Fifty microlitre 
samples were set up in quadruplicate or triplicate wells in a 
96-well flat-bottomed plate. The wells immediately surround-
ing the samples had been prepared to contain 100 j.tl incom-
plete RPM! to prevent significant evaporation from test 
wells during the assay. The plate was placed in a gas modula-
tor chamber and gassed with 3% CO 2. 1% 02,  and 96% N2 
for 3 min before being placed at 37°C for 24h. From the 
remaining sample, pre-invasion smears were made to count 
the exact pre-invasion parasitaemia on a Giemsa-stained thin 
smear. After 24h, Giemsa-stained thin smears were made 
from all wells and the parasitaemia was assessed by counting 
1000 RBC. The invasion rate is the post-invasion parasita-
emia divided by the pre-invasion parasitaemia. 
Invasion inhibition assays were carried out using rabbit 
polyclonal IgG to MSP-1-42 (Singh et at., 2003). We also 
tested 'a monoclonal antibody to MSP-1 (Blackman et al., 
1990; McBride and Heidrich, 1987), two other rabbit poly-
clonal antibodies to MSP-1 (gift from Dr. Mike Blackman) 
and a rabbit polyclonal IgG to AMA-1 (gift from Dr. Allan 
Saul), however, none of these reagents gave, significant inhi-
bition of invasion with R29 or TM284. For the assays with 
the anti-MSP-1-42 antibody, the starting cultures were 
diluted to 0.9-1.3% parasitaemia with RBC and resus-
pended to 2% haematocrit with no added antibody (con-
trol) or a final concentration of 1.5mg/mI of anti-MSP-1 
IgG. Assays were set up and invasion rates were assessed as 
described above, with triplicate wells for each antibody and 
control. To ensure that the invasion-inhibitory antibody 
did not disrupt rosettes, samples of the rosetting parasites 
were incubated with the MSP-1-42 antibodies at the above 
concentration for 30 min at 37°C and then the rosette fre-
quency was assessed. 
2.3. Assessment of rosette frequency 
A 200 p.1 aliquot of culture suspension containing mature 
pigmented trophozoite-stage parasites was stained with 
25 p.g/ml ethidium bromide for 5 min at 37°C. Ten micro li-
tres of culture suspension was placed on a microscope slide 
and covered with a coverslip. The stained sample was 
viewed with a 40x objective using a Leica fluorescence 
microscope with both UV and brightfield light to allow 
visualisation of both iRBC and RBC simultaneously. Two 
hundred iRBC were counted and scored for rosetting, with 
a rosette being defined as an iRBC binding two or 
more RBC. The percentage of the 200 iRBC in rosettes 
is termed the rosette frequency (RF). For the invasion 
assays, rosetting cultures had a RF of above 65% and non-
rosetting cultures had a RE of less than 6%. 
Statistical analysis was done with Statview 5.0.1 soft-
ware. The invasion rates of isogenic rosetting and non-
rosetting parasites were analysed with a paired Student's 
t test, paired by experiment to control for variations in 
invasion due to RBC donor, RBC age, and human sera. 
The percentage inhibition of invasion by the MSP-1-42 
antibody of rosetting and non-rosetting parasites was ana-
lysed with a Student's t test. 
3. Results and discussion 
3.1. Invasion rates of isogenic rosetting and non-rosetting 
parasites 
We first set out to investigate whether isogenic rosetting 
and non-rosetting parasite lines derived from R29 and 
TM284 differed in their invasion rates under standard 
in vitro culture conditions. Over seven (TM284) or eight 
(R29) experiments, there was no significant difference in the 
invasion rates of the isogenic rosetting and non-rosetting 
lines (Table 1, P=0.86 and P=0.21, paired Student's t test, 
TM284 and R29, respectively). We therefore confirmed the 
previous findings of Clough' et at. that rosetting does not 
enhance invasion (Clough et al., 1998). 
3.2. Invasion rates of isogenic rosetting and non-rosetting 
parasites in the presence of antibodies to MSP-1 
To examine the hypothesis that rosetting may enhance 
invasion in the presence of host invasion-inhibitory anti-
bodies (Figs. 1A and B), we studied the invasion rates of 
isogenic rosetting and non-rosetting parasites in the pres-
ence of antibodies to MSP-1-42 (Singh et al., 2003). In two 
experiments with both TM284 and R29, we found that the 
isogenic rosetting and non-rosetting parasites did not differ 
significantly in the percentage inhibition of invasion in the 
presence of the M SP- i-42 antibodies (Table 2, P=0.62 and 
Table I 
Rosette frequency and invasion rate for two pairs of isogenic P. falcipa-
rum rosetting and non-rosetting parasites 
Strain 	Ra 	N 	RFb 	Invasion ratec 	Paired I t estd 
TM284 	R+ 	7 	74(4.8) 	6.7(l.6) 	P= 0.86 
R— 7 3(2.4) .6.6 (2.0) 
R29 	R+ 	8 	77(8.3) 	5.3(l.8) 	P= 0.21 
R— 8 2(1.6) 4.4(1.6) 
a R, rosetting phenotype; R+, rosetting; and R—, non-rosetting. 
RF, rosette frequency counted as percent iRBC binding two or more 
uninfected RBC; mean (standard deviation). 
Invasion rate is the number of ring-iRBC from triplicate or quadrupli-
cate wells from each experiment after 24 It invasion divided by the starting 
schizont parasitaemia; mean (standard deviation). 
d Paired t test for the invasion rate of the isogenic R+ and R— cultures 
paired by experiment to account for variations due to RBC age, RBC 
donor, and human sera. 
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2 
on inhibition of two pairs of isogenic rosetting and non-rosetting P. 
rum parasites 
Experiment R 	RFb Invasion rate' 	Inhibition   
Control MSP-1 Ab 
R+ 	70 	7.4 (1.2) 4.9(0.1) 	33.3 
R- 2 	6.8 (1.4) 4.7 (0.3) 30.2 
2 	 R+ 	68 	9.0 (1.2) 6.2 (0.9) 	31.2 
R- 0 8.7 (0.2) 5.2 (0.7) 40.2 
1 	 R+ 	76 	5.1 (1.2) 3.8 (0.3) 	24.4 
R- 0 	2.5(0.3) 1.8 (0.2) 28.0 
2 	 R+ 	76 	5.9 (0.3) 3.4 (0.2) 	42.9 
R- 0 	4.3(l.2) 3.1 (0.3) 28.9 
R, rosetting phenotype; R+, rosetting; and R-, non-rosetting. 
RF, rosette frequency counted as percent iRBC binding two or more 
rifected RBC. 
Invasion rate is the mean (standard deviation) number of ring-iRBC 
n triplicate wells after 24h invasion divided by the starting schizont 
Percent inhibition of invasion of the isogenic R+ and R- parasites in the 
tence of the MSP-1 antibody compared to the control invasion rate. There 
no significant difference in the inhibition between the R+ and R- para-
(P= 0.62 and P=0.63, Student's ttest, TM284 and R29, respectively). 
0 = 0.63, Student's t test, TM284 and R29, respectively). 
['he mean inhibition of invasion for rosetting parasites was 
13.0% (95% confidence interval 25.5-40.5%) and for non-
osetting parasites was 31.8% (95% confid6nce interval 
6.3-37.3%). Therefore, we found no evidence to support 
he hypothesis that rosettes protect merozoites from inva-
ion-inhibitory antibodies as hypothesised in Fig. IA. 
nstead, the data suggest that rosetting parasites are inhib-
ed by invasion-inhibitory antibodies to the same extent as 
Lon-rosetting parasites (Figs. I  and C). 
Although we have found no evidence to support the 
ypothesis that rosettes protect merozoites from invasion-
thibitory antibodies, because of the variation in the exper-
nents shown in Table 2, we cannot completely exclude the 
ossibility of a. minor difference in invasion inhibition 
etween rosetting and non-rosetting parasites. To increase 
ie sensitivity of these experiments, we attempted to iden-
fy a reagent that would provide greater inhibition of 
)setting for repeated assays, however, none of the other 
agents to MSP-1 and AMA-1 that were tested (see Sec-
on 2) showed any significant invasion inhibition in either 
29 or TM284. We also attempted to examine the inhibi-
ry effect of the MSP-1-42 antibodies on R29 and TM284 
iltures under shaking conditions, however, no inhibition 
1' invasion was seen when the cultures were shaken rather 
Lan static (data not shown). 
To ensure that our results were not due to rosettes being dis-
pted by the invasion-inhibitory antibodies, we assessed the 
lect of the MSP-1-42 antibodies on rosetting. For both R29 
id TM284, we found that the RF did not change in the pres-
ce of the MSP-1-42 antibodies (R29-control with no anti-
)dy 48% RF, 1.5mg1mi MSP-1-42 52% RF; TM284-control 
ith no antibody 83% RF, 1.5mg/mi MSP-l-42 84 1/o RF). 
It is unclear whether rosettes are stable during schizog-
ony or whether they break apart before the schizonts rup-
ture. Our results point towards the latter being the most 
likely possibility. This suggestion is consistent with previ-
ous findings showing that the RBC forming the rosette are 
not preferentially targeted during invasion (Clough et al., 
1998). 
In the invasion inhibition experiments (Table 2), the 
data show a trend towards rosetting R29 parasites having 
higher overall invasion rates than R29 non-rosetting para-
sites in the control cultures without added antibodies. How-
ever, as shown in Table 1, an analysis of a larger number of 
experiments does not support a significant difference in 
invasion rates between these isogenic lines. 
Although we have found no evidence to support the 
hypothesis that rosettes protect merozoites from invasion-
inhibitory antibodies, it remains possible that rosettes may 
affect the interactions of iRBC with other components of 
the host's immune system. Contact-dependent activation of 
natural killer cells-an important first line in innate immu-
nity against P. falciparum-has been reported (Artavanis-
Tsakonas et al., 2003), and this activation may not occur if 
uninfected RBC surround the iRBC. Contrary to this, bind-
ing of iRBC to dendritic cells has been shown to modulate 
the function of antigen-presenting cells to possibly delay an 
immune reaction (Urban et al., 1999), so rosetting may pre-
vent the binding of iRBC to receptors on the surface of 
dendritic cells and may promote dendritic cell activity. Fur-
thermore, rosettes may shield the iRBC from phagocytosis 
by macrophages and neutrophils. Future experiments will 
compare natural killer cell activation, dendritic cell modu-
lation, and phagocytosis of rosetting and non-rosetting par-
asites in an attempt to understand the biological function 
of rosetting. 
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